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Abstract
The aim of this project was to develop a marker system to analyse cell lineage in 
mouse skin. This should provide useful information on the usual size and organisation 
of clones in the epidermis and give some clues as to how cell replacement is normally 
controlled in the epidermis and to the possible location of the stem and progenitor 
cells. As there is no marker gene currently available in the murine epidermis a marker 
gene had to be designed and introduced. This was accomplished by generating 
transgenic mice with a novel marker gene inserted into their DNA. An Escherichia 
coli lac Z  gene was used as a cell marker and activated in single cells following 
treating the mice with a chemical mutagen. The marker could be activated by a point 
mutation in the sequence of an oligonucleotide inserted at the 5' end of the lac Z  gene, 
replacing the ATG initiation codon of the gene. Two different marking strategies were 
devised. One specific for the chemical mutagen N-nitro-N'-methyl-N-nitosoguanidine 
(MNNG) and the other for the chemical mutagen acetoxyaminofluorene (AAF). 
Oligonucleotides were designed, synthesised and cloned in front of the lac Z  gene to 
generate oligo//<zc Z fusion marker genes. Test constructs without initiation codons 
and control constructs with initiation codons were designed and cloned at the same 
time for both the MNNG and AAF strategies. The fusion genes were then tested in 
vitro by transfection in to murine epidermal cell lines. No expression was detected in 
the inactive marker gene designed to be activated by MNNG, whereas high expression 
was obtained from two control constructs which both contained and in-frame ATG 
initiation codon in the sequence of the oligonucleotide cloned into the lac Z  gene. The 
MNNG-responsive marker gene was shown to be activated in stably transfected murine 
epidermal cell lines in response to treatment with MNNG at a frequency of 
approximately 4.3 x 10'3 per clonogenic cell. Subsequently the work with the AAF 
strategy was discontinued as there was insufficient time to pursue both strategies and 
positive results had been obtained with the MNNG construct. Twenty-two transgenic 
founders were generated with three marker gene constructs (Act-LacZA, K5-LacZD and 
KS-LacZ^ by pronuclear microinjection of fertilised embryos. Lines of transgenic 
mice were bred from the founders and the expression of the marker genes were 
analysed. Expression from a control lac Z  fusion gene driven by a BKIII (keratin 5) 
promoter was detected by staining skin tissue with the chromogenic p-galactosidase 
substrate 5-bromo-4-chloro-3-indolyl p-D-galactoside (X-gal). The expression of the 
P-galactosidase protein was observed in the epidermal basal layer and the hair follicles 
of transgenic mice. The expression was highest in newborn mice and gradually
XIII
diminished as the mice reached adulthood. It was subsequently shown that targeting 
the expression of an activated H-ras oncogene to the epidermis with the same promoter 
results in a high frequency of malignant tumours. The implications of these results to 
the biology of the skin are discussed. Expression of the MNNG-activated test marker 
gene under the control of a (3-actin promoter was also detected. Activation of the 
marker gene was detected in serial sections of murine brain tissue from transgenic mice 
treated topically with MNNG at birth. No activation was detected in other tissues 
probably due to the low level of expression of the marker gene. The explanation of 
these results and the implications for developing a marker system to work efficiently in 
the epidermis are discussed.
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CHAPTER 1
Introduction.
1. Introduction
1.1 Stem cells and hierarchies.
During adult life tissues are characterised by differing rates of cell division (Lajtha, 
1979). The purpose of cell division is to maintain the number of cells, in a tissue, at a 
constant level by replacing those lost by death and injury.
Some tissues lose their capacity to divide almost totally. Most of the cells, in such 
organs, are formed during foetal development and are retained throughout adult life. 
This occurs in skeletal muscle and nerve tissues (Hall and Watt, 1989; Stockdale, 1992; 
Marvin and MacKay, 1992). Other body organs, e.g. the liver, retain the capacity to 
divide in response to the appropriate stimuli. The cell turnover and division rate in these 
tissues is usually low. The last category of tissues, such as blood, testis or stratified 
epithelia are constantly renewing. In these systems continual loss of mature functional 
cells is compensated by the division of more primitive cells.
There is considerable evidence that cell replacement, in body tissues, occurs via a 
proliferative hierarchy, which is populated by the division of stem cells. When these 
cells divide they produce progenitor cells which, although they retain the capacity to 
divide, are now committed to differentiate and form fully functional, mature cells. The 
progenitor population has the effect of multiplying each stem cell division and is 
therefore designated the transit amplifying population. These cells divide a number of 
times before becoming terminally differentiated, mature cells.
It is likely that the stem cells of renewing populations are multipotential. There is clear 
evidence in the haemopoietic system that a single undifferentiated cell is capable of 
giving rise to all the differentiated cell types of the blood including erythrocytes, 
lymphocytes, macrophages and polymorphonuclear leukocytes (Lemischka, 1992). The 
small intestine is another example of a renewing cell population. In this system there is 
evidence that columnar, mucous, enteroendocrine and Paneth cells are all descended 
from the same origin (Winton and Ponder, 1991).
Even in the epidermis there is tentative evidence that the stem cells are multipotential. It 
seems likely that cells responsible for populating the interfollicular epidermis are also 
capable of populating the hair follicles. When epidermis is transplanted from sites of the 
body which do not produce hair on to dermis from hair-producing sites the transplanted
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epidermis will start to produce hair (Sengel, 1986; Reynolds and Jahoda, 1992). Also 
cells which seem to be responsible for re-population and maintenance of the hair follicles 
are capable of differentiating in vitro to produce interfollicular epidermal cells (Lenoir et 
al., 1988).
The functions of these tissues are very similar. They are all designed to produce large 
numbers of mature functional cells which have a short life-span. Hence it may not be 
surprising that these systems should all operate in the same fashion. The haemopoietic 
system and the small intestine certainly both operate via a similar proliferative hierarchy 
despite markedly differing tissue organisation. That both of these tissues have evolved 
to operate in the same fashion suggests that these mechanisms provide some advantage 
to the tissue.
There are probably several reasons why tissues should operate via a hierarchy descended 
from a multipotential stem cell. Initially all the separate cell types in each tissue evolved 
from a common precursor cell i.e. a fertilised egg. The hierarchy probably allows a finer 
degree of control of the amount and type of cells produced. Signalling a stem cell to 
divide should result in the production of more cells than the division of a transit 
amplifying cell. If one cell type was more urgently required than another, then the 
balance of differentiation could be altered in favour of the required cell.
A system that operates via a multipotential stem cell also has the advantage of reducing 
the size of the stem cell compartment. Stem cells are by definition long-lived. This 
could potentially make them very sensitive to carcinogenic transformation. The smaller 
the stem cell pool, therefore, the fewer the number of targets in which this 
transformation can occur. Also if each stem-cell division is amplified by subsequent 
division of the committed progenitor cell this reduces the number of divisions through 
which the stem-cell must pass. This in turn reduces the chance of DNA damage to the 
stem cell during division.
In both the haemopoietic system and the small intestine the stem cells are kept in an area 
separated from the main functional area of the tissue. Stem cells for the blood are 
located in the bone marrow while the small intestinal stem-cell is located in the crypts. 
Both these tissues are to different degrees exposed to the environment. Keeping the 
stem-cells in an area removed from this exposure to the environment protects them from 
damage that could be inflicted by environmental factors. Separation of the stem-cells 
from the tissue allows the environment of the stem-cells to be very carefully controlled. 
Creation of a tightly controlled niche for the stem-cells allows fine control of their 
division and differentiation to properly re-populate the tissue. This carefully controlled
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environment is more easily generated for a small number of cells. This may be another 
factor which contributes to the generation of a hierarchy. As the stem-cells are vital to 
the renewal capacity of the tissue it is understandable that they should be well protected 
from environmental damage and kept under tight control.
Comparison of the skin to other systems would suggest there should be a proliferative 
hierarchy in the skin and that the stem cells for this hierarchy should be located in a well- 
protected niche, preventing environmental damage to the cells. The existence of a 
hierarchy can be confirmed by measuring the cell cycle times of keratinocytes in the 
basal layer. Analysis of the population by [3H]-thymidine labelling demonstrates the 
existence of populations of quickly and slowly cycling cells (Potten, 1981). Slowly 
cycling cells have been found in both the basal layer of the epidermis and in the hair 
follicle. The basal layer of the epidermis must be subject to extreme stress from the 
environment. The hair follicle may, therefore, represent a better niche in which groups 
of stem cells can be carefully controlled. There is evidence too that cells from the hair 
follicle are at least bipotential. They are able to differentiate to form interfollicular 
epidermis as well as hair follicle cells. There are however areas of skin without hair 
follicles and it is unlikely that these areas are regenerated from follicle stem cells. 
Tissues in areas without hair, such as monkey palm epidermis, are often organised in a 
more complicated fashion than the simple stratified epithelium found on the back of a 
mouse. This still suggests that follicle stem cells may not be required for epidermal 
maintenance. How homeostasis is maintained in the epidermis is still not fully 
understood.
One of the main problems in studying stem and progenitor cell populations is that they 
are defined by their potential, i.e. how they will behave. Removing these cells from their 
environment may alter how they behave. One way to get round this problem is to study 
cells in situ, by using an in vivo marking system. When cells responsible for replacement 
in the epidermis are marked they should give rise to areas of marked cells which are 
maintained throughout the lifetime of the animal. If the cells marked are not ultimately 
responsible for epidermal re-population, the marked clones produced by these cells will 
eventually be lost from the skin as these cells are replaced by the division of progenitor 
cells. Whether or not the cells identified by this technique are "true stem cells" is open 
to question. It may be that in the event of injury or damage that the lineage may go 
further back than the cells identified by this technique. A marking system should be able 
to identify cells which are responsible for epidermal cell maintenance and those cells 
which are around for long enough to act as targets for carcinogens.
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The aim of this project is to use an E. coli lac Z  gene as a marker to determine epidermal 
cell lineage in murine epidermis in vivo. The marker gene will be activated at fixed times 
by application of a chemical mutagen. Lineage analysis will be performed in vivo on the 
skin of transgenic mice carrying the marker gene. By examining the skin tissue of the 
mouse at varying lengths of time after gene activation in discrete cells, it should be 
possible to determine the normal patterns of proliferation in the epidermis. This will 
allow the identification of the cell population normally responsible for epidermal 
replacement.
1.2 Embryos and embryonic stem cells.
Nowhere is the concept of stem cells more clearly demonstrated than the development of 
an entire organism from a single egg cell. The process of embryonic development 
requires co-ordinated diversification of a multitude of different cell types from a single 
fertilised egg (Wolpert, 1988; Smith A. G., 1992; Gardner and Beddington, 1988). The 
first divisions of this cell produce a number of identical cells known as blastomeres each 
of which has the capacity to produce mature cells of every lineage. There is no evidence 
that, in mammals, the regional specification of the embryo is controlled by maternally 
derived determinants deposited in the egg. The subsequent division of the blastomere 
cells and the generation of cellular diversity is controlled by interactions between the 
cells and between the embryo and the environment.
The initial stages of embryonic development involve the creation and expansion of the 
extra-embryonic tissues and of the pluripotential founder cell lineage. This is supported 
by evidence from cell marking studies in which the ability of different populations of 
cells to contribute to tissues was analysed in chimeric mice created by fusing genetically 
distinct embryos from different mouse strains. The first separation which occurs is 
between the trophectoderm and the inner cell mass (ICM) (Johnson and Ziomek, 1981; 
Gardner, 1983). The cells of the trophoectoderm only generate the trophoblast (part of 
the placenta). The cells of the ICM are able to generate all the embryonic and extra- 
embryonic tissues except the trophoblast (Chisholm et al., 1985). The ICM is then 
divided into epiblast and primitive endoderm. The epiblast cells are found throughout 
the embryo except in the trophoblast and the extra-embryonic endoderm whereas the 
primitive endoderm cells are restricted to the colonisation of the parietal and visceral 
yolk-sac endoderm (Snell and Stevens, 1966; Gardner, 1985; Beddington, 1986).
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Despite their complexity, mammalian embryos exhibit a greater degree of plasticity than 
simpler embryos. It is possible to aggregate several murine pre-implantation embryos 
and generate a normally sized viable foetus. It is also possible to kill a large proportion 
of the cells of a murine blastocyst or egg cylinder and the embryos will still form a viable 
foetus (Snow and Tam, 1979). Thus the embryo has a large capacity to repair damage 
or injury. The repair capacity is dependent on the presence of pluripotential stem cells 
whose fate can be reprogrammed and the existence of a flexible signalling system to 
modulate the behaviour of the cells.
Grafting experiments show that these cells are not irreversibly committed to the 
formation of particular tissues and that the cells may contribute to any cell lineage 
(Grobstein, 1952; Beddington, 1982). Teratocarcinomas may be readily generated by 
ectopic grafts of cells from epiblast tissues from early embryos taken from inbred mouse 
strains (Stevens, 1970; Solter et al., 1970). These tumours are able to form multiple 
differentiated cell types and may be benign or malignant. The earlier the cells are 
removed from the embryo the more chance there is of malignancy (Damjanov et al., 
1970). These tumours are formed with such a high frequency it seems that the process 
is unlikely to involve a transformation event but instead is a result of the disturbance of 
the normal growth and differentiation of these cells (Stevens, 1983).
The teratocarcinomas contain a readily identifiable stem cell population known as 
embryonal carcinoma cells (EC cells). These cells may be readily propagated in culture 
and clonal lines can be established. In culture the cells often remain multipotent and can 
produces tumours containing a variety of cell types (Evans, 1972: Bemstine et al., 1973; 
Martin & Evans 1975). The cells in culture remain morphologically very similar to the 
ICM and epiblast cells (Martin, 1975; Martin, 1980). Some of these cell lines can be 
introduced and incorporated into a new blastocyst (Brinster, 1974; Mintz and Illmensee, 
1975; Papaioannou et al., 1975). The EC cells can then participate in normal 
development, contribute extensively to a variety of different tissues and can produce 
normal healthy chimeric animals. Despite the obvious pluripotentiality of these cells they 
rarely contribute to the germ line. This is probably because most of the EC cell lines are 
aneuploid and often show a reduced developmental capacity in vitro. As these cells are 
not normal their use in developmental studies in the mouse is obviously limited.
It was subsequently discovered that cells could be cultured directly from blastocysts 
when plated out onto a feeder layer of mitotically inactivated murine embryonic 
fibroblasts (Evans and Kauffman, 1981; Martin, 1981). These cells can be established 
from whole blastocysts as well as isolated epiblast cells and are now known as
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embryonic stem cells (ES cells). They are morphologically very similar to the EC cells 
possessing a prominent nucleus and very little cytoplasm. The cells are capable of 
differentiating to produce multiple cell types in vitro (Doetschman et al., 1985) and in 
vivo in teratocarcinomas (Evans and Kaufman, 1981). The cells can colonise blastocysts 
and contribute extensively to chimeric mice without generating tumours and very often 
have a normal diploid karyotype. The cells are capable of colonising the mouse germline 
and transmitting the ES cell genotype to normal offspring (Bradley et al., 1985). These 
cells seem to be a non-transformed pluripotential stem cell population.
Embryonic stem cells are able to integrate into a host blastocyst and participate in 
normal development (Beddington and Robertson, 1989; Lallemand and Brulet, 1990). 
The cells are therefore able to respond to, and generate the full repertoire of regulatory 
signals which control murine embryogenesis. These cells may be exploited in trying to 
characterise regulators of stem cells and their mode of action. It is possible that these 
regulators may be important not only in the control of stem cells during embryogenesis 
but may also be important in the control of stem cell populations in the adult.
Another important application of ES cells is their ability to generate transgenic mice 
(Robertson, 1986; Capecci, 1989). This is made possible as the ES cells will colonise 
the germ-line of mice when introduced into blastocysts. One of the main advantages of 
using this system is that defined mutations in specific genes can be generated. The 
selection of rare homologous integration events is possible when DNA is transfected into 
a murine embryonic stem cell line.
The study of embryonic stem cells has, along with renewing cell populations such as the 
haemopoietic system has established a number of principles for the maintenance of 
tissues by stem cells. The most important implication of the work with the embryonic 
stem cells is that as all tissues are originally derived from pluripotential stem cells it is 
likely they will be maintained by a similar cells to the ones from which the tissues were 
originally derived i.e. stem cells. This principle certainly holds true for the haemopoietic 
system and it is becoming increasingly obvious that other tissues with slower cell 
turnover rates (e.g. the liver and part of the central nervous system) are also maintained 
by the division of stem cells. The maintenance of tissues by stem cells is fast becoming a 
general rule of developmental biology rather than an exception for tissues with a high 
cell turnover rate. As the epidermis consists of a renewing cell population with a high 
turnover rate it seems likely that it will be maintained by the division of stem cells and 
there already exists a great deal of evidence that this is the case.
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1.3 Haemopoiesis and regulation of stem cells.
The haemopoietic system must be capable of regenerating cells throughout the lifetime 
of an animal. The turnover of cells in this system is very high. In the human this system 
needs produce as many as 3.7 x 1011 cells per day to replace cells lost by natural wastage 
(Dexter and Spooncer, 1987; Whetton and Dexter, 1993). The mature functional cells 
produced by this system have a high degree of specialisation. Erythrocytes are designed 
to carry oxygen and carbon dioxide. T and B lymphocytes are involved in the 
generation of specific immune responses. The function of platelets is to help blood clot. 
Macrophages and granulocytes are the general scavengers which also act as accessory 
cells for the immune system. Obviously, considering the high numbers of cells produced 
and the incredible diversity of function among these cells a tightly controlled system is 
required to regulate cell production.
This basis of this system is the production of all the cell types from a common set of 
multipotential stem cells. The stem cells originate in the yolk sac of the embryo and 
migrate to the foetal liver before moving on to the bone marrow, where most of the 
haemopoietic cell production occurs in the adult (Dexter and Spooncer, 1987).The 
number of stem cells is relatively small but they exist throughout life by generating a 
transit amplifying population which multiplies every stem cell division.
There is no easy assay for the presence of stem cells but evidence of their existence has 
been established. Following ablation of an animal's haemopoietic system with radiation 
or cytotoxic chemicals the entire tissue can be replaced if the animal is infused with 
normal bone marrow cells. Studies have shown that very few infused cells can replace 
the entire haemopoietic system of the animal. As little as 0.01% of the total number of 
bone marrow cells infused into a mouse can replace its entire complement of 
haemopoietic cells and the recipient animal will have a normal life span with a apparently 
normal haemopoietic system (Boggs et al., 1982; Schofield et a l ,  1986).
The mature cells in these radiation chimera experiments described above have been 
demonstrated to come from the transplanted donor cells (Abramson et al., 1977). 
Radiation-induced karyotype markers were used to tag the donor cells in a transplant 
experiment. The results showed conclusively that cells of both the myeloid and 
lymphoid lineages were derived from the same engrafted bone marrow cells. This 
finding was extended more recently when retroviruses were used to mark the progeny of
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single stem cells (Joyner et al., 1983; Williams et al., 1984; Lemischka et al., 1986; 
Lemischka, 1992). These pieces of evidence demonstrate that pluripotent stem cells of 
the haemopoietic system actually exist.
Attempts to isolate haemopoietic stem cells date back to the development of the in vivo 
spleen colony forming assay (CFU-S), which can be used to quantify stem cells (Till and 
McCulloch, 1961; Wu et al., 1968). This development of the CFU-S assay was 
followed a few years later by the description of an in vitro equivalent (Bradley and 
Metcalf, 1966). The limitations of these assays were recognised very shortly after they 
were described. It is possible by velocity or equilibrium centrifugation to separate the 
cells which give rise to splenic colonies from those which give rise to colonies in vitro 
(Worton et al., 1969).
Specific antisera raised against cell surface molecules provided a more sensitive method 
of separating distinct populations of haemopoietic cells at different developmental 
stages. This in combination with the fluorescence-activated cell sorter (FACS) allowed 
the populations identified by specific antisera to be separated from other cells and used 
in functional assays (Herzenberg and Sweet, 1976). This technology along with 
clonogenic assays similar to those described above allowed the isolation of a population 
of cells proposed to contain stem cells. This cell population was originally isolated from 
murine cells on the basis of expression of stem cell antigen (Sca-1), low expression of 
Thy-1 and the absence of a range of molecules found on maturing and mature 
haemopoietic cells (collectively called linneg). These cells were termed the Thy- 
l loLinnegSca-l+ subset (Spangrude et al., 1988; Spangrude, 1989).
It has subsequently been shown that these cells can be further divided on the basis of 
rhodamine 123 fluorescence (Bertoncello et al., 1985; Spangrude and Johnston, 1990). 
The Thy-1 toLinnegSca-l+Rhodu11 subset of cells does contain haemopoietic stem cells 
(Spangrude and Scollay, 1990; Smith et al., 1991). Single Thy-lk)LinnegSca-l+Rhodu11 
cells have been injected into lethally irradiated mice and been shown to generate clones 
containing T and B lymphocytes, monocytes and granulocytes. Long-term repopulating 
ability and secondary transfer was observed in a subset of the cells demonstrating that 
some of these cells satisfy the strictest definition of stem cells.
It is still not clear how individual stem cells actually contribute to the process of 
haemopoiesis. It is clear however that the stem cells seem to evolve. Stem cells purified 
from foetal liver by the same Thy-lloLinnegSca-l+ criteria as from adult bone marrow 
seem to have a different developmental potential from stem cells purified from adult
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bone marrow (Ikuta et al., 1990). For instance, only foetal stem cells have the capacity 
to differentiate into Vy3+ T-cells in the foetal thymic microenvironment (Harvan and 
Allison, 1988; Harvan and Allison, 1990).
A number of different approaches have been used to attempt to discover how individual 
stem cells contribute to steady state haemopoiesis during the lifetime of an animal {e.g. 
Mintz et al., 1984; Smith et al., 1991). If a small number of Thy-ltoLinnegSca-l+ cells 
are introduced to a lethally irradiated animal almost 10% of the cells contribute to the 
regenerative haemopoiesis. If 100 Thy-1 ^ Lin^Sca-1+ cells are injected usually about 8 
of them will contribute to the regeneration. Most of the clones generated by these cells 
contain multiple lineages including B and T lymphocytes, monocytes and granulocytes. 
The clones accounted for between 1 to 65% of circulating white blood cells and could 
be maintained for long periods of up to 1 year or more. There was no correlation 
between the clone size and the length of time for which the clone persisted. The reasons 
for the heterogeneity of this response remains unclear and may be due to an inherent 
difference in the self-renewal capacity of the cells or their opportunity to interact with 
different microenvironments that promotes a capacity for self-renewal.
When unique retroviral insertion sites are used as clonal markers for haemopoietic stem 
cells similar results were obtained (Keller et al., 1985; Dick et al., 1985; Lemischka et 
al., 1986). This work confirmed that stem cells could give rise to large multilineage 
clones which could account for the majority of peripheral blood cells. Analysis of the 
evolution of these clones has shown that the haemopoietic system can be repopulated 
oligoclonally after radiation. Initially, in the first few months after irradiation there 
seems to be extensive fluctuation of the repopulating clones. After a few months though 
an oligoclonal system is established which seems to persist indefinitely (Jordan and 
Lemischka, 1990: Capel et al., 1989; Keller and Snodgrass, 1990). In contrast when 
this experiment was repeated using a competitive repopulation assay the results indicated 
that the number of stem cells contributing to haemopoiesis was proportional to the 
number of cells introduced (Harrison et al., 1988 ; Ansell and Micklem, 1986).
In normal individuals, who have not been subjected to radiation the number of stem cells 
present is much larger than the dose given in any of the transplant experiments described 
above. The clonal composition of haemopoietic cells in females heterozygous for an X- 
linked marker gene was analysed. Analysis of humans (Fialkow, 1973) and mice 
(Micklem et al., 1983) in this way suggests usually about 20 clones contribute to 
haemopoiesis at any one time. Repopulation of the haemopoietic system can be 
achieved with small numbers of stem cells however it is likely that oligoclonal
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repopulation has been observed because limiting numbers of stem cells have been 
introduced.
In a normal mouse there are approximately 20 000 Thy-lloLinnegSca-l+ cells only 20 of 
which seem to contribute to steady state haemopoiesis. However when these Thy- 
l k)LinnesSca-l+ cells are injected into lethally irradiated hosts about 1 in 10 cells can 
contribute to the regeneration of the haemopoietic system. The cells must be activated 
in response to signals from the host, probably growth factors.
The processes of differentiation and commitment of cells in the haemopoietic system 
have been extensively studied by in vitro clonogenic soft gel cultures (Metcalf, 1977). 
Using such systems it is possible to distinguish multipotent stem cells from more 
committed progenitor cells. The way that all these cells respond in tissue culture is 
governed by growth factors. The development of both multipotential stem cells and 
lineage restricted precursor cells occurs only in the presence of growth factors. Cells 
will die irrespective of the stage of development they have reached if growth factors are 
removed from the culture (Metcalf, 1977; Dexter and Spooncer, 1987).
It is obvious that the growth factors are serving several separate functions, helping the 
cells to survive, differentiate and proliferate. A large number of the growth factors 
involved in these processes have now been purified and identified (e.g. GM-CSF: Gough 
et al., 1984). After identification the factors can be cloned and by making use of 
recombinant DNA technology large amounts can be produced and purified to 
homogeneity. This has allowed an assessment of the roles of different growth factors in 
haemopoiesis in vitro. The elucidation of the structure and function of growth factors 
and receptors will be important in understanding how stem cells make decisions about 
self-renewal and differentiation.
In analysing the behaviour of cells in a proliferative hierarchy such as the haemopoietic 
system it is important to realise that the environment or niche in which the cells are 
located plays a very important role in the development of the cells (Whetton and Dexter, 
1993; Graham and Pragnell, 1992; Ogawa, 1993). A vital component of this niche is the 
interaction of the cell with the surrounding network of stromal cells in the bone marrow 
(Dexter, 1982). Strong support for this concept comes from work done in vitro with 
long term marrow cultures (Dexter et al., 1984). Bone marrow derived stromal cells 
can support haemopoiesis in the absence of added growth factors, whereas stromal cells 
from other tissues such as liver are unable to support the system. Hence the bone 
marrow stromal cells must be providing the right extracellular matrix and growth factors
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to support the growth and development of the haemopoietic cells. Some 
myeloproliferative disorders have been shown to be caused by defects in the stromal 
cells rather than the haemopoietic target cells e.g. the steel (SI) and dominant white 
spotting (W) loci (McCulloch et al., 1964; McCulloch et al., 1965). These loci have 
subsequently been discovered to encode the haemopoietic stem cell growth factor, SCF, 
and its receptor c-kit (Geissler et al., 1988; Zsebo et al., 1990; Huang et al., 1990).
It has now been established that stromal cells and resident bone marrow macrophages 
produce a variety of cytokines (Shirai et al., 1993; Temeles, 1993). Some of these, such 
as stem cell factor (SCF), can be produced in both soluble and membrane bound forms 
and may have a dual role to play acting as both an adhesion molecule and a growth 
factor (Williams et al., 1992). Many of the cytokines produced by the bone marrow 
stromal cells interact specifically with components of the extra-cellular matrix 
(Gordon,1991; Gordon et al., 1987). The interactions of the cytokine with components 
of the extra-cellular matrix such as heparin sulphate proteoglycans may be important in 
preventing proteolysis and help promote specific interactions between the cytokine and 
its target cell (Roberts et al., 1988).
Haemopoietic progenitor cells have been shown to bind directly to extracellular matrix 
components which are produced by stromal cells (Siczkowski et al., 1992). The 
modification of the proteoglycans alters the affinity with which the progenitor cell bind 
to the extra-cellular matrix. This may allow the creation of specific microenvironments 
which can help to control the behaviour of the progenitor cells. The idea of distinctive 
microenvironment within the bone marrow stroma is supported electron microscopy 
studies of femoral tissue. A 110 kDa protein was localised to a small proportion of 
stromal cells which are associated with sites of B-cell lymphopoiesis (Jacobsen et al., 
1992).
The growth factors which help to control haemopoiesis and their receptors are now 
being identified and purified. The effect of the growth factors have on the behaviour of 
stem cells and other cells in the proliferative hierarchy is now being characterised. Some 
of these effects are probably quite complex and cytokines will act synergistically in 
combination with other growth factors. The story is far from complete but it seems likely 
that other hierarchical systems of cell replacement may be controlled by growth factors 
in a similar fashion. It may be possible to better understand the control of cell growth in 
the epidermis by understanding how the growth control is achieved in other systems 
such as haemopoiesis. Already there is evidence that a protein, M IP-la, acts as an
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inhibitor of both haemopoietic stem cells (Graham et al., 1990) and epidermal stem cells 
in vitro (Parkinson et al., 1993).
1.4 Cell hierarchies in the crypts of the small intestine.
The adult mouse intestinal epithelium contains four principal differentiated cell types. 
These cell types are columnar enterocytes, goblet cell, enteroendocrine cells and Paneth 
cells. These cells are produced and constantly renewed in a well ordered manner. 
Studies performed on mice indicate that the four principal cell types are produced from a 
common multipotential stem cell located near the base of the epithelial structures known 
as the crypts of Lieberkiihn (Cheng and LeBlond, 1974b; Kirkland, 1988).
There are approximately 300 to 550 cells in each ciypt depending on its location in the 
small intestine (Gordon et al., 1992; Potten and Loeffler, 1990). Cell division in the 
intestine is confined to the crypt. About two thirds of the cells in the crypt divide every 
12 hours and the crypt produces between 300 and 400 new cells per day. About 13 to 
16 cells leave the crypt every hour and migrate up the surrounding villus as they 
differentiate.
Cell differentiation and migration are tightly linked in the mouse intestine. Enterocytes, 
goblet cells and endocrine cells mature as they migrate up the villus in an orderly fashion 
from the crypt to the villus apex. The cells are subsequently shed into the intestinal 
lumen. The whole process of migration takes around 2 to 3 days (Wright and Irwin, 
1982). Paneth cells differentiate as they descend to the bottom of the crypt. The Paneth 
cells remain at the bottom of the crypt for about three weeks before they are removed by 
phagocytosis (Cheng and Leblond, 1974a). Again the number of crypts per villus is 
dependent on the location of the villus. In the proximal duodenum there are about 14 
crypts per villus whereas in the ileum there are only six crypts per villus. In the colon 
there an no villi and the cells migrate out into a hexagonal surface epithelial cuff 
surrounding the orifices of the crypts (Schmidt et al., 1985a).
Tritiated thymidine labelling and clonogenic radiation assays have provided insights into 
the number and location of stem cells in the mouse intestinal epithelium (Potten and 
Morris, 1988; Potten and Loeffler, 1990). It is obvious that the highly functional Paneth 
cells at the bottom of the small intestine cannot be the stem cells. The cells leaving the 
crypt no longer divide and cannot form the stem cell compartment. The stem cells must
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be located within the 200 - 350 cells in the crypt which are actively dividing. Analysis of 
the morphology of the crypt leads to the conclusion that the stem cells are most likely to 
be located in the ring of epithelial cells which is positioned just above the Paneth cells at 
the bottom of the crypt.
A number of studies have looked at the cell cycle times in each of the different positions 
in the crypt (Potten, 1986). The length of the cell cycle time decreases as cells move up 
the crypt into the villus. After a continuous labelling with [3H]-thymidine the cells which 
retain label for the longest time seem to be located towards the base of the crypt 
suggesting that the stem cells which should be more slowly cycling than the transit 
amplifying population are more likely to be located in the lower part of the crypt.
There are a number of potential problems associated with this type of kinetic data. As 
cells are continually moving up the crypt it is hard to determine the original position of 
the cell when it was initially labelled. It is also hard to estimate the fraction of non­
proliferative cells at a given position in the crypt. The small number of mitoses at the 
bottom of the crypt make it hard to obtain statistically significant data. It is also possible 
that the result could be affected by Circadian fluctuations and that the radioactive label 
may disturb the kinetics of the tissue. It has been shown that some of the cells near the 
base of the crypt may be especially sensitive to irradiation.
Regenerative clonogenic assays have been used to attempt to determine the number of 
stem cells in each crypt {e.g. Withers and Elkin, 1969; Withers and Elkin, 1970; Potten 
and Hendry, 1985; Hornsey, 1985; Potten et al., 1983). The results from the use of this 
technique really estimates the number of potential stem cells in the tissue and this may 
not actually represent the number of cells which would normally act as stem cells in the 
unmanipulated tissue. The estimate obtained from this method is that each crypt 
contains about 30 - 40 potential stem cells (Potten et al., 1987). The number of 
potential stem cells identified by this technique changes depending on the dose of 
radiation administered. As the radiation dose is increased so the estimate of the stem 
cell number increases. This suggests that the more severe the tissue injury, the greater 
the number of cells which can respond to the damage by proliferation. This could be 
explained by more differentiated transit cells replacing the damaged stem cells to repair 
the injury. Crypts can be sterilised by exposure of the bottom part of the structure to 
weak (S particle radiation (Hendry et al., 1989). This confirms that the majority of cells 
in the upper portion of the crypt are unable to act as stem cells in the tissue. It is very 
likely that the number of actual stem cells in the tissue is less than the number of 
potential stem cells in the tissue. The best estimate from the kinetic data is that each
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crypt contains about 4 - 1 6  stem cells located directly above the Paneth cells (Loeffler 
and Grossman, 1990; Potten and Loeffler, 1990).
Cell marking techniques have also been used to analyse the organisation of stem cells in 
the mouse intestinal epithelium and produce a different estimate of stem cell number in 
the intestine. One method of cell lineage marking that has been adopted is X- 
inactivation in mice. X-inactivation is a random process which occurs in female mice by 
embryonic day 6. Stem cells and their descendants will express only the allele of a gene 
which is on the chromosome which is not inactivated (MacMahon et al., 1983). Female 
mice were used which were heterozygous for a two phosphoglycerate kinase alleles 
(Pgk-la / Pgk-lb) which code for different isozymes that can be separated by 
electophoresis. When whole crypts are microdissected from adult heterozygous female 
mice each crypt only expressed one allele or the other (Ponder et al., 1985). This result 
was confirmed using another enzyme marker located on the X-chromosome glucose-6- 
phosphate dehydrogenase (G6PD). This alleles of this enzyme G6PD and G6PDX are 
separated in situ by a histochemical stain. Small intestinal crypts from heterozygous 
females were examined (Griffiths et al., 1988). Analysis of 400 000 crypts demonstrated 
that the structures were monoclonal, derived from a single stem cell.
This hypothesis has been supported by other cell lineage markers located on other 
chromosomes. Aggregation chimeras were prepared by fusion of blastocysts of two 
strains of mice which varied at the major histocompatibility locus H-2. The embryos 
fused contained either the H-2k or the H-2b allele (Ponder et al., 1983). Specific 
antibodies were used on the tissues of the chimeric mice to differentiate between the 
cells descended from each progenitor population (Ponder et al., 1986). Again during 
the analysis of several hundred thousand crypts in adult mice no mixed crypts were 
observed suggesting the crypts were monoclonal in origin.
The results of the chimeric mouse experiments were extended in small intestine by 
application of a different marker system. The Dlb-1 locus on chromosome 11 codes for 
the expression of a binding site for the carbohydrate lectin, Dolichos biflorus (Ponder et 
al., 1985b; Uiterdijk et al., 1986). The gene has two codominant alleles, Dlb-la 
determines expression of the carbohydrate locus on the vascular epithelium but not on 
intestinal epithelium. The other allele Dlb-lb determines expression of the carbohydrate 
on the intestinal epithelium but not in the vascular (Ponder et al., 1983; Schmidt et al., 
1985b). Aggregation chimeras were constructed by fusion of inbred mouse strain 
embryos that were homozygous for the Dlb-la allele with embryos homozygous for the 
D lb-lb allele. The cells in the small intestine expressing the D lb-lb allele are easily
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detected by staining the tissue with a peroxidase conjugated lectin. Bands of staining 
cells were seen to stretch out of the DBA-positive crypts to the top of the adjacent 
villus. Villi in tissue preparations from adult mice are composed of cells from several 
crypts and were seen to contain bands of cells from wholly positive or wholly negative 
crypts. Crypts containing DBA-positive and DBA-negative cells were never observed. 
It could be shown that the three cell types enterocytes, goblet cells and Paneth cells in a 
crypt had the same DBA phenotype (Schmidt et al., 1985a; Ponder et al., 1985a). This 
work agrees with earlier studies that suggest that intestinal crypts are monoclonal in 
origin and also shows that the villi are polyclonal, composed of cells derived from 
several different crypts.
Although the use mouse embryo aggregation chimeras is an extremely powerful tool for 
looking at the organisation of stem cell hierarchies the technique has a few drawbacks. 
It is possible that cells of a similar genotype may tend to group together and 
produce an artificial degree of monoclonality in the crypts (MacLaren, 1976). Also it is 
not possible to mark cells at various stages of development.
These problems were overcome by the development of a mutation assay. Breeding of 
the mouse strains which are homozygous for the different alleles results in the 
production of mice which are heterozygous and have one copy of each allele of the gene. 
These heterozygote mice can then be treated with a mutagen or under go spontaneous 
mutation which will oblate expression of the gene on the intestinal epithelium by 
mutating the D lb-lb locus in the occasional cell (Winton et al., 1988; Winton et al., 
1989; Schmidt et al., 1990; Winton et al., 1992).
If the cell mutated is a multipotential stem cell then after a sufficient time period all the 
cells in each crypt would either stain with the lectin or not stain with the lectin. This 
would imply that each crypt is derived from a single cell. If crypts were derived from 
multiple stem cells a mutation in the D lb-lb locus in one stem cell should only prevent 
expression in some of the cells in each crypt. If a shorter time period is left after 
mutagen treatment of the intestine clones may be present which only cover part of each 
crypt. This would probably be the result of mutation of cells in the transit amplifying 
population which are eventually replaced by division of the stem cell at which time the 
crypt cell population becomes uniform. It would also be possible to detect stem cells 
present in the embryo which may generate large patches of wholly positive or wholly 
negative cells.
These expectations were confirmed by analysis of the spontaneous mutation rates of the 
allele of heterozygous mice in whole mounts of the intestine stained with the peroxidase-
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conjugated lectin (Winton and Ponder, 1990; Winton et al., 1991; O'Sullivan et al.,
1991). In young adult animals, single or groups of two or more negative crypts were 
seen at a frequency of approximately 4 crypts per intestine examined. As the animals 
aged the frequency of single negative crypts but not of groups of negative crypts 
increased. The increase is in the region of 1-10 x 105 crypts per year in each intestine. 
Wholly negative crypts are seen to accumulate at a similar rate to mixed crypts in serial 
section of intestinal epithelia. The presence of mixed crypts indicates that there is 
probably a transit amplifying population present.
Chemical mutagens can be used to increase the number of mutations observed and 
analyse the maintenance of the stem cell hierarchies in the adult mouse. In the small 
intestinal crypt, mutations were induced in heterozygote Dlb-la /  D lb-lh mice with the 
point mutagen ethlynitrosourea (ENU). ENU is an ideal mutagen for this purpose as it 
has a high mutation rate, relatively little cytotoxicity and it is metabolised quickly 
(Schmidt et al., 1990). The results generated led to the conclusion that a single 
multipotent stem cell maintains each small intestinal crypt in the adult mouse. This type 
of analysis was also performed in the colonic crypt epithelium with the X-inactivated 
G6PD gene (Griffiths et al., 1988). Patches of low enzyme activity were observed in 
normal C3H mice treated with dimethyl hydrazine (DMH). These patches were similar 
to that observed in the colon of heterozygous G6PD-deficient mice. The patches of low 
enzyme activity were restricted to whole crypts. This suggests that the colonic crypt in 
the adult is also maintained by a single stem cell. No mixed crypts were observed when 
using this technique which suggests that there were no mutations in the transit 
amplifying population or that the transit cells were cleared very quickly.
Earlier studies with chimeric animals suggested that as the crypts develop in the 
postnatal animal they are gradually organised into monoclonal structures. Crypts of 
mixed origin are found in the epithelium of 2 day old chimeric animals (Schmidt et al., 
1988). The villus ribbons associated with these crypts are not coherent but consist of 
patches of similar cells. As the animal matures these crypts are gradually organised into 
the monophenotypic pattern described in the adult. By postanatal day 10 the epithelium 
resembles that found in the adult, all the crypts are derived from single progenitor cell 
types and the crypts are associated with ribbons of cells stretching up to the tip of the 
villus. The mechanism by which this occurs has yet to be determined. It is possible that 
a single stem cell takes over the crypt or that the stem cells are | distributed when new 
crypts are formed by invagination of the intervillus epithelium or by crypt fission.
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Transgenic mice have also been used to analyse the stem cell hierarchy present in the 
intestine of the mouse. The liver fatty acid binding protein (L-FABP) is expressed in 
both hepatocyes and enterocytes (Sweetser et al., 1988; Roth et al., 1990). It is 
activated in enterocytes as the cells begin to differentiate (Roth et al., 1991a; Cohn et 
al., 1991). It is expressed at relatively high levels in the proximal small intestine and 
expression declines progressively towards the distal ileum (Sweetser et al, 1988). The 
promoter used was part of the rat Fabpl gene (Sweetser et al., 1986). The expression 
of the transgene in the intestinal epithelium was more widespread than that of the wild- 
type gene (Roth et al., 1990; Sweetser, et al., 1988). Inappropriate expression was 
observed in a variety of cell types and in the large intestine of adult transgenic animals. 
As the mice aged expression was gradually switched off. This started at the distal colon 
and gradually progressed to the proximal segments of the intestine.
All cells of an individual crypt were seen to express the transgene at the same level 
(Roth et al., 1991b). Mixed crypts containing cells with varying expression levels were 
never observed. Furthermore the crypts were often grouped into small patches of tissue 
which had similar expression levels. These observations are consistent with the 
hypothesis that a single multipotent stem cell is responsible for populating the intestinal 
crypts. The expression of the transgene in co-ordinated patches may imply that the 
crypts are derived from a single progenitor cell. This cell may even maintain clusters of 
crypts in the adult mouse. It is also possible that patches of cells may have been derived 
from one crypt by the process of crypt fission.
Another property of the stem cells present in the murine intestine is that these cells will 
maintain their identity if they are removed from their normal environment. The cells 
from different sections of the intestine undergo slightly distinct programs of 
differentiation. If tissue is transplanted from various sections of intestine from mouse 
embryos on day 15 to 16 of development and grafted into subcutaneous tissue of nude 
mice the tissue is vascularised and continues development. The cells in the graft express 
markers which are appropriate for the tissue of origin of the graft (Rubin et al., 1991; 
Rubin et al., 1992). The same conclusion is reached when analysing the tumours of 
multiple intestinal neoplasia (Min) mice (Moser et al, 1990). Traces of differentiating 
cells are found in the spontaneous tumours which arise throughout the intestine of these 
mice. The differentiation programme of the cells in these tumours is always appropriate 
to the area of the intestine in which the tumour arose (Moser et al., 1992). These 
studies suggest that the stem cells are able to express positional information irrespective 
of its surrounding environment.
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1.5 The existence of stem cells in adult liver.
The existence of stem cell hierarchies have long been postulated in rapidly proliferating 
tissues such as the adult haemopoietic system described above. Recently though similar 
hierarchies have been proposed to exist in more quiescent tissues such as adult liver 
(Sigal et al., 1992; Thorgeirsson, 1993). Liver is characterised by a long cellular life 
span and although the tissue retains its capacity to divide in response to the appropriate 
stimuli, the turnover rate in this tissue is very low.
The structure of the liver is very well defined. The tissue is divided up into a large 
number of functional units of hepatic parenchyma. The functional unit, called the acinus, 
is composed of a cylinder of hepatic parenchymal icells surrounding a central vein, or 
terminal hepatic venule (Jones and Spring-Mills, 1983). The acinus is divided into three 
zones which are based on the microcirculatory pattern (Campara and Reynolds, 1989). 
Zone 1 is the region nearest to the portal triad and is termed the periportal region, zone 2  
is the central region and zone 3 is the region surrounding the terminal hepatic venule. 
There are marked morphological, biochemical and functional differences between the 
hepatocytes located in each of the three zones (Jungermann, 1986; Traber et al., 1988). 
Cells in zone 1 are smaller than the cells in zone 2  which are of intermediate size. The 
cells in zone 3 are larger than the cells in the other zones (Loud, 1968). Other 
differences are observed in the morphology of mitochondria, endoplasmic reticulum and 
glycogen granules. Cells in zone 1 are usually diploid but in zone 2  and 3 the cells are 
increasingly polyploid (Wilson and Leduc, 1948). Cells from zone 1 have a greater 
proliferative capacity than those in zone 3 (Gebhardt, 1988). There are differences in 
gene expression between cells in the different zones. Enzymes for glycolysis and 
glycogen synthesis are restricted to zone 3 (Andersen et al., 1983; Jungermann, 1986) 
whereas expression of a-fetoprotein is restricted to the periportal cells. Other changes 
in gene expression between the cells in different zones have also been observed.
The explanation of the differences between these cells has often been assumed to be that 
the liver cells are adapting to the environment which surrounds them (Andersen et al., 
1983; Jungermann, 1986; Traber et al., 1988). As blood flows unidirectionally through 
the sinusoid from the portal J triad to the terminal venule the cells in zone 3 must be 
exposed to different concentrations of metabolites after cells in zones 1 and 2  have 
removed them from the blood. The cells in the various zones then adapt to the various 
concentrations of oxygen, substrates and hormones (Bennet et al., 1987; Shiojiri et al., 
1991; Kanamura and Asada-Kubota, 1980).
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This idea is supported by a study which shows that the direction of blood flow in the 
liver does alter the expression of many genes, including glycolysis, gluconeogenesis and 
oxygen consumption. This study was performed by retrograde perfusion of the liver 
which reverses the direction of the blood flow (Thurman and Kauffman, 1985). 
However expression of other genes such as a-fetoprotein or glutamine synthase are not 
effected (Bennet et al, 1987; Gaasbeek-Janzen et al., 1987). If zone 3 hepatocytes are 
transplanted to the spleen they retain their capacity to produce cytochromes P-450b and 
e in response to sodium phenobarbitol (Maganto et al., 1990). Zone 1 cells do not 
usually produce these proteins and upon transplantation to the spleen the cells remain 
unable to respond to phenobarbitol. This response is not dependent the direction of 
blood flow or the sinusoidal microenvironment.
A possible explanation of the remaining differences between the cells in different zones is 
that the cells are at different stages of maturation. Rare mitoses seem to be present 
equally spread throughout the zone (Messier and LeBlond, 1960). It is usually thought 
that all hepatocytes have an equal capacity for proliferation, despite the heterogeneity in 
gene expression. Arber et al. (1988) have proposed that in adult liver stem cells give 
rise to a cell hierarchy similar to that found characterised in other tissues. This is 
supported by the evidence suggesting cells migrate from the periportal region to the 
central region. After injection of rats with tritiated thymidine labelled cells are first 
observed next to the portal triad within 300 pm of the rim of the acinus. The cells then 
move at a speed of 2.5 {im per day until they reach the terminal hepatic vein in the centre 
of the acinus about 148 days later.
This not only supports the idea of a stem cell compartment but seems to confirm that the 
heterogeneity of gene expression observed in the cells occurs because these cells are at 
different stages of maturation. The liver stem cells do not seem to expand quickly in 
response to liver damage (Farber, 1984), however this could be due to a lag phase 
before stem cell activation. Stem cell activation is only likely to occur when there is 
severe damage to the mature cells.
Studies of carcinogenesis provide further evidence of the existence of stem cells (e. g. 
Evarts et al., 1987; Germain et al., 1985; Germain et al., 1988a; Snell, 1983). 
Transformation occurs usually in a population of small cell in the periportal region. 
These cells have been termed oval cells and consist of scant cytoplasm and a relatively 
large ovoid nucleus. These cells have been proposed as the stem cells in the adult liver, 
although the normal cellular couterparts to the transformed oval cells have yet to be 
identified. The oval cells are morphologically similar to bile duct cells but possess
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features of hepatocytes. The oval cells are able to divide to produce hepatocytes in vitro 
(Evarts et al., 1987) and can form hepatocyte colonies in vivo when transplanted into 
the liver (Evarts et al., 1989). These cells have been shown to differentiate to bile duct 
cells in vitro (Hayner et al., 1984). This suggests that the liver stem cells may be 
multipotential and suggests that the cells may have a similar pattern of differentiation to 
hepatoblasts isolated from embryonic liver (Germain et al., 1988b).
This idea is further enhanced by work which suggests that oval cells similar to those 
found in the liver are also found in the pancreas (Reddy et al., 1984; Rao et al., 1990). 
The oval cells from the pancreas show very similar patterns of gene expression to the 
oval cells of the liver. The oval cells in the pancreas proliferate when copper deficiency 
is induced in experimental rats. The proliferation of oval cells is accompanied by the 
atrophy of acinar cells in the pancreas. When the rats are returned to a normal diet the 
pancreas is seen to contain a number of hepatocytes, suggesting that the oval cells of the 
pancreas are also able to differentiate to the hepatocyte lineage.
1.6 Lineage studies and stem cells of the nervous system.
During embryonic development changes in the morphology and gene expression reflect 
the division of the neuroepithelium into regions which correspond to the major 
subdivisions of the adult central nervous system. Neurons and glia are formed during 
development on a precise schedule (McKay, 1989; Marvin and McKay, 1992). The 
neurons are generated first followed by the different types of glia. Neuronal precursor 
cells are found only in the developing brain in mammals however quiescent glial 
precursors are retained in the adult brain. In this system the stem cells seem to have a 
limited life span in vivo as the stem cells for the majority of the tissue are lost soon after 
birth.
Thymidine labelling studies carried out on the cerebral cortex show that it develops from 
the inside out (Angevine and Sidman, 1961; Rakic, 1988). Cell division takes place in 
the ventricular zone and the progeny of the dividing stem cells migrate outward once 
they have become post-mitotic. When new neuronal cells are created they must migrate 
past the older cells to their assigned positions. This migration is disrupted in the reeler 
mutant mouse which leads to the formation of a cerebral cortex with inverted layers 
which are highly disorganised (Caviness and Sidman, 1973). The cells are still able to 
make the connections appropriate for their birthdates (Caviness, 1976; Drager, 1981;
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Lemmon and Pearlman, 1981). The mechanism by which neurons acquire their identity 
is therefore independent of the process of migration in these cells (McConnell, 1991). A 
series of elegant transplantation experiments demonstrated that the neuronal cells 
become committed to a particular fate within 4 hours of their final S-phase and migrate 
accordingly (McConnell, 1988; McConnell and Kaznowski, 1991). These results in 
combination with the results obtained in the reeler mutant mice indicate that multipotent 
neuronal stem cells become committed to a specific fate, in response to extracellular 
signals, when the cells are located in the proliferative ventricular zone of the 
neuroepithelium.
Cell lineage analysis, along with cell culture and transplantation, has proved to be a 
powerful technique for analysis of the potential of neuronal stem cells (Sanes et al., 
1986; Price et al., 1987). One technique that has been used for this is the injection of a 
tracer dye into single cells. This has been applied to the study of vertebrate systems 
including zebra fish (Kimmel and Warga, 1987) and Xenopus (Hartenstein, 1989; 
Jacobsen 1985; Holt et al., 1988). It is restricted to large, accessible cells and has not 
been feasible in the study of the mammalian nervous system. The dye also become 
diluted as the cell divides making it hard to detect after a number of cell divisions. 
Another approach used has been the generation of chimeras by the fusion of primitive 
cells or embryos (Balaban et al., 1988; Goldowitz, 1989; Herrup, 1986). This technique 
does not really provide information about the lineage of single cells. The technique most 
widely used in the analysis of the mammalian nervous system has been the infection of 
the cells with retroviruses. Retroviral marking exploits the fact that retroviruses 
integrate a DNA copy of their genome into the DNA of the host. By using replication 
incompetent retroviruses any gene of interest can be transferred to a dividing cell (Cepko 
et al., 1984; Cepko, 1988; Sanes, 1989; Walsh and Cepko, 1990). A virally transmitted 
(3-galactosidase gene can be used as a simple, histochemical marker which is not diluted 
and passed on to all the progeny of the infected cell (Price et al., 1987; Price, 1987; 
Sanes etal., 1986) .
In many parts of the nervous system individual ventricular cells can give rise to a wide 
range of neuronal cell types (Turner and Cepko, 1988; Turner et al., 1990). Single 
progenitor cells can give rise to all types of neuron in the retina (Wetts and Fraser, 1988) 
and this is also the case in the optic tectum of the chick (Gray et al., 1988; Galileo et al., 
1990). In the spinal chord of both Xenopus (Hartenstein, 1989) and chick lineage 
(Leber et al., 1990) mapping experiments show that progenitor cells can produce both 
motor neurons and intemeurons. The fate of these cells can be altered by transplantation 
showing that the precursor cells are probably uncommitted (Placzek et al., 1990;
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Yamada et al., 1991). In the cerebral cortex clusters of neurons with a wide variety of 
morphologies located in different layers have been described although some lines of 
evidence suggest that early progenitors may give rise preferentially to cells in deep or 
superficial layers (Price and Thurlow, 1988; Walsh and Cepko, 1992; Austin and Cepko, 
1990; Walsh and Cepko, 1990).
Progenitor cells are not only capable of differentiating to produce many neuronal cell 
types but even glial cells as well (Luskin et al., 1988; Williams et al., 1989). Retinal 
neurons and Muller glial cells can differentiate from a common precursor cell even 
during the final cell division (Turner and Cepko, 1987; Wetts and Fraser, 1988). 
Common precursors have been detected in the chick optic tectum and the spinal cord. 
In the optic tectum clones have been observed which include neurons, astrocytes and 
radial glia (Galileo et al., 1990). In cerebral cortex the case is somewhat different. If a 
precursor cell exists for both neurons and glia it must represent a very small percentage 
of the precursor population. Most neurons are derived from cells which give rise to 
neurons alone (Luskin et a l,  1988).
Primary culture of cells from the rat optic nerve has led to the identification of glial 
progenitor cells which may act as stem cells involved in cell replacement in the adult 
central nervous system (Raff and Lillien, 1988; Noble et a l,  1992). In this system there 
is evidence that the stem cells in the adult tissue are different to the progenitors present 
during tissue development and that the stem cells of this system may be capable of 
asymmetric division.
In culture the 0-2A cell can give rise to both oligodendrocytes and type-2 astrocytes 
(Raff et al., 1983a,b; Ffrench-Constant and Raff, 1986). 0 -2A cells taken from the 
perinatal rat optic nerve can be induced to divide or differentiate by co-culture with 
type-1 astrocytes or by addition of platelet-derived growth factor (PDGF)and basic 
fibroblastic growth factor (bFGF) to the culture medium (Bogler et al., 1990; Wolswijk 
et al., 1989). Similar 0-2A progenitor cells can be identified in tissue from both 
perinatal and adult rat optic nerve (Wolswijk and Noble,1989; Wolswijk et al., 1990).
Comparison of the two cell populations show that they possess different properties. 
When cultured with type-1 astrocytes the 0 -2 k adult cells have a unipolar morphology 
whereas the 0-2APerinatal cells are usually bipolar (Wolswijk and Noble, 1989; Small et 
al., 1987). The adult progenitors had a longer cell cycle time and were less motile than 
their counterparts derived from perinatal tissue (Wolswijk et a l ,  1989; Noble et a l ,  
1988). Evidence suggest as the animals mature the 0-2APerinatal cells are replaced by
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cells of the 0-2Aadult type (Wolswijk et al., 1990) and work done in vitro indicates that 
some 0-2Aperinatal cells can be induced to generate 0-2Aadult progenitor like cells when 
co-cultured with purified cortical astrocytes (Wren et al., 1992). Cells of the O- 
2\pennatai symmetrically to produce larger populations of progenitor cells whereas 
their adult counterparts divide asymmetrically to generate one stem cell and on 
differentiated cell (Temple and Raff, 1986; Wren et al., 1992).
These results suggest that the 0-2Aadult cells represent a stem cell population present in 
the adult nervous system (Noble et al., 1992). The cells are continuously present 
throughout the life of the animal. They may be multipotential, giving rise to both 
oligodendrocytes and type-2 astrocytes although the existence of the latter cell type in 
vivo is disputed. There is also evidence that the 0-2Aadult cells can divide 
asymmetrically which is another property which stem cells have been postulated to 
possess (Lajtha, 1979). The cells can also be distinguished from their counterparts 
which are present during embryonic development.
1.7 Stem cell concepts.
The previous sections of this manuscript have discussed the properties of stem cells in 
two of the tissues, intestinal epithelium and the haemopoietic system in which they have 
been most widely studied. Also the prospects are examined for the application of the 
knowledge acquired about the behaviour of stem cells to other tissues in which the stem 
cells are less well characterised such as the liver and the central nervous system. The 
work on ES cells has shown that all tissues are originally derived from a common set of 
multipotential stem cells during embryonic development.
As well as the tissues described above a number of other tissues have been proposed to 
contain stem cells in the adult mouse. These include renewing tissues such as the testis 
(De Rooij, 1988) and in addition to skin other epidermal tissues such as the tongue 
(Potten, 1981), the limbal epithelium of the eye (Cotsarelis et al., 1989; Thoft et al., 
1991; Tseng 1991) and the epithelia of the breast (Rudland and Barraclough, 1988; 
Barraclough and Rudland, 1990) and the uterus (Padykula, 1991). Also other tissues 
such as cartilage (Solursh, 1989) have been proposed to contain stem cells.
It seems to be becoming more clear that cell replacement in most if not all tissues occurs 
via a proliferative hierarchy. This is true not only of the tissues with a fast turnover rate
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such as the haemopoietic system but also in tissues which have slower rates of cell 
division such as the liver. A great deal of work has been done on studying the 
proliferative hierarchy of cells and the control of this hierarchy in the haemopoietic 
system by growth factors {e.g. Sachs, 1987; Dexter and Spooncer, 1987; Spangrude et 
al., 1991; Whetton and Dexter, 1993; Ogawa, 1993). It is likely that there will be 
parallels between the haemopoietic system and other tissues proposed to contain stem 
cells in both the organisation and control of the proliferative hierarchy. The lessons 
learned from the study of haemopoiesis and other tissues such as intestinal epithelium 
should be take into account when analysing the behaviour of stem cells in other tissues.
As the epidermis of the mouse is a renewing tissue with a fast cell turnover rate this 
make it a good candidate tissue for the study of stem cells. Stem cells have already been 
proposed to exist in the epidermis. It is now almost 20 years since the epidermal 
proliferative unit was proposed by Potten (1974) and evidence for the organisation of 
epidermal keratinocytes into a proliferative hierarchy was discovered. The location of 
the stem cells and the organisation of the proliferative hierarchy in this tissue still 
remains a mystery. Contradictory lines of evidence suggest that the stem cells may be 
either located in the epidermal basal layer or in the hair follicles. The study of the 
epidermis has an advantage over that of the haemopoietic system as all the cells in the 
tissue remain in the one location and are not constantly moving round the body. This 
allows an in situ analysis of cell lineage to be used to analyse the proliferative hierarchy 
in the skin. The disadvantage is that the cells are not so easily dissaggregated and sorted.
The project described in this thesis has been directed toward the generation of an in situ 
marking system which can be used to analyse cell lineage in the skin. The remainder of 
the introduction discusses the evidence for the existence and the location of epidermal 
stem cells.
1.8 Epidermal structure.
The epidermis is arranged into a series of cell layers (Matoltsy, 1986). The outer layers
are composed of homy keratin-filled squames, which protect the organism from the 
environment. Cells in the inner layers are undergoing the process of differentiation to 
form the comeocytes. The most primitive cells in the innermost layers are capable of 
division and divide to replace cells lost from the top layers.
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Epithelial cells are the major components of the epidermis, constituting about 85% of 
the cells in the basal layer, but other cells are present in smaller numbers (Potten, 1974; 
Potten, 1976; Potten, 1981). The other cells include Langerhans' cells and melanocytes. 
The epithelial cells are arranged into four distinguishable layers (Matoltsy, 1986). These 
layers have been called the basal, spinous, granular and squamous layers on the basis of 
the morphology of the cells in each layer. The basal layer is located on the basement 
membrane, directly on top of the dermis. Cells move up through the layers as they 
differentiate to form an anucleated keratin-filled squame.
The epithelial cells in the basal layer are small cells with a high nuclear : cytoplasmic size 
ratio. These cells are involved in proliferating to provide cells for the differentiating 
layers. Cells leave the basal layer and move up into the spinous layers. As they do there 
is a large increase in the cytoplasmic volume of the cell and the keratinocytes start to 
synthesize the specific proteins and lipids which help to perform the protective functions 
of the squamous layers. As the cells continue to move up they pass through the granular 
layer where keratohyalin granules become visible in the cytoplasm of the cell. As the 
cells move up into the stratum comeum they release enzymes which attack and degrade 
all the organelles. The soluble components of the cell flow out into the extracellular 
space. The cellular keratin filaments fold up as the cell compacts to form a tough
squame and interdigitates with others as it does so.
In simple stratified epithelia, such as the trunk skin of the mouse, the differentiating cells 
are arranged in columns. Each column is made up of a simple stack of 10 - 15 single
differentiating cells (MacKenzie, 1969). Each of these columns rests on top of a group
of 10 - 12 smaller basal cells (MacKenzie, 1970). This is obvious when looking in 
transverse section through stained epithelial sheets. The hexagonal outline a single 
differentiating cell can be seen overlying a circular group of basal cells (Potten, 1974). 
In this system the only site of cell division is the basal layer and hence it is the obvious 
potential location for stem cells.
In more complex epithelia, such as monkey palm epidermis, there are more cell layers. 
These layers undulate into alternate shallow and deep ridges (Lavker and Sun, 1983). 
Cell division in this tissue occurs not only in the basal layer but, more frequently, in the 
suprabasal layers. On the basis of morphology the cells at the bottom of deep ridges are 
considered to be more primitive than the cells elsewhere in the epithelium. They have a 
higher nuclear : cytoplasmic size ratio, fewer keratin filaments and a larger number of 
melanosomes. The melanosomes are believed to provide protection for the cells against 
damage by ultraviolet radiation. On this basis these cells have been proposed to 
represent the stem cells for this tissue.
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This hypothesis can be strengthened by measuring the cell cycle times. The first cells to 
incorporate [3H]-thymidine are cells in the suprabasal layers. This indicates that these 
cells have a relatively fast cycle time. If the labelling is continued for a long period of 
time until most of the cells are labelled and left for a long chase period, the cells which 
remain labelled for the longest period of time are the cells at the bottom of the deep 
ridges. This suggests that these cells are the most slowly-cycling population. An 
obvious conclusion from this data is that the more slowly cycling cells on the basal layer 
are the progenitors of a transit amplifying population found in the suprabasal layer.
1.9 Kinetic analysis of epidermal cell renewal.
1.9.1 Epidermal proliferative unit.
The basal layer of the epidermis is the only site of cell division in simple stratified 
epithelia as found on the trunk of a mouse (Potten, 1974). This population of cells was 
classically considered to be homogeneous, i.e. all the basal cells had an equal capacity to 
proliferate. Examination of the cells found here show that 15% of the cells are non- 
keratinocytes and will not contribute to the epidermal cell compartment. The remaining 
population of keratinocytes has been shown to consist of cells which are at various 
stages of the cell cycle, as well as some cells which may be post-mitotic (Wright, 1983).
It can be clearly demonstrated that cells in the mouse epidermis are organised in 
columns. If the epidermis is removed carefully so the columns are intact, it is possibleto see 
a group of approximately 10 - 1 2  basal cell underlying a single column of differentiating 
cells (Potten, 1974; MacKenzie, 1969; MacKenzie, 1970). This figure can be confirmed 
by counting the number of differentiating cell columns per mm2 and comparing this with 
the number of basal cell nuclei per mm2. If this is done the number of basal cell nuclei is 
approximately 10 times the number of differentiating cell columns in the same area. This 
supports the idea that a single differentiating column overlies about 10 basal cells. As 
cells in the skin are relatively immobile, Potten proposed that the differentiating cell 
column was the product of the division of the basal cells beneath the column. According 
to this theory each differentiating column was populated only by the underlying group
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of basal cells. The structure was termed an epidermal proliferative unit and it was 
predicted that each separate unit should contain its own stem cell.
1.9.2 Proliferative indices.
There are many ways to examine the population kinetics of a tissue such as the 
epidermis. The simplest of these methods are the mitotic index or the labelling index. 
These measurements indicate the proportion of cells which are at a particular stage of 
the cell cycle. The mitotic index is easily measured by counting the number of mitoses in 
an epidermal section and is usually somewhere in the vicinity of 1 - 2% for cells in the 
basal layer of murine epidermis (Iverson et al., 1968; Wright, 1983).
The labelling index is calculated by injecting [3H]-thymidine into the mouse either 
systemically or intradermally. The [3H]-thymidine is taken up by the dividing cells and 
identifies the number of cells in S phase. The thymidine is completely broken down after 
40 minutes and this technique represents a flash exposure to the label. The number of 
cells in S phase identified by this method is usually in the range of 2 - 10%, although this 
if complicated by a pronounced circadian rhythm of division in the epidermis (Weinstein 
et al., 1984). The problem with these methods is that they require assumptions about 
other phases of the cell cycle i.e. an increase in the number of cells in S phase could be 
due to an increase in the length of this phase as well as an increased proliferative rate. 
These methods are not very informative for analysis of the behaviour of individual cells.
1.9.3 Cell cycle analyses.
A more informative method of looking at the proliferation is to look at the rate of entry 
of cells into a particular phase of the cell cycle (Duffill et al., 1977; Wright & Appleton, 
1980). The mitotic rate or birth rate can be measured by local or systemic exposure to a 
drug, such as vincristine, which has the capacity to arrest cells in metaphase. It does this 
by interfering with the function of the mitotic spindle. By looking at the accumulation of 
cells which are arrested in metaphase it is possible to calculate the birth rate of cells in 
the tissue. When this technique is used to look at mouse skin the birth rate is around 
0.0093 cells cell-1 hour _1. It is also possible to look at the entry of cells into S phase by 
labelling twice with tritiated thymidine.
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Another method used to examine cell proliferation in the epidermis is to look at transit 
time of [3H]-thymidine labelled cells to the comified layers of the epidermis. For mouse 
epidermis this is about 5 - 9  days, although this method has a tendency towards 
minimum values as the first cells to reach the upper layers of the epidermis will be 
counted (Epstein and Maibach, 1965). There is a discrepancy when comparing the time 
for flash-labelled cells to reach the upper layers of the epidermis and the known transit 
rate of cells through the cell layers. This is consistent with the cells spending 2 - 3 days 
on the basal layer, maturing before migrating to the suprabasal compartment. This is 
further evidence of the heterogeneity of cells on the basal layer of the epidermis.
Perhaps the most powerful technique for estimating the length of the cell cycle in the 
skin is to determine the fraction of labelled mitoses. This method is based on counting 
the number of dividing cells which are labelled after a pulse of tritiated thymidine. 
Samples are taken at regular intervals after administration of a pulse of label and the 
percentage of mitoses which are labelled, is calculated. There is an initial rise as the cells 
labelled in S phase begin to go through mitosis. The lag time of this curve represents the 
length of S phase for the labelled cells. This is followed by a reduction in the percentage 
of labelled dividing cells which increases again when then initially labelled cells, which 
have already divided once, divide again. The length of time between the occurrence of 
the two peaks provides an estimate of the cell cycle time in the tissue.
The two published estimates of the cell cycle time in murine trunk epidermis predict a 
cell cycle time of 80-110 hours (Hegazy and Fowler, 1973; Wright, 1983). In the first of 
these as much as 80% of the cells labelled in the first peak appeared to contribute to the 
second peak although this is considerably less in the second experiment which estimates 
about 20-30% of the cells in the first peak contribute to the second. Some cells 
contributing to the first peak in this experiment do not ever go back into S phase. 
Obviously there is insufficient evidence to make any firm conclusions from this type of 
experiment. The results do suggest some variability in the length of cell cycle times in 
the epidermis. This can be explained by the existence of a possible hierarchy in which 
the progenitor cells have a slower cycle time.
There are problems in interpreting the data from such an experiment. This approach 
assumes that the cell population in the epidermis is asynchronous i.e. all the cells are at 
varying stages of the cell cycle. In the epidermis this is not the case as there is a 
pronounced circadian rhythm in this tissue. Another problem occurs when labelled cells 
migrate to the comified layers. Here the cells undergo nuclear degradation and release 
their breakdown products into the extracellular spaces. The breakdown products can be
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reutilised by other cells which may become labelled if they use tritiated thymidine from 
other cells.
1.9.4 Label retaining cells.
Another method to analyse cell production rates in vivo is to use a continuous labelling 
technique. This involves continuous exposure to [3H]-thymidine until all the cells in the 
epidermal basal layer become labelled. The labelled cells are analysed at a series of time 
points after administration of [3H]-thymidine has been stopped. The faster cycling cells 
effectively dilute the label left in their DNA as they divide while more slowly cycling 
cells appear to retain label for longer periods. Hence this method can be used to identify 
slowly cycling cells in the epidermis. After about 100 hours of continuous exposure 
approximately 95% of cells in the basal layer are labelled (Hamilton and Potten, 1972). 
This is surprising as 15% of the cells are non-keratinocyte cells which are assumed to be 
post-mitotic. This technique works optimally when used on newborn mice, although it is 
still impossible to label all the cells and examination of labelled skin reveals that some of 
the unlabelled cells are almost certainly keratinocytes (Potten, 1981).
If skin is transplanted and examined in vitro it can be shown that some cells acquire label 
at a significantly lower rate than others, suggesting that these cells have a slower cycle 
rate (Barrandon and Green, 1987; Fusenig, 1986; Dover and Potten, 1983; Jensen et al., 
1985; Watt, 1988). These cells appear to be located in the centre of the postulated 
epidermal proliferative unit. This result can be confirmed by labelling epidermis in vivo. 
Approximately one month after epidermis has been continually labelled for a week a low 
number of cells can be seen to retain label (Morris et al., 1985). These cells are 
presumably slow-cycling and are located towards the centre of the epidermal 
proliferative unit. Electron microscopy performed on skin treated in this way 
demonstrates that most, though not all, the label-retaining cells (LRCs) are keratinocytes 
(M orris^ al., 1986).
It is impossible to exclude the possibility that these cells are prevented from cycling by 
damage inflicted by the [3H]-thymidine uptake. It is unlikely that this would delay cells 
for more than a few hours. 24 hours after treating skin with 12-#-tetradecanoylphorbol- 
13-acetate (TPA) it is possible to distinguish labelled mitoses. This suggests that it is 
still possible for these LRCs to divide. It can be shown by double-labelling experiments 
with [3H]-thymidine and [14C]-benzo(a)pyrene that the slowly cycling cells also retain 
carcinogen for long periods of time. One unexplained feature of the label retaining cells
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is that they seem to be more strongly labelled than expected. There is greater than a 
two-fold difference between the labelling in the LRCs and other cells in the skin 
suggesting that the cells must have a very slow cell cycle or that mechanisms operate in 
these cells to conserve the label (Potten, 1981).
If skin containing LRCs is disaggregated and the cells plated out in culture then the 
colonies formed usually contain several lightly labelled cells in the middle (Potten and 
Morris, 1988). This suggests that the LRCs have divided in the formation of the cell 
cluster. If the same procedure is carried out on skin which has been pulse-labelled then 
the resultant colonies, if they contain labelled cells at all, contain only single labelled cells 
and very often, do not include any. Obviously this indicates the cells labelled by pulse- 
labelling do not divide in the production of keratinocyte cultures in vitro. This suggests 
that the LRCs have a greater proliferative capacity than other cells in the epidermal basal 
layer.
Kinetic data reveals that there is considerable heterogeneity among keratinocytes in the 
epidermal basal layer of simple stratified epithelia. There is considerable evidence to 
support the existence of a cell hierarchy presumably populated by the occasional division 
of slowly cycling stem cells. In continuous labelling experiments it is never possible to 
label all the cells in the epidermal basal layer. It is impossible to tell if these are post­
mitotic mature cells or very slowly cycling cells. Most of the experiments are 
compatible with the idea of the epidermal proliferative unit as proposed by Potten. 
However kinetic labelling experiments do not provide definitive evidence of the 
existence of a proliferative unit. The result of kinetic experiments in the crypts of the 
small intestine estimated that the stem cell compartment consists of between 4 - 1 6  
actual stem cells per crypt (Potten and Loeffler, 1990). However there is quite clear 
evidence from lineage analysis in this tissue that a single stem cell is sufficient to 
populate an entire crypt and there was no suggestion that crypts are usually populated by 
more than a single cell. Attempts using aggregation chimeras to examine patch size in 
the skin failed to provide any visual evidence of the existence of discrete proliferative 
units in the skin. In summary, although kinetic data strongly suggest the existence of 
proliferative units in the skin they do not provide definitive evidence and the possibility 
of stem cells in other locations in the skin further complicates this debate.
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1.10 Hair follicle stem cells.
1.10.1 Outer root sheath cells.
Slowly cycling cells have also been shown to exist in the hair follicles. These cells retain 
label in the same fashion as the cells located in the epidermal basal layer. Administration 
of [3H]-thymidine twice daily for one week from day 3 after birth is sufficient to label 
nearly all the cells in both the epidermal basal layer and in the hair follicles. 4 weeks 
after labelling LRCs were found in the bulge area of the outer root sheath (Cotsarelis et 
al.t 1990). This is in the sheet of cells surrounding the hair , just underneath the 
sebaceous gland. No LRCs were found in the matrix area of the hair near the dermal 
papilla.
This suggests that the slowly cycling cells in the hair follicle are located in the bulge area 
of the outer root sheath and that the cells surrounding the hair bulb near the dermal 
papilla are the transit amplifying population. It had previously been assumed that stem 
cells for the hair follicle would be located near the bulb of the hair beside the dermal 
papilla. The existence of LRCs in the bulge area of the outer root sheath in newborn 
mice can be confirmed in adult mice using a continuous supply of [3H]-thymidine 
administered by an osmotic pump. If skin was treated with TPA during the initial stages 
of the labelling process more cells in the bulge area were seen to be labelled. This 
suggests that bulge cells are stimulated to divide by application of TPA.
The bulge cells have also been distinguished as carcinogen-retaining cells and may be 
important target cells during multi-stage chemical carcinogenesis. The formation of 
tumours during this process has been strongly correlated with the stage of the hair cycle 
the mice were undergoing at the start of treatment. The yield of tumours increases when 
the treatment is started during the resting phase of the cell cycle when the cells of the 
outer root sheath would probably be more accessible to carcinogenic chemicals. This 
also implies that a large number of the tumours derived in this system come from the hair 
follicle.
Cells in the bulge area have also been characterised ultrastructurally by electron 
microscopy. They seem to be primitive cells expressing very few differentiation 
markers. These cells have a high nuclear : cytoplasmic ratio and very sparse expression 
of keratin proteins. There would be advantages of locating stem cells in the bulge area 
of the outer root sheath. The stem cells would be located in the permanent portion of
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the hair follicle whereas the cells near the dermal papilla undergo cyclic degradation 
during the catagenic phase of the hair cycle. This area may be resistant to plucking as 
cells from the outer root sheath are often left behind and the bulge area is further away 
from the hair shaft that cells surrounding the papilla. The bulge area is a well 
vascularised area of the follicle which should help maintain the stem cells in a stable, 
well-nourished, environment.
In a previous report it had been shown that outer root sheath cells were capable of 
shifting their differentiation to form cells which have an interfollicular epidermal 
phenotype when cultured under suitable conditions (Coulomb et al., 1986; Lenoir et al, 
1988). When plucked human scalp hair follicles are implanted on dermal equivalents the 
regeneration of epidermis seems to be better than epidermis formed by disaggregated 
basal keratinocytes treated in the same fashion (Asselineau et al., 1986). It seems 
unlikely that this could be due to contamination of the preparation with interfollicular 
keratinocytes, as both the upper and lower portions of the outer root sheath were 
equally capable of generating epidermis in vitro. If the result was due to contaminating 
keratinocytes a greater number should be present in the upper portion of the outer root 
sheath which is closer to the rest of the epidermis. It is to impossible to detect any 
interfollicular keratin production in any of the cells in the outer root sheath.
The bulge area of human scalp is much less pronounced than that found in hairs from 
either the human trunk or the skin of mice. It is quite possible that cells from the bulge 
area are more easily removed by plucking and it could be these cells which are 
responsible for generating the interfollicular type epidermis.
This finding was confirmed and extended in another study which demonstrated that a 
shift to interfollicular phenotype was also observed when disaggregated outer root 
sheath cells were cultured on dermal rafts at the air-liquid interface (Limat et al., 1991). 
In this case the epidermis produced was not quite as well differentiated as that produced 
by the keratinocytes treated in the same manner. However the keratinocyte cultures 
differentiated more quickly resulting in the loss of viable cells. Cultures set up from the 
outer root sheath cells appeared to be more primitive , but maintained a viable epidermis 
for longer than the keratinocyte cultures. The cells from the outer root sheath started to 
express markers of keratinocyte differentiation which they do not normally express.
The findings of the reports cited above are quite compatible and suggest a location for 
epidermal stem cells other than the basal layer of the epidermis. It is obvious that there 
are slow-cycling potential stem cells located in the permanent portion of the hair follicle. 
It is equally obvious that these cells are quite capable of generating interfollicular
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keratinocytes. The bulge area of the outer root sheath represents a good environment 
for stem cells in a well nourished and probably easily controllable area. Cells located in 
the epidermal basal layer must be exposed to considerable environmental stress in a 
highly changeable surrounding. Cells in the basal layer may also be susceptible to 
mechanical damage more readily than cells in the hair follicle. Hence the bulge area of 
the outer root sheath seems an equally probable location for epidermal stem cells as the 
basal layer. It seems possible that the basal layer stem cells are temporary stem cells 
which are replaced by the division of cells in the follicles.
1.10.2 Germinative cells.
Although there is considerable evidence which identifies the outer root sheath as the 
location of stem cells in the hair follicle, other work suggests another possible location 
(Reynolds and Jahoda, 1991a, b). This work suggests that the stem cells may be located 
in the cell layer which is directly opposed to the dermal papilla. This layer has been 
termed the germinative layer. Cells from this layer are capable of proliferating and 
forming organotypic structures when cultured with dermal papilla cells. Other hair cell 
types such as outer root sheath cells or basal epidermal cells do not show any response 
when cultured with dermal papilla cells, but attached to dishes and proliferated when 
cultured with skin fibroblasts.
There may be several problems in designating these cells as stem cells for the hair 
follicle. The cells do not seem to be slow cycling. The only slow cycling cells found in 
the hair follicle which retain radioactive label for long periods were located in the outer 
root sheath. The germinative cells are not located in the permanent portion of the hair 
follicle. As the hair goes through its normal cycle part of the follicle is lost and then 
regenerated.
The germinative cells seem to be located in the part of the follicle which is lost during 
the cycle. Secondly it seems likely that outer root sheath cells are capable of 
regenerating the population of germinative cells once the lower end of the follicle bulb is 
removed. A piece of evidence which strongly supports this idea is the induction of hair 
follicles by the dermal papilla in glabrous epidermis (Jahoda and Reynolds, 1993; 
Jahoda, 1992). This suggests that epidermal stem cells are capable of forming both the 
interfollicular epidermis and hair follicles.
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There is no evidence to suggest that germinative cells are capable of differentiating 
towards the interfollicular epidermal phenotype although work from the same group 
indicates that hair follicles can be induced in glabrous epidermis (Reynolds and Jahoda,
1992). When cultured along with skin fibroblasts these cells remained inactive. It 
therefore seems unlikely that these germinative cells could be the stem cells for both the 
follicle and the interfollicular epidermis. It is possible however that the environment 
generated in culture was not suitable to support the transdifferentiation of these cells 
from the follicular to the epidermal phenotype. Another potential problem with this 
study is that while it was necessary to prepare germinative cells by careful dissection the 
outer root sheath cells were prepared from plucked hairs. Obviously this may have 
damaged or left behind any potential stem cells.
One possible explanation of these observations is that the germinative cells could be a 
transit amplifying population derived from the outer root sheath cells. The transit 
amplifying population then become able to respond more easily to the signals from the 
dermal papilla. It is perhaps not very surprising that dermal papilla cells are capable of 
inducing the transdifferentiation of glabrous adult epidermis. After all it seems unlikely 
that the epidermis in different areas of the body would be composed of different cells 
types. The differences between epidermis in different body sites are probably generated 
in response to the different environments. Epidermis in all areas of the body is likely to 
contain the same type of multipotential stem cell. It would obviously be of interest to 
attempt to discover which cells in glabrous epidermis are affected by the dermal papilla. 
It would be also be interesting to discover whether dermal papilla cells are capable of 
inducing new follicle production in normal interfollicular epidermis.
1.11 Identification of clonogenic cells in the epidermis.
Another method of analysing the division capacity of epidermal cells is to look at the 
response of cells to damage and how the damage is repaired by the tissue. If all cells in 
the basal layer were equally capable of acting as stem cells then it would be expected 
that all cells would be equally capable of responding to damage by proliferating (Potten 
and Hendry, 1973; Potten, 1981). This idea can be tested by treating skin with radiation 
in vivo.
This technique was originally developed in vitro. Cells plated out at low density divide 
without very much movement and hence form exponentially growing colonies. By
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applying a size and time limit on the number of divisions required to produce a colony it 
is possible to estimate the number of clonogenic cells which have been killed by the 
treatment. This technique can also be applied to in vivo situations.
It is hard to determine the proper shape of the curve in vivo, because only the very high 
dose regions can be determined. This usually produces a straight line. This straight line 
can be worked back to a zero dose to give a figure for the total numbers of clonogenic 
cells in the epidermis. This does not take into account however that there would a 
shoulder on the curve as cells would be capable of surviving and repairing a certain 
amount of radiation damage. The shoulder on the curve can be estimated by analysing 
split level data i.e. giving two separate doses of radiation which are equivalent to a 
single dose given at the same time and analysing the difference between the two. 
Sufficient time must be must be allowed to elapse for cells to repair the damage inflicted 
by the first dose. This should give an estimate of the repair capacity of the cells.
The number of cells in the basal layer of the epidermis usually works out to be 
approximately 1.5 x 104 cells per mm2 in the interfollicular epidermis, and approximately 
the same number in the hair follicles. This gives a figure of about 3.0 x 104 total basal 
cells per mm2. Extrapolation of the straight line obtained for cell response to radiation 
results in a figure of about 1.0 x 106 clonogenic cells per mm2. When the figure of 
clonogenic cells per mm2 is estimated by using split level data it works out between 309 
to 1107. This represents about 2 to 7% of the total basal cells and roughly correlates 
with the number of proliferative units as proposed by Potten (1974). This suggests that 
there may be one clonogenic cell and hence one stem cell per proliferative unit.
In the same studies it was noticed that there are some especially efficient clonogenic 
cells located in the hair follicles. These cells were often seen to produce bigger colonies 
than their interfollicular counterparts and colonies derived from follicles were often able 
to produce hair. These data again indicate the possibility that hair follicle cells may be 
more primitive, less well differentiated cells than interfollicular keratinocytes and may be 
better able to act as stem cells for the interfollicular epidermis.
1.12 Cell lineage analysis and marking.
The ability to trace cell lineages is critical to the study of many developmental 
phenomena. Analysis of cell lineages allows us to determine the number of cells that 
give rise to a given structure, the rate at which cells grow and the origin of the various
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cell types that form a tissue in the mature animal (Crick and Lawrence, 1975; Ponder, 
1987). Cell marking is a technique which can be used to identify single cells or groups 
of cells and their descendant clones in an animal. It can be used to identify cell lineages 
and to analyse the contribution a cell makes to a tissue during normal or abnormal 
development.
This technique has been used to great effect in tissues such as the intestinal crypts, 
haemopoietic system and the central nervous system as described earlier (Hall and Watt, 
1989; Winton and Ponder, 1991; Marvin and MacKay, 1992). The application of this 
technique to the analysis of cell division and replacement in the skin should help to 
reveal how cell turnover is controlled. Analysis of clone size should contradict or 
support the current theories on the location of epidermal stem cells either in the basal 
layer of the epidermis or in the outer root sheath of the hair follicle.
There are several properties a marker should possess in order to make it useful (Ponder 
1987). Firstly it should be cell-autonomous i.e. its expression should be limited to cells 
of the appropriate genotype and not diffusible into other cells. Ideally it should be stably 
expressed under all conditions. It is important that the marker should not affect the 
behaviour of the marked cells in any way. It must also be detectable in situ if the marker 
is to be used to analyse the organisation of single cells or groups of cells in a tissue.
An ideal marker would be expressed in all tissues at all stages of development, however 
it is unlikely that this would ever be achieved in practice. This is not required if the 
study is limited to a particular tissue. It is also helpful if both populations are marked 
otherwise it is necessary to assume that the unmarked cells belong to the other 
population which is not necessarily the case. If attempting to look for small groups of 
cells in a tissue it is much better that these cells be the marked cells for positive 
identification.
1.12.1 Cell lineage analysis in Caenorhabditis and Drosophila.
Cell lineage experiments in invertebrates have been designed to elaborate how the cells 
of the embryo are capable of generating the adult. Intuitively there are two possible 
ways that cells may be induced to form the patterns required for the development of 
adult organs. Cells may divide to generate large clumps of cells used to make adult 
organs with no regard to their ancestry. An alternative method of pattern formation 
would be that the entire lineage of a cell would be invariant. Cells would divide in a
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fixed an pre-programmed pattern to generate organs arising from specific sets of related 
cells.
The latter method is almost exactly what happens during development in the small free- 
living nematode Caenorhabditis elegans (Gilbert, 1994; Schierenberg 1989). The work 
done with this organism demonstrates the enormous potential of lineage studies. These 
studies along with the extensive work on the genetics of the organism have ensured that 
C. elegans has become a well-known model organism for developmental biologists. 
This organism has a number of favourable properties for the study of embryogenesis. 
The embryo can develop outside the mother in a drop of water. The embryo is small 
and the eggshell is transparent allowing development to be observed conveniently under 
the microscope. The developmental process is rapid and take less than 12 hours from 
fertilisation to hatching.
These advantages in combination with the simplicity and reproducibility of the 
development of this organism has allowed the entire cell lineage of the nematode to be 
determined both throughout embryonic development and post-embryonic stages 
(Sulston and Horvitz, 1977; Sulston et al., 1983; Kimble and Hirsch, 1979). It is 
possible to write this out in the form of a branching tree. Cell lineages were visualised in 
the developing embryo under a microscope with Nomarski optics. The embryonic cell 
lineage is essentially invariant giving rise to a total of 671 cells during development of 
the nematode, 113 of which undergo programmed cell death. In the nematode the 
patterns of division, programmed death and terminal differentiation are constant from 
one individual to another. During post-embryonic development approximately 10% of 
the cells continue to divide eventually generating about 1000 somatic cells in the adult 
and about 2000 germ cells a few days after hatching.
Analysis of normal embryogenesis in C. elegans has produced some insights into the 
developmental principle which underlie the formation of the embryo (Strome and Wood, 
1983; Sulston et a l,  1983). In the first hour after the onset of cleavage in the embryo 
five somatic founder cells (termed AB, MS, E, C and D) and the primordial germ cell 
(P4) are created by a series of unequal divisions. Most of the founder cells contribute to 
a number of different tissues. Most tissues are derived from more than one founder cell. 
The gut and the germ line however arise solely from single founder cells, E and P4 
respectively. Bilateral symmetry seems to originate very early within the establishment 
of individual lineages. This happens as early as the first division in the MS, C and D 
lineages. Even during the last division of a cell it is possible for it to give rise to two 
different cell types.
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Programmed cell death occurs during the formation of the nematode from the embryo. 
More than 100 cells die at specific positions during embryogenesis. Mutations which 
prevent this type of programmed cell death do not cause abnormal phenotypes on the 
adult worms (Ellis and Horvitz, 1986). Cell death is not therefore a prerequisite for 
normal development. The patterns of division and establishment of sublineages are 
repeated throughout the maturation of the embryo. This makes it likely that the different 
lineages were established by a process of duplication and divergent evolution.
Two fundamentally different cleavage patterns are observed during the process of 
development in the nematode embryo. During generation of the germline an unequal 
division of cells is observed similar to that proposed for stem cells. Conversely x
throughout development of the soma, cell division produces cells of similar size and 
behaviour. The mechanisms which control development can be further revealed by 
disruption of the causal chain of events controlling embryogenesis. Embryos have been 
manipulated in various ways and the effects on cellular development can be interpreted 
in the light of the lineage information already gathered. Numerous mutants have been 
isolated which show effects during embryogenesis (Kenyon, 1994; Ambros & Moss, 
1994; Gilbert, 1994). Studies on these mutants have concluded how important maternal 
gene expression to supply the egg with essential gene products is to embryogenesis in 
the nematode. This is also similar in many other organisms such as Drosophila. Only a 
small region of the cytoplasm in the egg is vital for correct development. The embryo 
can compensate for lost cytoplasm and experimentally induced dwarf eggs can generate 
the full complement of founder cells and develop normally.
Another technique that can be used to disrupt embryogenesis in order to study the 
resultant effects on embryogenesis is cell ablation (Shierenberg, 1989). A number of cell 
ablation experiments have been performed in the embryo of C. elegans by repeatedly 
pulsing the nucleus of selected blastomeres with a laser beam. The Ep cell is the 
posterior daughter of the founder cell E and is the precursor of the posterior half of the 
nematode intestine. When this cell is ablated the worm hatches with a normal anterior 
half-gut which ends blindly and no posterior half (Laufer et al., 1990). The ablated cell 
remains intact and is located in the posterior half of the animal. These worms are still 
able to move and feed normally but die after a few days without reaching adulthood.
This demonstrates a general principle of development in the nematode. The lineage of 
cell is invariant and if a precursor cell is removed then all the progeny of the ablated cell 
are missing when the worm hatches. The control of development in this organism is 
largely cell autonomous.
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The invariant development of the nematode is probably exceptional and development in 
other organisms including flies, mice and humans is much more indeterminate (Gurdon, 
1992; Kimmel and Warga, 1987; Garcia-Bellido et al., 1979). The origin and destiny of 
cells can not so easily be visualised in other organism as they are in the nematode worm 
C. elegans and hence the cell lineages can not be analysed. To analyse lineage in an 
organism such as Drosophila melanogaster an objective method that will put an 
indelible mark on an embryonic cell which will be displayed in all of its descendants in 
the adult (Crick and Lawrence, 1975; Akam, 1987; Ingham, 1988). In Drosophila, 
lineage analysis has been accomplished primarily though the generation of mosaic 
animals be genetic techniques.
Mosaic flies have been commonly generated through mitotic recombination (Lawrence 
et al., 1986; Harrison and Perrimon, 1993). X-rays are used to induce chromosome 
breaks which result in the exchange of parts between homologous chromatids. This 
exchange occurs very rarely and a picture of cell lineage is built up bit by bit, by looking 
at clones found in a large number of individuals. One such marker gene is multiple wing 
hairs (mwh). A mutation in this locus (mwhT) results in the production of a number of 
hairs by wing epidermal cells which usually only produce one hair. The mutant flies 
remain viable and fertile. Heterozygote flies are produced by crossing mwhT and mwh+ 
flies to produce FI heterozygote flies with an mwh~ /  mwh+ genotype. As the FI flies 
mature they are irradiated en masse with 1000 rads and the surviving adults are searched 
for clones with mwhT cells which are seen as patches of cells producing extra hairs.
A great deal of information can be elucidated by the study of clones. The later the 
irradiation, the greater the number of target cells and hence the higher the frequency and 
the smaller the size of the clones produced. These data allow the average frequency of 
cell division and the mean growth rate of the tissue to be calculated. When sister cells 
become labelled it is possible to compare the number of divisions followed by each cell. 
It is also possible to assess to which parts of the tissue the descendants of a marked cell 
contribute. By using this technique it was possible to show that late in development the 
clones mark only the bristles or the cuticle of the wing epidermis and that these cell 
types must be derived from separate sets of cells (Bryant, 1970). When clones are made 
earlier they can contain both cell types.
One of the most interesting aspects of cell marking and lineage studies in Drosophila is 
that the cell marker mutant genes have been combined with genes which effect cell 
behaviour. These mutations can either affect the developmental fate of the clone of cells 
such as engrailed {en) or the speed of growth of the cells such as Minute (Crick and
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Lawrence, 1975; Morata and Lawrence, 1975). Minute* homozygote cell clones grow 
faster than Minute*/Minute~ heterozygote cells. The use of the latter mutation led to the 
discovery of cell compartments and competition. If a marked cell grows faster than its 
neighbours it will make larger patches in the adult fly. It is obviously of interest to 
determine whether or not there are limits to the territory that can be occupied by the 
descendants of a single cell.
It was discovered by the use of the Minute growth mutation that marked clones are 
confined to precisely determined domains which have been termed compartments 
(Lawrence, 1981, 1988; Ingham and Martinez Arias, 1992). A Minute* clone generated 
in a heterozygote animal grows more quickly and competes out the cells around it until it 
comes up against a compartment border. When embryos are irradiated at the blastoderm 
stage a marked daughter cell is formed by a cell which has undergone homologous 
chromatid exchange, at the next mitosis in developmental stage 9. The cell even if it 
grows relatively rapidly only colonises one precisely defined part of each segment at 
either the anterior or the posterior of the developmental segment. The cells will never 
colonise both anterior and posterior compartments (Garcia-Bellido et al., 1973). Hence 
even as early as the blastomere stage the cells of the embryo must be allocated to make 
either the anterior or posterior part of each segment.
If a similar experiment is performed before the embryo reaches the blastoderm stage a 
fast-growing clone can colonise several compartments. Hence it is possible to determine 
the precise timing of cell allocation in the developing embryo. These experiments 
indicate that the allocation of cells to the anterior or posterior segment compartments 
occurs some time after the beginning of the blastoderm and before the epidermal cells 
enter a second post-blastoderm mitosis. Cells are still able to colonise different 
appendages such as leg and wing but are confined to either the anterior or posterior 
compartment in both (Morata and Lawrence, 1977). Colonies generated later are 
confined to either the leg or wing. At even later stages the colonies in the wing are 
restricted to either the dorsal or ventral side. These results indicate how compartments 
develop in a progressive fashion and show that in the young embryo the wing and leg in 
the same segment have a common origin.
Lineage studies lead to the conclusion that following the blastoderm stage the embryo is 
divide into stripes of determined cells. These cells will generate either the anterior or 
posterior compartments of the adult segments. The lineage studies also seem to indicate 
that all the cells are allocated and that there are no intermediate cell capable of 
contributing to more than one compartments.
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The work on compartments has been confirmed and extended by the investigation into 
the function of another mutant fly gene, engrailed (DiNardo et al., 1994; Heemskerk et 
al., 1991; Vincent and O’Farrell, 1992). A great deal of work on this gene has 
depended largely on the same sorts of cell lineage experiments as described above. The 
function of this gene can be investigated in flies in combination with a clonal marker to 
establish the requirement for the gene in cells (Morata and Lawrence, 1975, 1979; 
Lawrence and Morata, 1976; Morata et al., 1983). The results of these experiments 
determine that engrailed was a selector gene necessary for all posterior cells, not only 
for determining the pattern that the cells form but also in maintenance of a separate 
identity from the anterior cells. When the gene was cloned and antibodies raised against 
the protein the gene was determined to be expressed in a pattern of stripes which first 
appear in the young embryo and persist indefinitely in the cell of the posterior 
compartments.
The engrailed mutation was combined with the Minute mutation as well as a cell marker 
and the effect of the removal of the wild type engrailed allele from clones of cell was 
tested. Another advantage of using this system is that strong engrailed alleles that are 
lethal to the whole animal can be tested in clones. Removal of engrailed expression 
from the anterior cells cell has no effect. When the expression is removed from 
posterior cells changes only those cells which no longer express the gene. The posterior 
cells acquire some characteristics of the anterior cells but are not organised in exactly 
similar patterns. When stronger engrailed alleles were used the pattern of marked 
posterior clones was considerably more disorganised (Komberg, 1981).
It seems that the removal of engrailed expression from posterior cell affects their 
'affinity' for mixing with anterior cells, although this is not a direct effect of engrailed 
which is a nuclear protein. The degree of intermingling at the compartment border is 
reduced an this separates the anterior cells from the posterior and prevents clones of cell 
spanning the compartment border. When engrailed expression is removed from 
posterior cells the cells acquire anterior-like adhesive properties. The cell can then cross 
the compartment border displacing anterior cells as they go. All these experiments serve 
to illustrate that the anterior cells are different to the posterior cells and that these 
differences are dependent on the engrailed gene.
Recently a novel method of marking cells in Drosophila has been described (Struhl and 
Basler, 1993; Harrison and Perrimon, 1993). This method circumvents the problems 
with using X-irradiation for clonal induction. The typical dose of X-rays used in such 
experiments gives a low rate of clone formation and a high rate of cell lethality. Two
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different strategies have been used which exploit the site-specific yeast recombinase, 
FLP. The first method uses mitotic exchange in the same manner as X-ray induced 
recombination. Two homologous chromosomes carry an FLP recombination target site 
(FRT) at the same chromosomal position, with a mutation on one homologue. The FLP 
recombinase gene is expressed under the control of a heat shock promoter and catalyses 
exchange of the chromosome arms specifically at the FRTs. This can generate patches 
of mutant tissue in an otherwise normal animal much the same way as the x-ray induced 
recombination.
The other variation of this method is the 'flp-out' technique. A bacterial lac Z  gene is 
expressed under the control of a constitutive promoter. The lac Z  gene contains a 5' 
transcriptional stop sequence flanked by two FRTs, inserted into the coding sequence. 
Expression of the FLP recombinase again under the control of a heat shock promoter 
results in specific excision of the transcriptional stop sequence by recombination 
occurring at the FRTs. This restores the reading frame of the lac Z  gene which is now 
expressed under the control of its own promoter. The expression of the gene is passed 
on to the progeny of the marked cell and creates clones useful for analysis of cell 
lineage.
This second technique has already been used to great effect in the analysis of the 
function of the function of the wingless (wg, DWnt-l)and hedgehog (hh) genes in the 
creation of ventral patterns in the Drosophila leg (Struhl and Basler, 1993; Basler and 
Struhl, 1994). Clones of cell were randomly induced to express the wingless protein in 
the leg imaginal discs. When these clones are located in the prospective ventral portions 
of the leg disc the cell develop normally. When the induced cells are located in the 
prosepective dorsal parts of the disc the clones give rise to ventrolateral patterns and 
seem to exert a ventralising influence on neighbouring wild-type cells. Some work has 
been performed in the application of this technique to mice although it has not been 
widely used to generate lineage information in this organism yet (Wahl et al., 1991). 
Despite not having been extensively used in cell marking, this type of technique has been 
now used to generate a tissue specific knockout in mice (Gu et al., 1994).
1.12.2 Cell marking in mammals.
One method of indelibly marking cell in mouse tissues is to generate aggregation 
chimeras with mouse embryos. This can be done in several separate ways, either by
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fusing two embryos (Schmidt et al., 1987, 1988), injecting cells into a blastocyst 
(Lallemand et al., 1990) or repopulation of a tissue after damage i.e. a bone marrow 
transplant (Joyner et al., 1983). Embryo aggregation chimeras have been used to 
analyse the clone size of cells in the skin. Embryos from mouse strains which have 
different H-2 haplotypes were fused. The two parental cell types were distinguished in 
skin whole mounts by using monoclonal antibodies directed against the H-2 molecules. 
This study found no evidence for the existence of an epidermal proliferative unit 
populated by a single stem cell as, at areas of overlap between the patches of parental 
cells, columns of differentiating cells were found which contained both parental cell 
types. If each column was populated by a single stem cell each differentiating column 
should be of one parental cell type or the other. This was also found to be true of hair 
follicle which were seen to contain a mixture of parental cell types. It is not really 
possible to analyse the behaviour of single cells in this system or to tell whether a group 
of cell is descended from a single progenitor.
Another method for cell marking which is able to analyse the behaviour of single clones 
of cells is to use retroviruses (Soriano and Jaenisch, 1986). Cells can be infected with a 
replication-incompetent retrovirus which contains a gene which is not normally present 
in the tissue and can be detected in situ with a histochemical stain. One gene which can 
be used in this fashion is the E. coli lac Z  gene (Price, 1987). This type of marking has 
been used to analyse the lineage of cells in the nervous system (Price et al., 1987; Walsh 
and Cepko, 1988; Austin and Cepko, 1990) and the retina (Turner and Cepko, 1987) as 
well as in post-implantation mouse embryos (Sanes et al., 1987) and in renal 
development (Herzlinger et al., 1992). The study on post-implantation mouse embryos 
helped to define some of the lineage paths for the skin (Sanes et al., 1987). By infecting 
embryos at a series of timepoints after fertilisation of the embryos it was possible to 
demonstrate when the precursor cells which form both the epidermis and the periderm 
(the outermost layer of epidermal cells which is shed before birth) become restricted. 
The embryos were infected with the virus on day 7, 9 and 11 after fertilisation. When 
the clones were analysed on day 13 it was obvious that clones from embryos injected on 
day 9 included both epidermal and peridermal cells. Clones from embryos injected on 
day 11 were restricted to either the epidermis or the periderm.
There would be problems in applying this technique to analysis of clone size in adult 
murine epidermis. It may require cell division before the virus genome can integrate an 
the cell becomes marked (Ponder, 1987). If the virus is only present for a short time and 
the stem cell cycle is very long then it may prove very hard to mark a stem cell. Also 
there is the problem of access of the virus to the cells, if the virus does not have access
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to the cells it cannot infect them. At the very least it would be necessary to inflict 
serious tissue damage to allow the virus access to all the epidermal cells. This might 
affect the result obtained from the experiment.
1.13 Aim of the project.
The aim of this project is to develop and use a marker system to analyse cell lineage in 
the skin. This should provide useful information on the usual size and organisation of 
clones in the epidermis and give some clues as to how cell replacement is normally 
controlled in the epidermis and to the possible location of the stem and progenitor cells.
As there is no marker gene currently available in the epidermis a marker gene can be 
introduced. This can be accomplished by generating transgenic mice with a novel 
marker gene inserted into their DNA. Potentially every cell of the mouse may express 
the marker gene. As the E. coli lac Z  gene is not expressed by mammals this makes this 
gene very suitable for the purpose (Price, 1987). The gene can be used as a cell marker 
by altering the expression of the gene by treating the mice with a chemical mutagen. 
Altering expression of the transgene in this fashion would provide a means of marking 
cells in a similar way to the experiment performed on the small intestinal epithelium with 
lectin markers (e.g. Winton et al., 1988). The lac Z  gene codes for a protein, (3- 
galactosidase which is easily detectable in situ by a simple histochemical stain. The stain 
is suitable for use on cultured cells as well as tissue sections and whole mount 
preparations.
It is important to consider that expression of a gene in transgenic mice is unlikely to be 
ubiquitous. Ideally the transgenic marker should be expressed in all tissues at all stages 
of development. It is unlikely that this would be achieved in practice. Transgenes are 
often subject to alteration of their expression by methylation of the genes and by 
imprinting. This will probably lead to variable patchy expression of the transgene in 
vivo. The project involves looking at a small minority of cells in the population. This 
combined with the probable variation in expression levels of the marker means that it 
would be advantageous if the cells which were marked could be positively identified i.e. 
the cells that express the lac Z  gene.
Cells can be positively identified if the marker gene is switched on in marked cells rather 
than switched off. If the transgene coding for the (3-galactosidase protein, includes a 
point mutation in the coding sequence then expression of the gene can be switched on, in
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the cells to be marked, by reversing the mutation. It is necessary that the point mutation 
must prevent expression of the gene. When then mutation is reversed the coding 
sequence of the gene is restored and expression of the protein is allowed. Detection of 
the intact protein by the histochemical stain for p-galactosidase gene allows 
identification of the cell as a marked cell.
Using this reverse mutation strategy also gets round another potential problem in 
generating transgenic mice for this purpose. Usually when transgenic mice are 
generated, by injecting fertilised embryos, multiple copies of the injected DNA integrates 
into the mouse genome (Palmiter and Brinster, 1987; Westphal and Gruss, 1989). 
Attempting to mutate every copy in one cell in order to mark it, would be next to 
impossible. Using the reverse mutation strategy, mutation in only one of the integrated 
transgenes would be required to cause expression of the protein and mark the cell. In 
this case high transgene copy number may be an advantage as this may increase the 
frequency with which marked cells are generated by increasing the number of targets for 
the mutagen.
Point mutation is a rare event and a specific reverse mutation to activate a gene would 
be even less frequent. There may be problems generating sufficient marked cells to 
detect in vivo. In order to attempt to increase the frequency of this reactivation it was 
decided to design a mutation in the marker gene which correlates with the specificity of 
particular chemical mutagen. It has since been shown that using this type of approach a 
reverse mutation rate of 1 x 1CT3 can be achieved when treating cells in tissue culture 
with mutagens (Schaff et al., 1990).
In order to increase the mutation frequency still further it is possible to engineer a 
construct which has a number of target sites, a mutation at any one of which will result 
in gene reactivation. This can be done by replacing the ATG translation initiation codon 
with an oligonucleotide which encodes a number of target sites for a chemical mutagen. 
Mutation at any one of these target sites results in the production of an in-frame start 
codon which will begin translation of the protein in the oligonucleotide and read on into 
the lac Z  gene. This should produce a fully functional p-galactosidase fusion protein 
which has the first few amino acids of the normal protein replaced by amino acids 
encoded by the oligonucleotide. A mutation in this site is also likely to prevent 
expression of the protein whereas amino acid substitutions in the coding sequence of the 
gene may not completely inhibit protein function. Predicting which amino acid 
substitutions would prevent expression could prove to be very tricky. Stop codons in 
the coding sequence may also prove to be leaky and allow some expression of the 
protein.
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1.14 Mutagenesis.
In order to increase the chances of developing a useful marker system it was decided to 
design two different oligonucleotides. Each oligonucleotide is designed so it can be 
activated by a separate chemical mutagen. The mutagens were selected because they 
have defined specificity of mutation and induce different types of mutational events.
1.14.1 N-nitro-N'-methyl-N-nitrosoguanidine.
N-nitro-N'-methyl-N-nitrosoguanidine (MNNG) is a mutagenic alkylating agent. It 
requires metabolic activation before producing a methyl diazonium ion which is a 
reactive species capable of methylating DNA (Bums et al., 1987). MNNG is a powerful 
mutagen and is more powerful than other common DNA alkylating agents 
methylnitrosourea (MNU) and methyl- (MMS) by 100 and 500 times respectively, in 
causing cell transformation (Doniger et al., 1985; Cupples and Miller, 1989). The 
potential of alkylating agents to transform cells and hence presumably to cause 
mutations correlates with the amount of 0 6-methylguanine adduct they produce. 
MNNG can cause other DNA lesions but the 0 6-methylguanine adduct seems to be the 
major mutagenic lesion. This adduct probably causes mutations in the DNA by 
mispairing with thymidine during DNA synthesis to produce G:C to A:T transitions.
MNNG is active in epidermal cells and is capable of transforming epithelial cells in vitro 
and is capable of inducing tumours in vivo {e.g. Rhim et al., 1986; Pai et al., 1983; 
Weissman et al., 1989). The compound also induces unscheduled DNA synthesis in 
primary cultures of murine epidermal cells which suggests the compound is actively 
damaging DNA in these cells (Sawyer et al., 1988).
In a forward mutation assay in the lac I  gene of E. coli it can be shown that > 97% of 
the mutations caused by MNNG are G:C to A:T transitions (Bums et al., 1987). If the 
influence of the surrounding sequence is taken into account it can be shown that 
mutations are far more likely to occur at a guanine residue flanked on the 5' side by 
another purine. This was despite the fact that inactivating mutations could have 
occurred at G residues flanked by either purine or pyrimidine residues.
Mutation was even more likely to occur if the 5' flanking base is a G residue. The 
mutation rate at a guanine residue flanked by a 5* G was 9 and 2 times higher 
respectively than at guanine residues preceded by a 5' pyrimidine or 5’ adenine. This
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specificity of mutation has been shown to apply to other alkylating agents as well 
(Glickman et al., 1987), and is also maintained in mammalian cells. Cells were 
transfected with a shuttle vector encoding the lac I  gene. Stable transfectants were 
treated with the alkylating agent nitrosomethylurea (NMU). When mutations in the 
shuttle vector were analysed > 95% of the mutations were G:C to A:T transitions and 
the same bias towards mutations at residues flanked by a 5' guanine was noted.
1.14.2 N2-acetylaminofluorene.
As the first oligonucleotide was designed as the target for a point mutagen it was 
decided to design the second for a mutagen which caused an alternative type of 
mutational event. N2-acetylaminofluorene (AAF) is a potent liver carcinogen {e.g. 
Poirier et al., 1991). When it is metabolically activated in male rat liver it is capable of 
producing two major DNA adducts which both occur on C-8 position of guanine 
(Beland et al., 1987). The most common adduct produced is an aminoflourene (-AF) 
adduct which accounts for 80% of the total DNA adducts. The next most common 
adduct is the acetylated form acetylaminofluorene (-AAF) which accounts for 15 - 20% 
of the remaining adducts.
When DNA is reacted in vitro with N-acetoxy-acetylaminofluorene (NAc-AAF) a 
reactive metabolite of AAF, -AAF adducts are formed on the C-8 position of guanine 
(Bumouf and Fuchs, 1985; Shibutani et al., 1991). In a forward mutation assay when 
the DNA containing the adducts is transformed into E. coll > 90% of the mutations 
recovered were frameshift mutations (Bumouf and Fuchs, 1985; Bumouf et al., 1989; 
Seeberg and Fuchs, 1990). Analysis of the sequence at which these mutations occur 
shows that they primarily occur at repetitive sequences and at specific sequences. A 
specific sequence at which the -AAF adduct causes a frameshift is the Nar I  restriction 
site 5'GGCGCC3' in the tetracycline resistance gene of pBR 322. The -AAF adduct 
causes a frameshift mutation by removal of a 2 base pair sequence GC to go from 
5GGCGCC3' to 5GGCC3'. This specificity can be further analysed by adding an extra 
GC base pair to the sequence to form a Bss HII restriction site 5GCGCGC3'. This 
reverts to the wild type sequence when exposed to NAc-AAF and transformed into E. 
coll in a similar fashion to the forward mutation assay. A reversion frequency of about 1 
x 10“3 is observed.
When the same analysis was performed with the -AF adduct the change observed was 
primarily base substitutions (Biachiara and Fuchs, 1985). The -AAF adduct is larger
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than the -AF adduct and may cause local DNA distortion. This distortion could cause 
slippage of the DNA polymerase during DNA synthesis resulting in a deletion of a GC 
dinucleotide from the sequence.
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CHAPTER 2.
Materials and methods.
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2. Materials and methods
2.1 Materials.
Restriction enzymes were obtained from Boehringer Mannheim, Lewes, East Sussex; 
New England Biolabs (CP Labs, Herts.); Northumbria Biologicals Limited (NBL), 
Northumberland; or from GibcoBRL, Paisley. Proteinase K, RNase A and Klenow 
fragment of Escherichia coli (E. coli) were obtained from NBL. Polynucleotide kinase 
was obtained from Pharmacia Ltd., Milton Keynes, Buckinghamshire, and Taq 
polymerase from Promega, Southampton.
The Sequenase™ kit used in double-strand sequencing reactions was from Cambridge 
Biosciences, Cambridge, and the SP6/T7 transcription kit used in the RNase protection
TMassay was obtained from Boehringer Mannheim. The Geneclean kit for DNA 
fragment isolation was obtained from Stratech Scientific Ltd., Luton, Beds. 
Deoxynucleotides and mixed hexanucleotides were from Pharmacia. All radioisotopes 
came from Amersham International P.L.C., Amersham, Buckinghamshire.
DNA size markers (Lambda/Hind III, d>X174/Hae III) for gel electrophoresis, and the 
RNA ladder used in Northern blotting were supplied by Gibco/Bethesda Research
TMLaboratories, Paisley, as were the Ultrapure agarose and urea. Nitro-cellulose and 
nylon membranes were supplied by Sartorius Instruments Ltd., Belmont, Surrey; Gelman 
Sciences Ltd., Broadmills Northampton and Amersham International.
Bacto-tryptone, bacto-agar and yeast extract were from DIFCO Laboratories, Detroit, 
Michigan, U.S.A. Phenol was delivered as a water-saturated liquid from Rathbum 
Chemicals Ltd., Walkerbum, Peebleshire. Ethanol was supplied by James Burroughs 
(F.A.D) Ltd., Witham, Essex. All other chemicals were obtained from BDH Laboratory 
Supplies, Poole, or Sigma Chemical Co. Ltd., Poole, Dorset.
Serum, media and supplements for cell culture were obtained from GibcoBRL, Paisley. 
Plastic-ware for cell culture was supplied by Nunc Intermed, Roskilde, Denmark; Sterlin 
Ltd., Feltham, Middlesex; or by Falcon™, Becton Dickinson, Dublin. Mice were from 
Harlan Olac Ltd., Bichester, Oxon.
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Plasmid pMC1871 was obtained from Pharmacia and the plasmid plrv-Neo-Act-LacZ 
was obtained from R. Beddington, Developmental Biology Unit, Department of 
Zoology, University of Oxford.
2.2 Oligonucleotide synthesis.
Oligonucleotide were synthesised on an Applied Biosystems 381A Synthesiser, using the 
manufacturer's protocols and reagents. After deprotection in ammonia at 55 °C 
overnight, the oligonucleotides were precipitated and used without further purification.
2.3 Analysis of oligonucleotides by polyacrylamide gel 
electrophoresis.
Oligonucleotide integrity was checked by electrophoresis on a polyacrylamide gel. 5 //g 
of oligonucleotide was dissolved in 10 //I dH20  and 3 //I of sequencing buffer was 
added. The solution was heated to 90 °C for 5 minutes. The sample was then run on a 
16% denaturing polyacrylamide gel. Oligonucleotides were visualised by shadowing on 
a TLC plate.
2.4 Restriction enzyme digestion of DNA.
Plasmid DNA was digested with 5 -1 0  units enzyme///g DNA for 1 - 5 hours depending 
on suppliers instructions. Genomic DNA was digested under overnight conditions with 
10 units///g DNA. Digestions were analysed for completeness, by gel electrophoresis.
2.5 Agarose gel electrophoresis.
Agarose gel electrophoresis of DNA was performed using the appropriate horizontal gel 
apparatus, with agarose concentrations between 0.7 - 2.0% w/v, depending on the
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desired fragment resolution. The agarose was dissolved and cast routinely in TAE 
buffer (40 h im  Tris-Cl pH 7.8; 20 m M  Sodium acetate; 1 m M  EDTA) which was also used 
as the running buffer. Ethidium bromide (1 /zgml'1) was either added direct to the 
molten agarose, or in the case of Southern blotting, the gel was soaked in an ethidium 
bromide solution, prior to UV illumination and photography.
2.6 General cloning techniques.
2.6.1 Purification of Fragments from Agarose Gels.
Using UV illumination the fragment of interest was excised with the minimum amount of 
agarose. Purification was carried out by two methods depending on fragment size. For 
fragments 500 bp - 3 kb the Geneclean™ technique (Stratech Scientific Ltd.) was used 
efficiently (see manufacturers instructions). For slightly larger DNA fragments 2 - 10 kb 
Spin-X tubes (supplied by Costar) were found to be most effective.
2.6.2 Removal of 5' Phosphate Groups from DNA.
The dephosphorylation of DNA for the purposes of minimising recircularisation of 
vector DNA was accomplished by treating the restricted DNA with calf intestinal 
phosphatase (Boehringer Mannheim). 10 - 20 //g of plasmid DNA was digested with a 
two - threefold excess of restriction enzyme until digestion was complete. Completion 
of digestion was checked by running a small aliquot of DNA on an agarose gel. The 
sample was then extracted with an equal volume of phenol :chloroform and the remainder 
of the DNA was then precipitated by addition of 2.5 volumes of ethanol. After 20 
minutes on ice the DNA was recovered by centrifugation for 30 minutes at 12 000 rpm.
The DNA was then resuspended in 90 jul TE buffer (pH 8.0). 10 y \  of 10 x CIP 
dephosphoiylation buffer (10 mM ZnCl2 ; 10 mM MgCl2 ; 100 mM Tris-Cl (pH 8.3)) was 
then added to the sample along with 2 units of CIP enzyme. This was incubated at 37 °C 
for 30 minutes when another 2 units of CIP was added and the incubation continued for 
another 30 minutes. After incubation EDTA (pH 8.0) was added to a final 
concentration of 5 mM and the reaction heated to 85 °C for 15 minutes to inactivate the
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CIP. The solution was then extracted with phenol and phenol: chloroform. DNA was 
then precipitated by addition of 0.1 volumes of 3m sodium acetate (pH 7 .0) and 2.5 
volumes of ethanol. The DNA was recovered by centrifugation at 12 000 rpm. The 
pellet was washed in 70% ethanol, dried and the DNA resuspended in TE buffer (pH 
8.0).
2.6.3 Ligation of Fragments.
The ligation of DNA fragments was performed using bacteriophage T4 DNA ligase. 
Fragments with sticky complementary ends were ligated overnight at 14 °C, whereas, 
blunt-end ligations were carried out at 4 °C for at least 24hrs. The total quantity of 
DNA per reaction varied, but the molar ratio of insert to vector was always greater than 
3:1. The quantitation of vector to insert DNA was accomplished roughly, by gel 
electrophoresis. The vector DNA was usually phosphatased, according to Section 2.6.2, 
to minimise vector recircularisation. Fresh commercial 5 x ligation buffer was routinely 
used. The volume of the reaction was kept to a minimum, usually 5-10 fih
2.7 Oligonucleotide cloning technique.
2.7.1 Annealing of single stranded oligonucleotides.
Oligonucleotides were synthesised and purified as described above and were then 
checked by polyacrylamide gel electrophoresis. Complementary oligonucleotides to be 
annealed were mixed in an 1.5 ml Eppendorf tube at total volume of 100 fi\, at a 
concentration of 20 figm l1. The solution was the covered with an equal volume of 
liquid paraffin to prevent evaporation. The oligos were heated for 5 minutes at 90 °C in 
a beaker of water and left to cool slowly in the beaker which was placed in a polystyrene 
cover to retain heat. When the beaker had cooled to room temperature the paraffin was 
removed from the oligonucleotide solution by extraction with chloroform : 
isoamylalchohol. This step was repeated twice. The annealing was checked by 
polyacrylamide gel electrophoresis as described above for single stranded oligos.
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2.7.2 Direct cloning of double stranded oligonucleotides into pMC1871.
The double-stranded oligonucleotides were cloned blunt-ended into the Sma I  site of 
the plasmid pMC1871. The ligation was performed as described in section 2.6.3 but 
with a greater than ten-fold molar excess of oligonucleotide. After ligation the T4 DNA 
ligase was inactivated by heating to 65 °C for 15 minutes. KC1 was added to a final 
concentration of 50 mM and the ligation was redigested with Sma I  enzyme to remove 
recircularised plasmid. After digestion, the restriction enzyme was inactivated by heat 
(65 °C for 30 minutes).
2.7.3 Sequence of oligonucleotides used for direct cloning.
Oligonucleotides were synthesised single stranded as described above Complementary 
pairs were annealed before cloning directly into plasmid.
A (1) +ve strand 
A (2) -ve strand 
B (1) +ve strand 
B (2) -ve stand 
C (1) +ve strand 
C (2) -ve strand 
D (1) -i-ve strand 
D (2) -ve strand 
E (1) +ve strand 
E (2) -ve strand
5' AAA GTG GTG GTG GTG GTG GTG GTG GTG GTG 3' 
5’ CAC CAC CAC CAC CAC CAC CAC CAC CAC TTT 3'
5’ AAA ATG GTG GTG GTG GTG GTG GTG GTG GTG 3' 
5' CAC CAC CAC CAC CAC CAC CAC CAC CAT TT T3'
5' AAA GTG GTG GTG GTG GTG GTG GTG GTG ATG 3' 
5‘ CAT CAC CAC CAC CAC CAC CAC CAC CAC T T T 3'
5’ AAA ATG GCG CGC GCG CGC GCG CGC GC 3'
5’ GCG CGC GCG CGC GCG CGC GCC ATT T T 3’
5' AAA ATG GCG CGC GCG CGC GCG CGC 3’
5' GCG CGC GCG CGC GCG CGC CAT TTT 3‘
All oligos used in cloning were purified by ethanol precipitation. 0.1 volumes of 3 M 
sodium acetate was added to the ammonia solution containing the oligonucleotide and 
the DNA was precipitated by addition of 3 volumes of ethanol. The sample was left on 
dry ice for 60 minutes and the centrifuged at 12 000 rpm, 4 °C for 15 minutes. The 
oligonucleotide was then resuspended in a smaller volume and reprecipitated. After the 
second precipitation the pellet was washed with cold 80% ethanol and recentrifuged. 
The pellet was then dried under vacuum and resuspended. The concentration of the 
solution was assessed by spectrophotometry.
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2.8 Bacterial transformation.
Commercial competent cells, DH5a™, supplied by GibcoBRL, were used for most 
routine cloning, otherwise competent cells were made according to Mandel and Higa 
(1970). All ligations were carried out in Falcon™ 2063 polypropylene tubes. DNA 
ligations were diluted 5-fold in 10 mM Tris-Cl (pH 7.5) and 1 mM Na2EDTA, and 1 - 5 //I 
(approximately 10 ng) of the dilution was added to 50 or 100 //I of thawed competent 
cells kept on ice. The cells were left on ice for 30 minutes, then heat shocked at 42 °C 
for 45 seconds. The cells were left to recover for 2 minutes on ice, then incubated with 
450 or 900 ju\ of L broth (supplemented with 20 mM glucose) at 37 °C for 1 hr. The 
tubes were centrifuged at 1 000 rpm for 5 minutes, the supernatant poured off, and the 
pellet gently resuspended in the residual supernatant. This was spread onto LB plates 
(1.5% w/v bacto-agar in L-broth) supplemented with normally 100 //gml'1 ampicillin or 
25 // gml'1 tetracycline. The plates were incubated overnight at 37 °C.
SURE competent cells (Stratagene, Cambridge) were used to clone repetitive sequence 
oligonucleotides into the vector pBRlacZ. All transformations into these cells were 
carried out in these cells were performed in Falcon™ 2059 polypropylene tubes, 
according to the manufacturer's protocol.
2.9 Purification of plasmid DNA.
2.8.1 Rapid small scale plasmid preparation for restriction enzyme 
analysis.
1-5 ml of L broth (with 100//gml'1 ampicillin) was inoculated using a loop. The cultures 
were incubated overnight at 37 °C. Cells were centrifuged in 2 ml Eppendorf tubes. 
The pellets were resuspended in 100 //I of lysis solution (25 mM Tris-Cl (pH 8.0); 10mM 
EDTA; 50 mM glucose; 0.5 mg/ml lysozyme). 200 //I of alkaline/SDS solution (0.2N 
NaOH, 1% SDS), was added to the tubes and mixed. 150 //I of NaOAc (pH 4.8) was 
then added and the tubes vortexed. After incubation on ice for 5 minutes, the tubes 
were centrifuged, and the supernatant added to a fresh tube containing 400 //I of 
isopropanol. The tubes were centrifuged at 10 000 rpm for 15 minutes. The pellet was
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left to air dry and resuspended in 200 ywl of dH20. A further precipitation step with 
100% ethanol was optional. RNase A (100 //gm l1 f/c) was included at the time of 
restriction enzyme digestion.
2.8.2 Medium scale preparation of high quality DNA for sequencing.
A 500 pi\ sample was taken from a miniprep culture and was then added to 50 ml of L- 
broth containing antibiotic (100//gml'1 ampicillin) and incubated for at least 16 hrs on a 
rotary shaker at 37 °C. The culture was then centrifuged for 5 minutes at 8 OOOrpm for 
5 minutes in a refrigerated centrifuge. After the supernatant was discarded, the pellet 
was resuspended in 5 ml STET buffer (8% sucrose, 5% Triton X-100, 50 mM EDTA, 50 
mM Tris-Cl pH 7.5). Boiled RNase and fresh lysozyme were added to concentrations of 
10 /Wgml1 and 0.5 mgml'1 respectively. The mixture was then decanted into a 30 ml 
polycarbonate tube (Sorvall) and after leaving for 10 minutes room temperature the 
sample was boiled for one minute and left on ice for a further 10 minutes. The tube was 
then centrifuged at 12 000 rpm for 10 minutes at 4 °C. The crude plasmid DNA was the 
precipitated by addition of 4 ml of ice cold isopropanol and wad pelleted by 
centrifugation as above. The pellet was resupended in 600 jul TE buffer (10 mM Tris-Cl 
pH 7.5, 50 mM EDTA). Protein contaminants are removed by extraction once with 
phenol:chloroform, then once with chloroform alone. After extraction the DNA was 
transferred into a 10 ml polycarbonate tube and precipitated by a the addition of an equal 
volume of 7.5 m ammonium acetate and 2.5 volumes of -20 °C ethanol. After 15 
minutes on ice the sample was centrifuged at 12 000 rpm for 10 minutes at 4 °C. The 
pellet was the rinsed twice with 70% ethanol, dried under vacuum and resupended in 
300 TE buffer.
2.8.3 Large scale preparation of high quality DNA.
A 10 ml starter culture was prepared overnight. This was then added to 500 ml of L- 
broth containing antibiotic (lOO^gml1 ampicillin) and incubated for at least 16 hrs. The 
culture was centrifuged in 500 ml Sorvall bottles at 5 000 rpm for 5 minutes at 4 °C. 
The pellet was resuspended in 25 mis of ice cold lysis solution (as Section 2.3.1). After 
15 minutes on ice 50 mis of alkaline /SDS solution (as Section 2.3.1) was added, and the 
solution mixed vigorously by swirling. Finally 37.5 mis of potassium acetate solution 
(60 mis 5m potassium acetate, 11.5 mis glacial acetic acid and 28.5 mis dH20) was
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added and the bottles incubated on ice for approximately 15 minutes. The bottles were 
centrifuged at 6 000 rpm at 4 °C for 15 minutes. The supernatant was decanted through 
gauze and isopropanol precipitated with 0.6 volumes of isopropanol. The pellet was 
resuspended in TE (10 mM Tris-Cl pH 8.0; 1 mM EDTA pH 8.0). The plasmid DNA was 
the further purified by equilibrium centrifugation in a continuous CsCl-EtBr gradient. 1 
gm l1 solid CsCl was dissolved in the DNA solution. Ethidium bromide was added to a 
final concentration of 740 //gml'1. The refractive index of the solution was checked to 
ensure the density of the solution was correct (1.55 gml1 ; refractive index = 1.3860). 
The DNA sample was then loaded into polycarbonate tubes and spun at 40 000 rpm for 
60 hours at 20 °C or at 80 000 for 16 hours at 20 °C. After centrifugation the lower red 
band containing the plasmid was removed from the gradient with a syringe. The 
ethidium bromide was removed from the DNA by extraction with 1-butanol. This was 
repeated at least 6 times and was continued until the red colour of the ethidium bromide 
had disappeared. The CsCl was then removed from the DNA by dialysis for 48 hours 
against several changes of TE buffer (pH 8.0).
2.10 DNA sequencing of cloned oligonucleotides.
Sequencing of double-stranded DNA was carried out using the Sequenase™ T7 DNA 
polymerase kit and [a-32P] dATP. 10 fig  of plasmid DNA was linearised with the 
appropriate restriction enzyme, ethanol precipitated and resuspended in 20 //I dH20. 
The primer used sequence oligonucleotides inserted in front of the lac Z  gene was the 17 
bp M l3 universal sequencing primer. The sequencing reaction was performed with end- 
labelled primer. The end-labelling reaction was carried out in a total volume of 10 fi\ 
(50 mM Tris-Cl pH 7.5,10 mM MgCl2, 1 mM EDTA, 5 ng primer, 5 units T4 DNA kinase 
and approximately 50 fiCi [a-32P] dATP). This reaction mixture was then incubated at 
37 °C for 30 minutes and stopped by addition of 1 fA of 0.1m EDTA. The kinase was 
then inactivated by heating to 70 °C for 15 minutes. 7 fi\ of the precipitated DNA 
template was combined with 3 fi\ of Sequenase™ sequencing buffer and 5 fil of the end- 
labelled primer. The remainder of the sequencing reaction was carried out with the 
reagents and the protocol supplied in the USB (United States Biochemical) Sequenase™ 
kit.
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2.11 General culture of mammalian cell lines.
2.11.1 Medium and supplements.
Epidermal cell lines (C50) were grown routinely in Special Liquid Medium (SLM, 
GibcoBRL) supplemented with 10% foetal bovine serum (FBS) and 4 mM glutamine. 
Cells were grown in 25, 75 or 175 cm2 flasks or 9 cm dishes gassed with 5% C 02, and 
placed in 5% C 02 ; 37 °C incubators. Cells were washed with phosphate buffered saline 
or PBS (0.14 m  NaCl; 27 m M  KC1; 10 m M  Na2HP04; and 15 m M  K2HP04). Trypsin for 
cell disaggregation was used at 0.025% w/v in PE (1 mM EDTA pH 7.8 in PBS). 
Trypsin was inactivated with 10-fold volume of serum containing medium. Cell numbers 
were estimated using a Coulter counter.
Fibroblast cell lines (NIH 3T3, ^2) were grown in Dulbecco modified Eagles medium 
(DMEM), (for 100 mis :10 mis 10 x DMEM; 1 ml 200 mM glutamine; 1 ml 100 mM 
pyruvate; 4.2 ml 7.5% sodium bicarbonate; 1 ml non-essential amino acids, in dH20).
2.11.2 Freezing and storage of cell lines.
Cells for freezing were grown to near confluence, typsinised and centrifuged at 1 000 
rpm for 5 minutes. The cells were resuspended in equal proportions of growth medium 
and freezing medium (25% FBS; 20% DMSO; 55% growth medium). Cells were stored 
in 1-2 ml Nunc™ vials in liquid nitrogen.
2.12 Transfection of mammalian cell lines.
2.11.2 Calcium Phosphate Technique.
5-10 fig  of supercoiled plasmid DNA was mixed with 35 fig  of carrier DNA (salmon 
sperm genomic DNA) in a solution of TE (1.0 mM Tris pH 8.0; 0.1 mM EDTA pH 8.0) 
to a final volume of 500 f i l  To this was added 400 fi\ of TE (as above) and 100 fi\ of
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2.5 m CaCl2 (refractive index 1.401). This mixture was added slowly to 1 ml of 2 x HBS 
(280 mM NaCl; 50 mM HEPES; 1.5 mM Na2HP04.2H20  pH 7.12) and left for 30 minutes 
at room temperature to form a precipitate. This was then added to 4 ml of medium, 
mixed gently and placed over a sub-confluent culture of cells. After 24 hours the 
transfection medium was replaced with fresh growth medium and incubated at 37 °C for 
a further 1-2 days. The cells were then split 1:10 and selection applied as appropriate. 
Transfected cells, containing the neomycin resistance gene (neo), were selected in 
medium containing G418 (Gibco BRL, Paisley) at a concentration of 400//g m l1.
2.12.2 Lipofection Technique.
The technique of cationic liposome mediated transfection was used to introduce DNA 
into a number of mouse epithelial cell lines. The protocol was as for the DOTAP™ 
reagent supplied by Boehringer Mannheim.
2.12.3 Electroporation Technique.
A 175 cm2 flask of confluent cells were trypsinised and the trypsin inactivated with 
serum containing medium. The cells were washed with phosphate buffered saline, PBS 
and resuspended in about 0.4 ml of PBS. In an Eppendorf tube 75 -150 jug of linearised 
plasmid DNA was resuspended in 0.4 ml of PBS and mixed with the cell suspension. 
The contents were transferred to a sterile Bio-Rad electroporation cuvette and 
electroporated in a Bio-Rad Gene Pulser™. The capacitance was set at 3 juF (not on 
extender), whilst the voltage was set at 0.8 kV. The cuvette was removed and the 
contents added to 50 - 100 ml of prewarmed growth medium and plated into 75 cm2 
flasks. Selection with G418 was started 24 - 48 hours after electroporation.
2.13 Generation ol replication deficient retroviruses.
Retroviruses containing the lac Z  fusion genes were generated by CaP04 transfection of 
the murine viral producer cell line ^2. After transfection cells were selected in DMEM 
medium containing G418 at a concentration of 1 mgml'1. The medium was changed
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every 3 days for 2 weeks. Surviving cells were pooled and used as viral producer cell 
lines as described below.
2.14 Preparation of retroviruses and infection of cultured 
cells.
Virus producer cell lines were grown until 80% confluent. The medium was replaced 
with the minimum volume of growth medium to ensure coverage. This was left for 24 
hours removed and filtered through a series of syringe filters 1.2 - 0.2 microns. 24 hours 
prior to harvesting the viral supernatant, 5x105 cells ( for infection) were seeded per 25 
cm2 flask. To each flask was added a mixture of 50 //I of viral supernatant, 150 //I of 
polybrene (0.8 mgml'1), made up to 5 ml with growth medium. After 48 hours the cells 
were split into 75 cm2 flasks and selection with G418 commenced if appropriate.
2.15 Staining of cultured cell lines for p-galactosidase activity.
Cells were stained in tissue culture flasks. The medium was removed from flasks and the 
cells were rinsed twice in PBS. Cells were then fixed in 2% formaldehyde (McQuilken, 
Glasgow), 0.2%  gluteraldehyde (McQuilken, Glasgow) in PBS for 1 hour on ice. After 
fixation the cells were again rinsed twice, in PBS. The p-galactosidase stain consists of: 
1 mgml'1 5-bromo-4-chloro-3-indolyl (3-D-galactoside (from a stock solution of 40 
mgml'1 in dimethylsulphoxide); 5 mM K3Fe(CN)6; 5 mM K4Fe(CN)6.6H20  and 2 mM 
MgCl2 in PBS. This stain was then added to the flask and the cells were cultured 
overnight at 37 °C in an atmosphere of 5% C 02. After staining the cells were then 
rinsed three times in PBS before visualisation by microscopy.
2.16 Treatment of cells with the chemical mutagen MNNG.
Cells to be treated were cultured in 175 cm2 until approaching confluence. The growth 
medium from the flask was removed and the cells washed in PBS (pre-warmed to 37 °C) 
three times and then once in serum-free SLM. 20 ml serum-free SLM with glutamine
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was then added to the flask and the medium. Serial dilutions on the stock solution of 
MNNG (3 mgml"1) were prepared in acetone. From these dilutions MNNG was added 
to the flask at concentrations ranging from 0.1 to 10//gml'1. Control flasks were set up 
containing acetone alone. The flasks were sealed and left at 37 °C for 3 hours. The 
cells were then washed and growth medium containing serum was replaced. The culture 
then left for 48 hours at 37 °C to recover from the mutagen treatment. The treated cells 
were then trypsinised, to remove them from the flask and counted. Cells were then 
plated out into 10 cm dishes at a density of 5 x 105 cells per dish. A small number of 
cells were also plated out into 25 cm2 flasks to test the number of the cells. After 2-3 
days the number the cells in 10 cm dishes were stained with X-gal as described in section 
2.14. The numbers of lac Z positive cells on each dish were then counted. The number 
of clonogenic cells plated out onto each dish was determined by counting the number of 
colonies formed by the 200 cells plated into the 25 cm2 flasks.
2.17 Preparation of genomic DNA from cultured cells.
Genomic DNA was prepared by treating adherent cultured cells grown in 75 or 175 cm2 
flasks with 2 or 5 mis of lysis buffer (50 mM Tris pH 8.0; 50 mM EDTA; 100 mM NaCl; 5 
mM dithiothreitol; 1% SDS and 0.5 mM spermidine) respectively. The cell lysate was 
scraped from the flask using a sterile scraper, and placed in a 15 ml Falcon tube, to 
which 200 ftl (10 mgml1 solution) of proteinase K was added. The tubes were 
incubated at 37 °C in a rotator, overnight. The contents were then phenol/chloroform 
extracted, and subsequently isopropanol precipitated. The viscous pellet was spooled 
onto a sealed glass capillary and washed in 70% then 100% ethanol, then allowed to air 
dry. The genomic DNA was finally resuspended in 200-400 fi\ of TE (10 mM Tris pH 
7.4; and 1 mM EDTA).
2.18 Preparation of RNA from cultured cells.
RNA was prepared using the RNAzol protocol (Biogenesis Ltd.). To 106 adherent 
cells, 0.2 ml of RNAzol was added directly to the flask, and the lysate scraped off using 
a sterile scraper. This was placed in a 15 ml Falcon™ 2059 tube and one tenth volume 
of chloroform was added. After shaking, the tube was centrifuged at about 5 000 rpm at 
4 °C for 15 minutes. The colourless upper phase was transferred to a fresh tube, and the
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RNA precipitated using an equal volume of isopropanol. The RNA was then pelleted 
and washed with 75% ethanol and allowed to air dry. The pellet was then resuspended 
in 50% ethanol in diethylpyrocarbonate (DEPC) treated water. Care was taken to 
ensure that all solutions used were RNase free. RNA was stored at -20 °C.
2.19 Southern blot transfer of DNA.
DNA fragments were separated by agarose gel electrophoresis and transferred to nylon 
membranes (Hybond-N™ or Biotrace-RP™) by the method of Rigaud et aL, 1987. The 
gel was soaked in ethidium bromide solution and photographed. It was then soaked in 
1.5m NaCl, 0.5m  NaOH for 2 x 20 minutes, and then in 1m NH4OAc, 0 .02m  NaOH for 2 
x 30 minutes. The gel was then transferred onto a nylon membrane (Hybond, 
Amersham, or Biotrace RP), by capillary transfer overnight in NH4OAc/NaOH transfer 
solution. Alternatively vacuum transfer of the gel was used according to manufacturers' 
guidelines. The membrane was then fixed by baking at 80 °C for 2 hours and hybridised 
as described in Section 2.22.
2.20 Northern blot transfer of RNA.
10-20 jug of total RNA was freeze dried and resuspended in freshly made sample buffer 
(50% formamide; 1 x MOPS; 16.6% formaldehyde up to 100% with (IH2O). This was 
incubated at 60 °C for 15 minutes, then on ice for 5 minutes. 5 ju\ of northern loading 
buffer (50% glycerol, 10 [um. Sodium phosphate pH 7.0, and a few bromophenol blue 
crystals) was added to the samples prior to loading the gel (1% agarose; 1 x MOPS; and 
18% formaldehyde). The gel was run in 1 x MOPS (for 1 litre of 10 x MOPS: 42g 
MOPS; 6.8g NaOAc; 3.7g EDTA pH 7.0). The RNA ladder was supplied by 
GibcoBRL. The RNA was blotted onto nitro-cellulose membrane (Sartorius ^  and 
hybridised as below, in Section 2.22.
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2.21 Preparation of radioactively labelled probes.
Labelled probes from double-stranded DNA were made by the random priming method 
(Feinberg and Vogelstein, 1983,1984). Approximately 50 ng of purified insert DNA 
was boiled for 10 minutes to ensure denaturation, and then labelled in a total volume of 
50 //l, containing 10 fi\ of oligonucleotide labelling buffer (OLB) and 2 //I of BSA (10 
//g/ml stock). Finally, 1.85 x 106 MBequerel of [a-32P] dCTP and 5 units of Klenow 
enzyme were added, and the reaction incubated at room temperature for at least 6 hours. 
The unincorporated nucleotides were removed by running the probe through a NICK- 
column™ (Pharmacia), and the specific activity estimated using a scintillation counter.
The recipe for oligonucleotide labelling buffer (OLB) was : 62 //11 m Tris pH 7.4; 6 //1 1 
m MgCl2; 1 jul 2-Mercaptoethanol; 2 //I 15 m M  dATP; 2 ju\ 15 m M  dGTP; 2 //I 15 him  
dTTP; 125 //12  m HEPES pH 6.6 and 50 //I 150 OD/ml calf thymus hexanucleotides 
(Pharmacia). It was stored in aliquots at -20 °C.
2.22 Hybridisation of radioactive probes.
Filters were prehybridised at 42 °C for minimum of 4 hours in sealed plastic containers 
with 20-50 ml of heated pre-hybridisation solution (50% formamide; 4 x SSPE (20 x 
SSPE was 3.6m  NaCl; 200 mM NaH2P 04 pH 7.4); 0.5% w/v dried milk (Marvel); 1% 
SDS; 10% dextran sulphate; 1 mgml"1 denatured salmon sperm DNA). After the allotted 
prehybridisation time, radio-labelled probe (see section 2.20) was denatured by boiling 
for 10 minutes and added direct to the solution. Blots were hybridised for a 16 - 20 
hours at 42 °C. Filters were washed on a shaker with 1 x SSC / 0.1% SDS, then 0.5 x 
SSC / 0.1% SDS, at room temperature each wash for 15 minutes. The final wash was 
with 0.1 x SSC / 0.1% SDS at 50-65 °C for 10-30 minutes with constant monitoring of 
the background with a Geiger counter. The filters were exposed to Kodak X-OMAT 
AR or X-OMAT S film at -70 °C in cassettes containing intensifying screens.
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2.23 Amplification of DNA and RNA by the polymerase chain 
reaction (PCR).
2.23.1 Amplification from genomic DNA
DNA was amplified according to Saiki et al. (1988). A 50 //I reaction containing up to 1 
jug of genomic DNA, or in the case of plasmid DNA, concentrations were in the 
picomolar range. Commercial lOx buffer supplied by Promega (500 mM KC1; 100 mM 
Tris-Cl pH 9.0 at 25 °C; 15 mM MgCl2; 0.1% gelatin w/v; 1% Triton X-100), each 
amplimer at 140//gm l1 and each dNTP (2.5 mM stock mix, 4 //I in 50 //I reaction) were 
combined in a 0.5 ml PCR tube. 2.5 units of thermostable DNA polymerase from 
Thermus aquaticus (Taq polymerase), (also supplied by Promega) was finally added to 
the mixture. Thermal cycling was controlled by a programmable heating block (Perkin 
Elmer Cetus, DNA Thermal Cycler 480 or GeneAmp PCR System 9600). Three-step 
temperature cycling conditions varied, depending on GC content of amplimers, and 
length of amplification.
Optimum amplimers were designed by a computer program (Oligo 4.0-2008 Primer 
Analysis Software), and made as in Section 2.13. In order, to avoid cross contamination 
of samples, aerosol resistant tips (ART™ supplied by BCL) were employed. In addition, 
positive controls were set up last.
2.23.2 Amplification from RNA.
Amplification of RNA was carried out according to the method of Bartek et al. (1991). 
10 //g  of RNA was dried in a Speedivac vacuum drier. The dried RNA pellet was 
resuspended in 10 //I of 2 x annealing buffer (800 mM KC1, 20 him Pipes pH 6.6), along 
with 1 jul RNasin (RNase inhibitor, Pharmacia), 1 jul 3' PCR amplimer (140 //gm l1) and 
8 //I of DEPC-treated dH20. The sample was heated to 85 °C for 5 minutes the 65 °C 
for a further 15 minutes. 40 //I of 5 x reverse transcriptase reaction buffer was then 
added to the mixture along with 10 //I 2.5 mM dNTP mix, 20 //I 0.1 M dithiothreitol 
(DTT), 9//1 RNasin and 71 jul ddH20. After mixing the sample was split into 2 x 100//1 
aliquots. 2 //I of reverse transcriptase enzyme was added to one aliquot and the other
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was used as a control for DNA contamination. Both aliquots are heated to 42 °C for 60 
minutes and then heated to 85 °C for 5 minutes to inactivate enzyme. After the tubes 
have been cooled on ice 5 jul of each reaction was used in a standard PCR reaction as 
described above.
2.23.3 Sequence of commonly used amplimers.
Sequence of amplimers used for screening genomic DNA and RNA for the presence of 
the lac Z  gene.
LacZA 5' AAT CGC CTT GCA GCA CAT CCC 3'
LacZB 5‘ CAT CGT AAC CGT GCA TCT GCC 3‘
LzUl 5' TGT CGT CGT CCC CTC AAA CTG 3’
LzLl 5’ TCA CCC TGC CAT AAA GAA A CT3'
LzU2 5’ GCA TAA ACC GAC TAC ACA A A T3’
LzL2 5' GCT TCA TCC ACC ACA TAC AGG 3'
LzU3 5' ATC TGG TCG CTG GGG AAT GAA 3'
LzL3 5' AAA CGG AAC TGG AAA AAC TGC 3<
LzU4 5' CAG TCA GGC T IT  CTT TCA CAG 3’
LzL4 5’ GCG GTC GGG ATA GTT TTC TTG 3'
LzU5 5' GCA GGT AGC AGA GCG GGT AAA3'
LzL5 5' AGT AAG GCG GTC GGG ATA G TT3'
All oligonucleotides for PCR were purified by precipitation by butanol as described by 
Kemp et al. (1993). The oligonucleotide was resuspended and the concentration of the 
solution was assessed by spectrophotometry. All stock solutions of oligonucleotides 
used in PCR were kept at a concentration of 140 gml'1.
2.24 Ribonuclease protection assay.
The probe for the RNase protection assay was generated using the SP6/T7 transcription 
kit (Boehringer Mannheim) following the manufacturers instructions. 10-20 pig of total 
RNA was dried down in a Speedivac, along with 1 x 106 cpm of probe. This was 
resuspended in 2 0 of 80% FAB (80% formamide; 400 mM NaCl; 40 mM Pipes pH 6.4;
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1 mM EDTA). This was incubated for 16 hours at 50 °C. The samples were then placed 
on ice and 300 jul of digestion buffer (10mM Tris pH 7.6; 5 mM EDTA; 0.3m NaAc pH 
7.0; and 40 //gml'1 RNaseA, 150 U/ml RNase T1 f/c). The samples were digested for 1 
hour at 30 °C and then 2.5 //I of 10 mgml'1 Proteinase K and 3.2 //I of 20% SDS were 
added and the mixture incubated at 37 °C for 15 minutes. 5 pi\ of yeast tRNA (1 m gm l1) 
carrier was added to each sample. The samples were phenol/chloroform extracted and 
precipitated with 100% ethanol followed by 70% and 100% washes. The RNA digested 
samples were freeze dried and resuspended in 5 //I of loading buffer (8 ml formamide, 1 
ml 10 x TBE, 20 pi\ 0 .5m  EDTA, 10 mg xylenecyanol, 10 mg bromophenol blue, and 1 
ml of dH20). The samples may be stored at -70 °C, or run on an 8% polyacrylamide gel 
(8m  urea; 1 x TBE; and dilution of 40% aciylogel solution, with ammonium persulphate 
and TEMED added prior to pouring). The samples were heated to 90 °C for 5 minutes 
prior to loading. Gel electrophoresis was at 40-50W for 2 hours. The gel was then 
dried down under heated vacuum and exposed to film (Kodak X-OMAT AR or S).
2.25 Preparation of DNA for microinjection.
DNA used for microinjection is linearised with as much vector sequence as possible 
removed. The presence of vector sequences can reduce expression of the transgene by 
up to 1000 times. Contamination of the preparation with organic solvents such as 
phenol or chloroform can have severely deleterious effects on the developing embryos so 
use of these chemicals was avoided.
The DNA construct was digested by restriction enzymes and loaded onto a standard 
agarose gel until good separation of the fragments is achieved. The DNA band in the 
low melting point agarose was then excised and heated to 70 °C until the agarose 
completely melts. 5 volumes of 0.5 M NaCl in TE (10 mM Tris-Cl pH 7.5; 1 mM EDTA) 
is added and the solution completely mixed. Incubation at 70 °C is continued for a 
further 10 minutes.
The DNANagarose mixture was then run through a disposable ion exchange column, 
NACS-52 Prepac (BRL) according to the manufacturer's instructions. This procedure 
was carried out in a hot room at 37 °C to prevent the agarose solution solidifying. In 
addition all solutions were maintained at 42 °C in a waterbath. The eluted DNA is 
precipitated by addition of 10 pig of carrier tRNA and 0.6 ml of cold 95% ethanol. After 
incubation on ice for 15 minutes the sample is centrifuged at 12 000 rpm, 4 °C for 30
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minutes. The DNA pellet is then washed several times with 70% ice cold ethanol. The 
pellet is then dried and resuspended in a small volume of TE buffer. At this stage the 
DNA can be checked by ultra-violet light spectrophotometry and agarose gel 
electrophoresis. The DNA was diluted to the desired concentration (~ 1-2 ngwl*1) with 
injection buffer (10 mM Tris-Cl pH 7.6; 1 mM EDTA). The sample was then extensively 
dialysed against several changes of a large volume of injection buffer at 4 °C over 48 
hours. The DNA preparation is stored in 20 pi aliquots at -20 °C.
2.26 Generation of transgenic mice.
Transgenic mice were produced using similar materials and methods to the protocols 
described by in Manipulation o f the mouse embryo : A laboratory manual (Hogan,B., 
Constantini, F., and Lacy, E. eds.). The method employed to transfer genes into mice 
during the course of this project was microinjection of DNA directly into the pronuclei 
of fertilised mouse eggs.
2.26.1 Pipettes, injection needles and injection chambers.
All glass capillaries for making pipettes and injection needles were obtained from Clark 
Electromedical Instruments, Reading. Handling pipettes were pulled over a Bunsen 
burner flame. Holding and transfer pipettes were manufactured from GC100 and 
GC120 glass capillaries respectively on a microforge (Model MF-9, Narishige Co. Ltd., 
obtained from Microinstruments Ltd., Oxford). The injection needles were made from 
GC100TF capillaries, pulled on a Flaming/Brown Micropipette Puller (Model P87, 
Sutter Instrument Co.)
2.26.2 Superovulation of female mice.
Three week old (C57BL/6J x CBA/J)F1 female mice were superovulated by injection of 
hormones. This procedure is performed to increase the number of fertilised eggs 
obtained from mice. It involves sequential injection of two hormones pregnant mare's 
serum (PMS) and human chorionic gonadotrophin (hCG). Pregnant mare serum was 
dissolved in 0.9% (w/v) NaCl at a concentration of 50 IUml'1 and stored in aliquots at -
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20 °C. Each mouse was injected intraperitoneaUy with 100 pi of PMS. The second 
hormone hCG was dissolved in dH20  at a concentration of 500 IUml'1 and was divided 
in 100 [0,1 aliquots, lyophilised and stored, protected from light, at -20 °C. Before use 
the hormone was resuspended in 1 ml of sterile 0.9% NaCl to give a final concentration 
of 50 IUml'1. 100 //I (5 IU)of the hCG was injected into the mice 46 - 48 hours after 
injection of the PMS. The female mice were then mated to MF 1 stud male mice 
overnight. Females were checked the morning after for coital plugs. Plugged female 
mice were used as embryo donors for the gene transfer.
2.26.3 Collection and culture of fertilised embryos.
Microdrop cultures were set up first of all. Four or five 30 fi\ drops of equilibrated M16 
medium were placed in a 35 mm petri dish. These drops were overlaid by 5 ml of liquid 
paraffin, which flooded the whole dish. The whole culture is then placed in a humidified, 
gassed (5% C02, 95% air) incubator and left to equilibrate.
Plugged ( C57BL/6J x CBA/J )Fj female mice were humanely killed by cervical 
dislocation. The two oviducts, each with a short segment of uterus were then dissected 
out of the animals. The oviduct was then placed in a 50 p,l drop of M2 culture medium 
(Biological Industries, Haemek, Israel) supplemented with 4 mgml1 bovine serum 
albumin (Sigma), in a 35 mm petri dish. The oviducts are visualised under a 
stereomicroscope at a magnification of approximately 20 times. 10 pi of 10 mgml'1 
solution of hyaluronidase (Sigma) was then added to a the drop of medium containing 
the embryos. The embryos were left for 1 - 2 minutes until the cumulus cells had 
become detached. The embryos were then removed from the medium and the cell debris 
and washed through six drops of M2 medium. The eggs were then washed once in M16 
medium and transferred to the drops of medium in the microdrop culture set up earlier 
and cultured for 2 hours at 37 °C prior to injection.
2.26.4 Pronuclear microinjection of fertilised eggs.
Mouse egg pronuclei were injected using a Nikon Diaphot TMD inverted microscope 
with Nomarski optics. Separate Leitz micromanipulators were used to direct the holding 
pipette and the injection needle. The holding pipette was controlled by an inverted 
micrometer syringe (Beaudolin, supplied by Microinstruments Ltd., Oxford). The entire
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system including the holding pipette itself was filled with Fluorinert FC77 (Sigma, 
Dorset). Injection needles were filled by capillary action and were then backfilled with 
Fluorinert FC77. Injection was regulated by air pressure which was controlled by a 50 
ml ground glass syringe.
An injection chamber was prepared for use as described in section 2.25.1 and 1 0 - 2 0  
fertilised mouse eggs were placed in the chamber. DNA solution is injected into the 
pronucleus by depressing the plunger on the 50 ml glass syringe. If the pronucleus is 
injected properly it should swell visibly. The needle is the removed quickly to prevent 
damage to the pronucleus and the injected egg is placed to one side of the injection 
chamber, away from the uninjected embryos.
Once all the eggs in the chamber have been injected the viable embryos are removed 
from the injection chamber, washed in M l6 medium and replaced in another microdrop 
culture. This procedure is repeated until approximately 100 fertilised eggs are injected. 
The embryos are the culture overnight in a humidified, gassed incubator at 37 °C. 
Overnight the embryos should divide to reach the two-cell stage.
2.26.5 Transfer of embryos into pseudopregnant fem ales.
MF 1 female mice (0.5 days p.c.) approximately 6-12 weeks old were used as recipients 
for injected embryos. Recipient mice were mated the night before with vasectomised 
MF1 stud males (obtained already vasectomised from Harlan Olac). Mice were visually 
inspected and those judged to be in oestrus were selected and mated with the stud males. 
The next day recipient mice were checked for coital plugs. Plugged mice were used as 
recipients for eggs injected with DNA on the previous day.
Recipient mice were anaesthetised by injection of 100//I of anaesthetic. The anaesthetic 
was made by mixing 1 volume of Hypnorm™ (Janssen Pharmeceutica, Tilburg) with 1 
volume of Hypnovel™ (Roche) and diluting with 2 volumes of sterile dH20 . The lower 
back of the mouse was then shaved. A transfer pipette (made previously as described in 
section 2.25.1) was then loaded with embryos. The eggs to be transferred were 
removed from the microdrop culture and washed twice in M2 medium. About 1 0 - 2 0  
embryos were transferred into each of the two oviducts in a recipient mouse. An 
incision in the skin and body wall is made just above the ovary. The body wall is then
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stretched to stop any bleeding. The fat pad attached to the ovary is then pulled through 
the incision and clipped with a serafine to hold it outside the body.
The mouse is the placed under a stereomicroscope. The swollen opening to oviduct, the 
infundibulum, was identified and a small tear was made in the bursa above it. The 
transfer pipette was inserted and the embryos were blown into the oviduct. The ovary 
was replaced and the incisions in the skin and body wall were then closed with stitches. 
The whole procedure was then repeated on the other oviduct. At the end of the 
operation the recipient mouse was left in a warm area to recover. Mice were monitored 
to see if they became pregnant and litters were assessed for the presence of transgenes.
2.27 Preparation of genomic DNA from mouse biopsies.
Genomic DNA was isolated from mice of various ages by biopsies of tail. 
Approximately 1 cm of tail was cut and placed in a microfuge tube containing 700 fi\ of 
lysis buffer (50 mM Tris-Cl pH 8.0,100 mM EDTA, 100 mM NaCl and 1% (w/v) SDS). 
30 fi\ of a 12.5 mgml1 solution of Proteinase K was added to the tube and it was 
incubated for 10 - 16 hours at 56 °C. After cooling and mixing 25 fi\ RNase (12.5 
mgml'1) was added and the sample and the tube was incubated at 37 °C for 3 hours. 750 
fi 1 of phenol was then added to the tube and it was placed on a vertical rotator for 30 
minutes. The sample was then spun in a microfuge for 15 minutes and the separated 
aqueous phase was transferred to a fresh tube. This extraction procedure was repeated 
with phenol : chloroform and with chloroform : isoamylalchohol. The DNA was then 
precipitated with 1.5 volumes of 100 % ethanol. The DNA was then spooled onto the 
sealed end of a glass micropipette and was washed in 70% and then 100% ethanol. The 
end of the pipette was broken off and placed in a microfuge tube containing 250 fxl TE 
buffer (10 mM Tris-Cl pH 8.0; 1 mM EDTA). The tube was then left overnight at 37 °C 
to ensure the DNA was properly dissolved.
2.28 Preparation of RNA from transgenic mouse biopsies.
A discontinuous CsCl gradient was used to prepare RNA from various mouse tissues. 
All solutions used in the protocol were DEPC-treated or made up with DEPC-treated 
dH20. The tissue sample was first of all ground in liquid N2 using a mortar and pestle.
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The powder was then scraped into a universal containing 8 ml of 5 m  guanidinium 
solution (5 m  guanidinium thiocyanate, 50 m M  Tris-Cl pH 7.0, 50 m M  EDTA, 5% (v/v) 
p-mercaptoethanol, 2% (w/v) sodium laurylsarcosine). A 14 ml polycarbonate tube was 
washed out with DEPC-treated dH20  and then filled with 2 mis of CsCl solution I (~ 5.7 
m  CsCl, 50 mM EDTA pH 7.0 ; refractive index = 1.3925). This CsCl solution was then 
underlaid by 2 ml of a CsCl solution II (~ 5.7 m  CsCl, 50 m M  EDTA pH 7.0 ; refractive 
index = 1.4025). The DNA solution was then carefully overlaid on top of the CsCl 
gradient. The tube was spun for 60 - 72 hours in an ultracentrifuge at 25 000 rpm and 
20 °C. After centrifugation the supernatant was removed from the tube leaving the 
RNA pellet at the bottom of the tube. The bottom of the tube was removed to allow 
access to the RNA pellet and the pellet was resuspended in 600 pi of dH20 . The RNA 
was then precipitated with 60 pi of 3 m  sodium acetate (pH 7.0) and 1.7 ml of ethanol. 
This was cooled to -20 °C for 3 hours and then centrifuged for 15 minutes at 12 000 
rpm, 4 °C. The RNA pellet was washed in 70 % ethanol and then resuspended in DEPC 
dH20 . Ethanol was added to the RNA solution to a final concentration of 50% and the 
sample was stored at -20 °C.
2.29 Staining of tissue for (3-galactosidase activity.
2.29.1 Staining whole murine tissues.
Staining of tissues was done according to the methods of Whiting et a l  (1991). Tissue 
samples to be stained were first of all fixed in 1% formaldehyde, 0.2% glutaraldehyde, 2 
mM MgCl2, 5 mM EGTA, and 0.02% NP-40 in PBS at 4 °C for 30 to 90 minutes, 
depending on size. Very large tissue pieces were partially dissected to permit full 
penetration of reagents. The samples were then washed in three changes of PBS plus 
0.02% NP-40 at room temperature for 30 minutes each. The samples were then stained 
in 1 mgml'1 5-bromo-4-chloro-3-indolyl p-D-galactoside (X-gal), 5 mM K3Fe(CN)6, 5 
mM K4Fe(CN)6.6H20  and 2 mM MgCl2, 0.01% sodium deoxycholate, and 0.02% NP-40 
in PBS at room temperature overnight in the dark. The samples were then washed again 
as described above and fixed overnight in 4% paraformaldehyde at 4 °C.
The fixed and stained tissue samples were then sent to the Pathology Department at 
Glasgow University Veterinary School. They were dehydrated, and embedded in
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paraffin wax. Sections were cut from the samples and the sections were dewaxed and 
counterstained with eosin. The sections were mounted and visualised by light 
microscopy.
2.29.2 Staining frozen sections.
Frozen sections were cut by Iain McMillan in the Pathology Department at Glasgow 
University Veterinary School. The frozen sections were washed with 0.02% NP-40 in 
PBS twice for 5 minutes. The samples were then fixed in 0.2%
glutaraldehyde, 2 mM MgCl2, 5 mM EGTA, and 0.02% NP-40 in PBS for 5 minutes. 
The samples were then washed twice with 0.02% NP-40 in PBS. The sections were 
then stained with 1 mgml'1 X-gal, 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6.6H20  and 2 mM 
MgCl2, 0.01% sodium deoxycholate, and 0.02% NP-40 in PBS. The staining was 
carried out for 36 hours in a humid 37 °C incubator in the dark. After staining the 
sections were again washed twice with 0.02% NP-40 in PBS for 5 minutes. The 
samples were then returned to the Pathology Department at Glasgow University 
Veterinary School. The sections were stained with eosin, dehydrated and mounted. The 
tissue sections were visualised by light microscopy.
2.30 Treatment of mice with chemical mutagen MNNG.
In order to reactivate the transgenic marker gene, mice were treated with the chemical 
carcinogen MNNG either by topical application or intra-peritoneal injection. For topical 
application a stock solution of 3 mgml'1 MNNG in acetone was made. A dose of 200/n\ 
(a total dose of 600 //g) of this solution was applied to the back of the mice in a fume 
hood. This dose was repeated as often as twice weekly. For intra-peritoneal injection a 
stock solution of 2.5 mgml1 MNNG in tricaprylan (Fluka) was made. This was injected 
in to pregnant mice at day 8 - day 15 of pregnancy. Mice to be injected were initially 
weighed and a volume of the stock solution was injected such that the mice received a 
total dose of 5-25 mgkg'Mlnouye and Murakami, 1978; Faustman et al., 1989)
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3. Results
3.1 Design of strategy for cell marking.
Design is of paramount importance to the success of cell marking experiments. Care 
was taken to design a flexible system with the potential to be applied to all tissues 
although the main focus of the research was murine epidermis. There are a number of 
methods previously used for cell marking and lineage analysis in mice as discussed above 
in Section 1.12.2.
The application of a classical cell marking technique to the clonal analysis of murine 
epidermis has yet to be successfully attempted. Comparison of the epidermis to other 
tissues such as the intestinal epithelia and the haemopoietic system indicates that cell 
marking would contribute a great deal of useful information to the understanding of the 
development and maintenance of this tissue. No cell marking technique used
has addressed the relationship between stem cell in the basal layer of the epidermis and 
the stem cells of the hair follicle. Marking of stem cells in the hair follicle could establish 
whether these cells usually contribute or are capable of contributing to the regeneration 
of interfollicular epidermis.
An attempt at classical cell marking had already been made in this laboratory. 
Recombinant replication-deficient retroviruses containing the Escherichia coli (E. coli) 
lac Z  gene as a marker were applied to skin which had been disrupted by abrasion 
(Boeger-Brown, 1993). The same technique has been used to generate tumours in the 
epidermis when the applied retroviruses contained mutant H-ras oncogenes. The 
tumours generated contained the retroviruses applied. Very few marked cells were 
observed when skin treated with lac Z-containing retroviruses was stained for the 
activity of P-galactosidase. This may be due to a low rate of infection or perhaps a low 
expression of the lac Z  gene in skin cells in situ although the retrovirus construct 
expressed lac Z  at high levels in tissue culture.
One of the main problems in designing a useful marker for murine epidermal cells is the 
lack of naturally occurring marker genes which have been used to great effect in cell 
lineage studies in Drosophila and the intestinal epithelium. For the purposes of this 
project it was decided to introduce a marker gene into transgenic mice. Expression of 
the gene in the epidermis would allow the epidermal cell to be marked and their lineage
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and contribution to the maintenance of the tissue to be determined. The use of 
transgenic mice would allow the development of a marker system in the epidermis which 
could also be applied to the analysis of cell lineage in different mouse tissues. This could 
be done by targeting the expression of the marker gene to the tissue of interest by 
altering the promoter which controls the gene. A ubiquitous promoter would allow 
expression of the gene in a wide variety of tissues and be useful in determining lineage 
throughout the mouse. A tissue-specific promoter could be used to engender high level 
expression of the marker gene in a tissue of interest although the marking in this case 
would be restricted to only one tissue.
The major problem encountered when using transgenic mice as a vehicle for cell marking 
is the expression of the introduced gene. It is vital to consider that the expression of an 
introduced transgenic marker gene could be patchy. The transgene may be expressed at 
a high level in one cell but in the neighbouring cell be expressed at a different level or 
even not at all. When the expression of the marker gene is patchy it is necessary to 
ensure that the gene must bej activated to mark the cell and not inactivated. If
the maker gene was to be inactivated to markcells it would be impossible to distinguish 
the marked cell clones from cells which had randomly shut down expression of the gene.
When the marker gene is activated by a genetic event the marked cell clones are 
distinguished as the only cells that express the gene in the tissue. There is no 
interference from background expression in other cells in the tissue as they do not 
express the gene. This makes identification of cell clones much more simple. The effect 
of patchy expression may be to disguise some marked cells by preventing expression of 
the marker gene. It will not cause cells to be wrongly identified as marked cells. There 
is a possibility that all cells in a clone may have similar levels of expression. This would 
mean that clones of cells would be composed entirely of cells expressing the gene or 
entirely of cells not expressing the gene. This would prevent any problems with 
identification of only parts of clones rather than the whole clones. The effect of patchy 
expression of a transgene in mice would then be to reduce the frequency of clones 
generated in the mouse but not to affect the outcome of the clonal identification.
When transgenic mice are generated by pronuclear microinjection of DNA usually a 
number of copies of the transgene integrate in a head to tail array. This would 
potentially create problems if trying to inactivate a gene to mark a cell. Obviously if a 
cell contains a number of copies of a marker gene it would be necessary to inactivate all 
copies of the gene to mark the cell and distinguish it from the rest of the population. 
This is not a problem if the marker gene requires to be activated and not inactivated. If
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a cell contains a number of copies of a marker gene which must be activated in order to 
distinguish it from the rest of the population the increased copy number may become an 
advantage. As the copy number is increased so the number of potential targets for 
activation is increased. This could lead to an increased frequency of marked cells 
generated when the mice are exposed to the activating agent.
3.1.1 Design of cell marking gene for use in transgenic mice.
The design of any marker gene must take into account the concepts discussed above. 
Initially a marker gene is required which can be expressed in all or most tissues of a 
transgenic mouse. A mechanism is required*) activate this marker in single cells at a low 
enough frequency to distinguish individual cell clones. The frequency of detection must 
still be high enough to allow easy identification of clones in mouse tissues. Thirdly to 
perform in situ analysis of clones of cells populating mouse tissues the marker gene must 
be easily distinguishable in tissue sections or whole mount preparations.
The Escherichia coli (E. coli) lac Z  gene was selected as a suitable candidate for a 
marker gene in the tissues of transgenic mice. The lac Z  gene is not expressed in 
mammalian tissue and so marked cells expressing the gene would be easily 
distinguishable from the rest of the tissue where the gene could not be expressed. It had 
already been widely used in analysis of cell clones and gene expression in a wide variety 
of murine tissues. These analyses have demonstrated that the protein product of the lac 
Z  gene is non-toxic and does not affect cell behaviour. This is a vital property of any 
marker gene used to analyse the population of normal mouse tissue by cell marking. If 
cell behaviour was affected by the expression of a marker gene the normal patterns of 
cell division may be disturbed, perhaps not only in the cells expressing the gene but also 
in the surrounding cells. This would render any conclusions reached by the use of the 
cell marking technique invalid, as the patterns of cell clones observed in murine tissue 
containing cells expressing the marker may be different from the patterns in normal 
tissue. The lac Z  gene does not seem to influence cell behaviour and therefore 
circumvents this potential problem.
The E. coli lac Z  gene codes for a protein product, p-galactosidase which is an enzyme. 
This enzyme is easily detectable in situ with a simple histochemical stain containing 5- 
bromo-4-chloro-3-indolyl P-D-galactoside (X-gal). This makes the lac Z  gene 
potentially very useful as a cell marker for analysis of the patterns of cell division|in tissues
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in vivo. Neither the protein nor the products of the histochemical stain are diffusible. 
This is also of tremendous importance. Diffusion of either the enzyme or the products 
of the stain could lead to the identification of cells which do not express the gene as 
marked cells because they acquire the marker or the stain from neighbouring marked 
cells.
Once a suitable marker gene for transgenic mice was determined it was then necessary to 
design a system for activation of the gene. Work going on in the laboratory at the time 
suggested that point mutation may provide a good system for activating marker genes. 
Point mutation was responsible for the activation of H-ras oncogenes in mouse skin 
tumours. An average of 12 and up to 50 skin tumours can be produced on the back skin 
of one mouse by treatment of the skin with chemical carcinogens as initiators and 
promoters (Kemp et al., 1993; C. Kemp, personal communication). Furthermore the 
activation of H-ras oncogene was dependent on specific changes in the gene sequence 
which could only be produced by treatment of the mice by specific carcinogenic 
chemicals.
After initiation of the tumours by activation of the ras oncogene the initiated cells must 
then undergo further changes before they can produce visible tumours on the back of the 
mouse. These changes are probably happen at a low frequency in cells and it is unlikely 
that every initiated cell produces a tumour. This means that if 50 tumours are produced 
the number of initiated cells which have suffered a point mutation at a specific base in 
the ras proto-oncogene by a single treatment with an initiating chemical carcinogen must 
be considerably higher than 50. It seems likely therefore that specific point mutation 
could be used as a method to activate marker genes at a reasonably high rate in murine 
epidermis.
The gene must be inactivated by a point mutation in its sequence before it can be used as 
a marker gene in this system. When this point mutation is reversed by the action of the 
chemical mutagen the marker gene is activated and distinguishes the cell from the 
background cells in the tissue. In the case of an enzyme (such as the lac Z  gene selected 
as a marker) this point mutation must interfere with the activity of the enzyme. This 
could be for instance be achieved by a point mutation which alters an amino acid at the 
active site of the enzyme.
The frequency of activation of the marker gene could be increased if the point mutation 
required to activate the gene correlated with the specificity of a particular chemical 
sequence. Chemical mutagens often induce certain mutations at a higher frequency than
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others. This occurs because the local DNA environment affects the interaction of the 
mutagenic chemical with the DNA and the shape distortion caused by the binding of the 
chemical to the DNA affects the resultant base substitution. Mutagenic chemicals will 
often mutate specific bases more frequently than others. N-nitro-N'-methyl-N- 
nitrosoguanidine (MNNG), for instance, methylates guanine residues more readily than 
to other nucleotide bases (the specificity of this chemical is more extensively discussed in 
Section l.|14.1).
It was decided to target the translation initiation codon (5 ATG3) of the lac Z  marker 
gene to prevent translation of the protein from the mRNA. This method could provide 
two separate advantages over mutation of a single amino acid residue. A mutation at 
this residue would be very likely to prevent wild-type function of the gene. If the gene is 
not translated from RNA to protein it can not function at all as an enzyme. Obviously 
there is still a possibility that such a mutation would be leaky as translation may be 
initiated at an alternate site. The gene would still have to be tested in tissue culture 
before use in transgenic mice as a marker gene.
Another reason for selecting the lac Z  5'ATG3’ initiation codon as the target for 
mutagenesis was that it allowed the insertion of more than one target site for the 
chemical mutagen. This could be accomplished by cloning an oligonucleotide containing 
a number of target sites for a chemical mutagen in front of the gene substituting for the 
initiation codon (Figure 1). Mutation at any one of the sites in the oligonucleotide 
would result in the production of an in-frame initiation codon which would result in the 
translation of the gene and activation of the gene. Mutation in the oligonucleotide may 
attach a few amino acids on to the amino terminus of the gene. It was thought that these 
few amino acids would be unlikely to affect the function of the gene as the (3- 
galactosidase protein has been used frequently as a fusion protein. This does not seem 
to affect the enzymatic function of the gene.
3.1.2 Design of the oligonucleotides for the fusion marker genes.
To increase the chances of producing a useful marker gene by the construction of the 
oligonucleotide-lac Z  fusions it was decided to design two different oligonucleotides as 
potential mutagen target sites. Each of these two oligonucleotides was constructed to 
contain target sites for a different type of chemical mutagen. One oligonucleotide was 
designed to be activated by a point mutagen, the other was constructed to by activated
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Figure 1. Diagram of the lac Z  marker gene strategy.
An oligonucleotide inserted in front of a lac Z gene with no initiation codon is used to 
activate the gene.
Lac Zgene with no 
ATG initiation codon
Oligonucleotide with target site for chemical 
mutagen inserted in front of gene
Exposure to the chemical mutagen causes 
a mutation in the sequence of the 
oligonucleotide which results in the 
production of an in-frame ATG initation codon
by a frameshift mutagen. The point mutagen selected was N-nitro-N'-methyl-N- 
nitrosoguanidine (MNNG - see Sections 1.17.1 and 3.1.3 for a discussion of the activity 
and oligonucleotide construction). This was selected because it is very mutagenic has a 
highly specific site of action. The mutations it causes have been characterised and it has 
been used successfully to induce H-ras mutations in murine epidermal cells in vivo. The 
frameshift mutagen selected was N2-acetylaminofluorene (AAF - see Sections 1)14.1 
and 3.1.4 for a discussion of the activity and oligonucleotide construction). This was 
selected because it also has a well characterised mutagenic activity and a highly defined 
target sequence. It is a potent liver carcinogen and although it is debatable whether or 
not it will have any mutagenic activity in epidermal cells. Treatment of mice with 
activated derivatives such as N-acetoxy-acetylaminofluorene should produce the 
appropriate DNA adducts. This will hopefully extend the range of tissues to which this 
technique can be applied.
Because of the lack of available restriction sites and the availability of lac Z  fusion 
vectors it was decided to clone these oligonucleotides blunt-ended into the fusion vector 
pMC 1871 (obtained from Pharmacia). The design and structure of the oligonucleotides 
is discussed below. At the same time as designing oligonucleotides with target sites for 
chemical mutagens it was necessary to engineer oligonucleotides which contained the 
predicted changes that would activate the gene. These would act as controls and allow 
testing to confirm that once the predicted mutation occurred it actually resulted in the 
activation of the lac Z  marker gene.
3.1.3 Structure of oligonucleotide activated by MNNG.
For the purposes of this project it was desirable to construct an oligonucleotide which 
contains as many target sequences as possible for MNNG, mutation at any one of which 
would result in the production of an in-frame ATG initiation codon. This can be done 
by constructing an oligonucleotide with a series of 5GTG3 codons and putting these 
sequences in frame with the gene (Figure 2). Direct repetition of these sequences 
ensures that a series of 5'GG3' mutagen target sites are produced. Mutation of the 3' G 
residue to an A will result in the production of an in-frame ATG start codon. The GTG 
codon specifies the amino acid valine so the reading frame will be maintained throughout 
the length of oligonucleotide. If mutation occurs anywhere along the length of the 
oligonucleotide at a predicted target sequence the protein should be translated with a 
small number of valine residues at the amino terminus. The oligonucleotide starts with a
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Figure 2. Structure of the oligonucleotide activated by MNNG.
The most frequent mutation induced by the chemical MNNG is a G to A transition at the 3' 
sequence G residue of a 5GG3 sequence. This known specificity was used to design an 
oligonucleotide which would activate a lac Z  gene with no initiation codon when mutated 
by MNNG to generate an in-frame initiation codon. The sequence of the test (A) and 
control oligonucleotides (B and C) are shown.
M N N G
I Oligonucleotide inserted in 
front of lac Z  gene
Test Oligo (A):
5 ‘
AAA GTG GTG GTG G
3‘
TG GTG GTG GTG GTG
Treatment with chemical 
mutagen MNNG
5‘
AAA GTG GTG GTG GT
\ 3'
G GTG GTG GTG GTG
met -  val -  val -  val -  val
Control Oligos:
(B) AAA ATG GTG GTG GTG GTG GTG GTG GTG GTG
(C) AAA GTG GTG GTG GTG GTG GTG GTG GTG ATG
series of three A residues in order to ensure that it has a proper ribosome binding site so 
the protein will be efficiently translated in the event of mutation (Kozak, 1983).
Control oligonucleotides were also designed which included ATG sequences at either 
the first or the last GTG codon. These were made to demonstrate that the gene would 
be expressed in the event of a mutation in the oligo. If mutations at the first and last 
GTG codons are capable of activating the gene this implies that mutation anywhere 
along the sequence of the oligo will activate the gene. The MNNG-mutation test 
oligonucleotide was named oligonucleotide A, the 5' ATG control was named 
oligonucleotide B and the 3' control was named oligonucleotide C.
3.1.4 Structure of oligonucleotide activated by AAF.
An oligonucleotide was designed to take advantage of the mutational specificity of the - 
AAF adduct (Figure 3). The oligo consists of an ATG initiation codon followed by a 
run of GC dinucleotides such that the ATG codon is two bases out of frame with the 
coding sequence of the gene. An -AAF adduct at any one of these should result in the 
deletion of a dinucleotide which will bring the initiation codon into frame with the rest of 
the gene. The coding sequence is maintained throughout the sequence of the oligo 
which should code for six alternating alanine and arginine residues before reaching the 
coding sequence of the gene. To ensure there is a proper ribosome binding site there is 
a sequence of three A nucleotides before the ATG (Kozak, 1983). A control 
oligonucleotide was also designed to ensure the gene would be expressed if the deletion 
took place and that the short amino acid fusion does not interfere with protein function.
Treatment of rats with AAF results in the production of the acetylated adduct on 
guanine residues in liver cell DNA (Beland et a l,  1982; Poirier et a l , 1983, 1992). 
However epidermal cells do not contain the enzymatic pathway which is responsible for 
generating the reactive metabolites in the liver (Kreik, 1974). In the liver the reactive 
species is formed by the action of a sulphotransferase enzyme which forms a sulphate 
ester from the oxygenated N-hydroxy-acetylaminofluorene (NH-AAF). Formation of 
this sulphate ester bond allows the generation of a nitrenium ion which is capable of 
reacting with DNA. In other tissues the acetylated adduct can be produced via the 
formation of the formation of another ester N-acetoxy-AAF.
As AAF cannot be metabolised in the skin it is not a potent carcinogen in this tissue. 
There is evidence that AAF does not damage DNA in epidermal cells as it does not
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Figure 3. Structure of the oligonucleotide activated by AAF.
The carcinogenic chemical AAF will cause the deletion of two base pairs in a 5GCGCGC3 
sequence. When the test oligonucleotide is exposed to the metabolically activated form of 
the AAF chemical a resultant two base pair deletion will bring the oligo into frame with the 
lac Z  gene. The sequence of the control oligonucleotide (E) is also shown.
GCGCGC
GCGC
Oligonucleotide inserted in 
front of lac gene
Test Oligo (D):
5'
AAA ATG GCG CGC GCG CGC GCG CGC GC
Treatment with chemical 
mutagen AAF
5' 3 ‘
AAA ATG GCG CGC GCG CGC GCG CGC
met - ala - arg - ala - arg - ala - arg -
Control Oligo:
(E) AAA ATG GCG CGC GCG CGC GCG CGC
cause unscheduled DNA synthesis in these cells (Sayer et a l,  1988). Treatment of 
epidermal cells with the reactive metabolite of AAF, N-acetoxy-acetylaminofluorene, 
does result in the production of -AAF adducts on the DNA in murine epidermal cell 
lines. These adducts are only present as 3 - 5% of the total DNA adducts formed 
(Poirier et al., 1979, 1980). The presence of these adducts in epidermal cells though 
indicates that this compound should be able to cause the reverse mutation in the 
oligonucleotide which will activate the lac Z  gene. This should be true not only in the 
epidermis but also in other tissues. The 26 bp AAF test oligo was named 
oligonucleotide D and the 24 bp control oligo with the in-frame ATG sequence was 
named oligonucleotide E.
3.2 Cloning of fusion genes and expression vectors.
3.2.1 Synthesis and analysis of oligonucleotides.
The first step in construction of the mutant lac Z  fusion genes was the synthesis of the 
specific oligonucleotides which were to act as target sequences for the chemical 
mutagens to activate expression of the lac Z  gene. The oligonucleotides were 
synthesised single-stranded on an Applied Biosystems 381A Synthesiser. A total of 10 
oligonucleotides were synthesised (the sequences of these oligonucleotides are described 
in Section 2.7.3). These represented the positive and negative strands of the two test 
and three control oligos to be cloned into the lac Z  fusion vector. The oligonucleotides 
were visualised in polyacrylamide gels by UV shadowing. Using this technique all the 10 
synthesised oligonucleotides were visualised and shown to be complete.
Once good preparations of all 10 oligonucleotides had been obtained the corresponding 
positive and negative strands were annealed (described in Section 2.7.1). Figure 4 
shows a selection of these oligos. Each of the oligonucleotides is represented by a single 
band which shows that each one of the oligos is intact. When the oligos have been 
mixed and annealed the band shifts to a new location. Each of the annealed oligo 
mixtures seems to consist mainly of annealed double-stranded oligos and very little 
single stranded product. Inspection of the gel perhaps suggest that the annealing of 
oligos 9 and 10 may have worked less well than the others. This may well be due to the
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Figure 4. U. V. shadowing of the oligonucleotides.
The oligonucleotides were run on polyacrylamide gels and visualised by U. V. shadowing to 
check the integrity and the annealing, (a) Gel showing oligos 1, 2, 3 and 4 before and after 
annealing to their corresponding partners, (b) Oligos 5, 6, 9 and 10 before and after 
annealing to their corresponding partners.
9/10
large number of GC repeats found in the oligos and the fact that these oligos would be 
able to self-anneal.
3.2.2 Cloning of oligonucleotides in pMC1871.
Once double-stranded oligos representing the two test and three control 
oligonucleotides had been obtained the next stage was to clone these in front of the lac 
Z  gene. This was done by cloning the oligos blunt-ended into the lac Z  fusion vector 
pMC1871. The structure of the pMC1871 plasmid and the cloning strategy are outlined 
in Figure 5. This vector contains an entire lac Z  gene which is missing the first eight 
codons of the lac Z  gene.
As the vector is missing the first eight codons it has no 5 ATG3' initiation codon which 
makes it perfect for use in this system. The oligos were cloned into the unique Sma I  
site of the fusion vector which is at the start of the lac Z  gene. Great care was taken to 
ensure that the oligos were cloned so that the ATGs or potential ATGs were in-frame 
with the rest of the lac Z  gene and that they would be capable of initiating translation of 
the lac Z  gene once in place. The pMC1871 vector was restricted with Sma I  restriction 
enzyme. The oligos were then cloned directly into the plasmid vector without 
modification.
After ligation the mixture was redigested Sma I  enzyme to remove unwanted 
recircularised bacteria and then transformed into bacteria as described in Section 2.8. 
The cloning strategy performed very well. A large number of colonies were obtained 
and when minpreps were performed on these clones 100% of the plasmids obtained were 
resistant to restriction with the Sma I  endonuclease.
3.2.3 Mutations in the sequence of the oligos cloned into vector.
All of the miniprep DNA samples checked were resistant to cutting with the Sma I 
restriction enzyme. This indicated that they may contain oligonucleotides. A few of 
these minipreps were selected for sequencing. These were then sequenced to reveal the 
orientation of the oligonucleotides and if the oligonucleotides were intact. DNA was 
prepared from the selected bacterial clones by the medium scale method described in
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Figure 5. Cloning of double stranded oligonucleotides into pMC1871.
(a) Outline of the cloning strategy, (b) Restriction endonuclease digestion of the plasmid. 1) 
1 kb ladder 2) Undigested pMC1871 3) pMC1871 digested with Sal /. Cuts out a 3.1 kb 
lac Z  gene. 4) pMC1871 digested with Sma /. linearises 7.5 kb plasmid. 5) Undigested 
pMC1871 containing ligated oligonucleotide. 6) pMC1871 containing oligo digested with 
Sal /. 7) pMC1871 containing oligonucleotide digested with Sma /. It does not cut.
(a) Sma I restriction site
pMC1871
te t pBR ori
excess of oligonucleotides.
Ligated DNA recut withSma I 
to remove recircularised vector.
Double stranded 
oligonucleotide
I
Not kinased.
Sm a  /enzyme.
Vector DNA purified, 
not phosphatased.
Ligated in 10 fold molar
(b)
1 2 3 4 5 6 7
I
Ligated DNA transformed into bacteria. 
Resultant plasmid should contain oligonucleotide.
Oligonucleotide inserted in front 
of lac Z gene.
lac Z  fusion gene
tet pBR ori
Section 2.9.2 or occasionally by the caesium chloride method described in section 2.9.3. 
Both methods were provided DNA of sufficient purity to give good sequencing results.
Unfortunately when the sequences of the oligos cloned into the plasmid pMC1871 were 
determined a very high mutation rate of the oligos was discovered. By this method a 
total of five oligonuctleotide A inserts and twelve oligonucleotide E inserts were 
sequenced. The oligonucleotide A sequence was designed to be activated by MNNG 
and consists of a run of GTG trinucleotides. Of the five oligonucleotide A inserts 
sequenced four were in the wrong orientation and one was in the correct orientation. 
One of the five oligo A inserts displayed the correct sequence but was in the wrong 
orientation. The other four oligonucleotides sequenced displayed mutations.
The most significant mutagenesis was observed in the cloning of the oligonucleotide D 
inserts. This oligo was designed to be activated by AAF and consists of a run of GC 
dinucleotides. Of the 12 oligo D inserts sequenced five were in the correct orientation 
but all 12 displayed a mutant sequence. Three mutant oligonucleotide sequences are 
shown in Figure 6. Some sequence compression is visible in both these sequences. All 
the mutations in the oligo D inserts sequenced were invariably addition or deletions in 
the run of GC dinucleotides. Ten of the mutations were deletions and the remaining two 
were addition mutations. Although it may have been possible to clone the 
oligonucleotide sequences based on a run of GTG trinucleotides by this system it seemed 
unlikely that the oligonucleotides based on the GC dinucleotide repeat would be cloned 
using this system.
3.2.4 Use of SURE™ bacteria to clone repetitive oligo sequ en ces.
As it was proving impossible to clone the oligonucleotides by the method previously 
described a strain of bacteria called SURE™ (Stop Unwanted Rearrangement Events) 
was purchased from Stratagene to enable the cloning of these repetitive sequences. 
These bacteria allow the cloning of pieces of DNA which are 'unclonable' in other strains 
of E. coli. Host bacteria can often delete foreign pieces of DNA which take up unusual 
conformations. The SURE™ bacteria have been engineered to carry mutations 
inactivating the pathways which catalyse the rearrangement of these DNA pieces. These 
include mutations in the rec B, rec C, uvr C and umu C genes. These mutations help to 
allow the cloning of highly unstable DNA structures such as cruciforms formed by 
inverted repeat sequences and Z-DNA. The Z-DNA conformation is formed by
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Figure 6. Sequencing of mutant oligos in pMC1871.
Sequencing of oligonucleotides in pMC1871. The oligonucleotides shown have all 
undergone rearrangements during the cloning procedure, (i) Mutant oligonucleotide B in 
reverse orientation. Nine base pairs have been deleted from the oligo. (ii) Mutant 
oligonucleotide D. Four base pairs have been added to the sequence, (iii) Mutant 
oligonucleotide E. Twelve base pairs have been deleted from the oligonucleotide sequence.
( i )
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stretches of alternating purine and pyrimidine residues. The oligonucleotide D and E 
sequences is based largely of dinucleotide GC repeats and therefore consist mainly of 
alternating purine and pyrimidine residues which might be expected to adopt the Z-DNA 
conformation. This may be the explanation for the deletions of the bases in the D and E 
oligonucleotides in the DH5a bacteria initially used.
Unfortunately the SURE™ E. coli carry an F  plasmid which carries the tetracycline 
resistance gene. As the selection for the pMC1871 plasmid is based on the tetracycline 
resistance gene it was necessary to reclone the lac Z  sequences into another vector 
which carried another resistance gene. The vector chosen for this purpose was pBR322. 
The cloning strategy for this purpose is described in Figure 7. The lac Z  sequences from 
the pMC1871 vector were excised with the restriction enzyme Sal I  and ligated into the 
Sal I  site in the tetracycline resistance gene of the pBR322 vector (described in Section 
2.7). After ligation the mixture was transformed into DH5a™ cells. The bacterial 
colonies were picked and replica-plated onto duplicate agar plates, one of which 
contained ampicillin as the selective antibiotic and the other contained tetracycline. A 
few colonies which grew on the ampicillin plate but not the tetracycline plate were 
selected. One of these plasmids contained the correct lac Z  insert. This plasmid could 
now be used to clone the oligonucleotides in front of the lac Z  gene in the SURE™ 
bacteria.
The new vector, named pBRlacZ, contains no Sma I  restriction enzyme site other than 
the one directly juxtaposed to the front of the lac Z  gene and therefore still allowed the 
cloning of the oligonucleotides into the unique Sma I  site in front of the lac Z  gene. The 
same cloning strategy was used to clone the oligos into pBRlacZ as described above for 
pMC1871 (see Section 3.2.2 and Figure 5).
The new cloning strategy still did not work perfectly. Only 50% of the minipreps from 
bacterial colonies produced by transformations of the SURE bacteria were indigestible 
by the Sma I  enzyme and therefore only 50% could contain inserts. It is possible that 
these bacteria may be more easily transformed by linear DNA although this was not 
tested. Alternatively the conditions for digestion of the plasmid may not have been 
perfect. Of these 50% approximately 75-90% proved to be impossible to sequence. 
This was despite the fact that the DNA preparations were intact and digested with 
restriction enzymes other than Sma /. Eventually detailed restriction analysis of the 
clones which could not be sequenced demonstrated that 100% of these clones had 
suffered a deletion of >200 bp of the plasmid sequence at the beginning of the lac Z  
gene, around the oligonucleotide. This deletion had also included the binding site for the
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Figure 7. Cloning of the pBRLacZ vector.
(a) Diagram of the cloning strategy, (b) Restriction enzyme digestion of the plasmids. 1) 1 
kb ladder. 2) pMC1871 digested with Hpa /. 3) pMC1871 digested with Pst /. 4) 
pMC1871 digested with Sal /. 5) pBRLacZ digested with Hpa /. 6) pBRLacZ digested 
with Sal I. 7) pBRLacZ digested with Pst /.
pBR322
pBR ori
Cut with Sal I 
restriction enzmye.
Sal I site
Linear pBR322 
DNA purified.
i
lac Z
L a c Z  gene ligated 
into the pBR322 vector.
I
(b)
Sma I 
restriction site
pBRlacZ
iau l .
PMC1871
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with Sal I enzyme.
Sal I site
1 2 3 5 6 7
pBR ori
universal primer and therefore as the primer site was deleted it was impossible to 
sequence these clones. The reason for these extremely frequent deletions remains a 
mystery. It is possible that they were caused by recombination with DNA sequences 
present in these SURE™ bacteria.
The remainder of the clones could however be sequenced. Of these approximately 75% 
contained oligonucleotide inserts. Remarkably, >90% of the oligonucleotide sequences 
were intact and had suffered no mutation. All of the 5 oligo inserts were eventually 
cloned by this method. Figure 8 shows the sequencing of a pBRlacZ clones containing 
oligos A, B, D and E. All of the oligos were present in the correct orientation and the 
entire sequence of the oligo can be read from the sequencing gel flanked by the 
appropriate plasmid sequences. Similar sequencing results have been obtained for the 
other oligonucleotide C demonstrating that it was cloned in the correct orientation in 
front of the lac Z  gene and is intact.
Each of the lac Z  fusion gene was named after the oligonucleotide that it contained. The 
fusion genes, named LacZ4, LacZ5, LacZc, LacZD and LacZ5 contained the 
oligonucleotides A, B, C, D and E respectively (the oligonucleotides are described in 
Figures 2, 3 and 5, and in Section 2.7.3 and the names of the constructs are outlined in 
Figure 9).
3.2.5 Cloning of lac Z  fusion genes into plrv-Neo-Act.
After constructing the oligonucleotide-Azc Z fusion gene the next step was to clone all of 
the fusion genes into expression vectors to test the marker genes in tissue culture. The 
plasmid vector plrv-Neo-Act-LacZ was selected for use as an expression vector. The 
vector is a replication-incompetent Muloney murine leukaemia virus (MoMuLV). The 
use of this vector had a number of advantages for the purposes of this project.
Firstly the expression of the lac Z  gene was driven by a 400 bp rat (3-actin promoter. 
This would allow expression of the marker genes in a wide variety of cell types. The 
vector also contained a neo gene which confers resistance to the antibiotic G418. This 
would allow the selection of stably transfected cell lines to test the effectiveness of the 
marker gene approach. In addition the vector contains both a cap site and a poly A tail 
for the mRNA which should help the expression of the cloned genes. The whole 
construct was part of a replication deficient retrovirus which would allow the production
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Figure 8. Sequencing of oligonucleotides in pBRLacZ.
Intact oligonucleotide sequences cloned into pBRLacZ. All sequences are in the correct 
orientation, (i) Intact oligonucleotide A. (ii) Intact oligonucleotide B (iii) Intact 
oligonucleotide B. (iv) Intact oligonucleotide E.
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Figure 9. Table of names of the constructs generated.
The lac Z fusion genes were named after the oligonucleotides that they contain. The 
expression vectors are referred to by the name of the promoter that controlled the 
expression of the lac Z fusion gene.
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of retroviruses containing the marker genes for infection of cells with single copies of the 
marker genes. This vector had previously been used to generate transgenic mice with 
the lac Z  gene and wide expression of the transgene in embryonic mice (Beddington et 
al., 1990). Expression of the transgene was almost ubiquitous in the early embryo and 
the construct would certainly be useful for analysis of lineage in the tissue of prenatal 
mice. Hopefully this would be useful for testing the marker gene in vivo in as well as in 
tissue culture.
The plrv-Neo-Act-LacZ vector was obtained from Rosa Beddington in Oxford. The 
vector already contained a wild-type lac Z  gene and could be used as a positive control 
in transfection experiments. It is subsequently referred to as Act-LacZvv/w ^ e. In order 
to clone the marker genes into the vector the wild-type lac Z  gene was removed by 
digestion with the restriction endonuclease Bam HI. The vector was then religated the 
resultant plasmid plrv-Neo-Act vector was used for the cloning of the marker gene 
constructs in pBRLacZ. These constructs were cloned into the Sal I  site in the 
polylinker in front of the (3-actin promoter. Figure 10 shows a diagram of the plrv 
construct and the cloning strategy used to insert the marker genes in front of the 
promoter.
The cloning of the marker genes into the plrv-Neo-Act vector was performed according 
to the methods outlined in Section 2.7. The vector was restricted with Sal I and 
phosphatased to prevent self-religation. The marker genes were removed from the 
pBRlacZ vector by restriction with Sal I  and the fragment separated on a low-melting 
point agarose gel. The band containing the 3.1kb lac Z  insert was isolated using 
Geneclean™. The plrv-Neo-Act vector was mixed with inserts at various 
concentrations and ligated with T4 DNA ligase in appropriate conditions overnight at 
14°C. All ligations were transformed into SURE™ competent bacteria in order to 
maintain the integrity of the oligonucleotide sequences.
Despite these precautions the cloning of these vectors proved to be very inefficient. A 
very low number of marker gene inserts were found in the plasmids obtained from 
minipreps of colonies obtained from transformation of the ligated vector insert mixtures 
into the SURE™ competent cells. The marker gene inserts seemed to act as inhibitors 
and prevented religation of vector alone. A lower number of colonies was frequently 
obtained with transformations vector/insert mixtures than vector alone. This did not 
seem to be due to a contaminant of the insert preparations as insert were ligated into the 
vector with very little problem. The low frequency of ligation was perhaps caused by 
the same mechanism which caused the deletions in the pBRlacZ/oligo ligations described
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Figure 10. Cloning of the lac Z fusion genes into plrv-Neo-Act.
(a) Outline of the cloning strategy, (b) Restriction enzyme digestion of the plasmids. 1) 1 
kb ladder 2) pBRLacZ4 digested with Hpa I. 3) pBRLacZ4 digested with Sal /. 3.1 kb 
band is the lac Z  gene. 4) plrv-Neo-Act linearised with Sal /. 5) Act-LacZA construct 
linearised by Not /. 6) Act-LacZ4 construct cut with Sal /. Removes lac Z  from the 
construct.
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in Section 3.2.4. Digestions of miniprep samples with restriction enzymes often revealed 
unusual band sizes which suggested that rearrangement of the vector was occurring. 
When the number of colonies obtained from the transformation of the vector/marker 
gene ligation were less than that of the vector alone no plasmids containing the correct 
insert were obtained. Even when the number of colonies obtained by transformation of 
the vector/marker gene ligation was greater than that of vector alone as little as 1% of 
the miniprep samples analysed contained the correct insert.
Eventually all the marker gene constructs and the control construct were cloned into the 
plrv-Neo-Act vector. Once the marker gene constructs were cloned into the plrv-Neo- 
Act vector the oligonucleotides were sequenced to check that their integrity had been 
maintained (Figure 11). All the constructs contained oligonucleotides which were intact 
and maintained their sequence. No mutations were observed in the oligonucleotide 
sequences during this cloning step.
Each vector was named after the lac Z  fusion gene it contained. The vectors were called 
Act-LacZ'4, Act-LacZ5, Act-LacZc, Act-LacZD and Act-LacZ^ and contained the fusion 
genes LacZ'4, LacZ5, LacZc, LacZD and LacZE respectively (Figure 9 describes the 
names of the constructs generated). The original vector which contains an intact lac Z 
gene under the control of a [3-actin promoter was used as a positive control when testing 
the oligo/lac Z  fusion gene constructs and is referred to as Act-LacZ*"^'^.
At the same time as the construction of the marker gene constructs another vector was 
generated as a negative control for the transfection experiments discussed in Section 3.3. 
This vector included the lac Z  gene with no ATG sequence and no oligonucleotide 
inserted in front of it. As the gene has no ATG start site inserted in front of the coding 
sequence of the lac Z  gene the mRNA transcribed from this gene should not be 
translated and the cells should not express the (3-galactosidase protein. This lac Z  gene 
was cloned directly from the vector pMC1871 into the Sal I  site in front of the p-actin 
promoter in the plrv-Neo-Act plasmid. This was achieved using exactly the same 
strategy used for cloning the oligo/lac Z  fusion genes into the same site as described 
above. This negative control construct was designated Act-Lac Z/^767 677.
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Figure 11. Sequencing of oligonucleotides in plrv-Neo-Act and plrv-Neo-K5 
constructs.
The oligonucleotides retained their integrity after subcloning into of the lac Z  fusion genes 
into expression vectors, (i) Sequencing of oligonucleotide D after subcloning of the LacZD 
fusion gene into plrv-Neo Act. (ii) Sequencing of oligonucleotide E after subcloning into 
the p!rv-Neo-K5 construct.
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3.2.6 Generation of plrv-Neo-K5 vector.
In order to obtain expression of the marker gene constructs specifically in epidermal 
cells principally in transgenic mice but also in epidermal cells in vitro, a vector 
containing an epidermal specific keratin promoter was constructed. This vector was 
constructed from the plrv-Neo-Act expression plasmid described in Section 3.2.5. This 
was used as a basis for the construction of a new expression vector because it contained 
a number of useful elements. This vector was based on a replication incompetent 
retrovirus and would allow the production of retroviruses and the vector contains the 
neo gene under the control of the viral LTR region which confers resistance to the 
antibiotic G418.
The promoter chosen for the epidermal specific vector was a 1.4 kb piece of the 5' 
sequence of the bovine keratin III (BK III) gene. This gene is equivalent to the human 
keratin 5 gene and is expressed in the basal layer of the epidermis in mouse (Byrne et al., 
1994). This promoter had already been shown to express at high levels in murine 
epidermal cell lines during the course of other projects going on in the laboratory. The 
new epidermal specific vector, named pIrv-Neo-K5, was constructed by swapping the
1.4 kb fragment of the BK III gene for the 400 bp (3-actin promoter present in the plrv- 
Neo-Act construct. The cloning strategy used to construct the pIrv-Neo-K5 expression 
vector is detailed in Figure 12.
The BKIII was ligated directly into the Bgl II/Bam HI sites in the plrv-Neo vector using 
the standard techniques described in Section 2.6. The plrv-Neo vector was 
phosphatased and mixed with different concentrations of the BKIII insert and was then 
ligated with T4 DNA ligase. Part of each ligation reaction was then transformed into 
SURE™ competent bacteria. In contrast to the results obtained with the cloning of the 
oligollac Z  fusion genes this cloning step worked very efficiently. Greater than 94% of 
the clones analysed contained the appropriate insert.
3.2.7 Cloning of lac Z fusion genes D and E into plrv-Neo-K5.
The lac Z  fusion genes were cloned into the pIrv-Neo-K5 construct in a similar fashion 
to the plrv-Neo-Act vector (Figure 13). The Sal I  enzyme site could not be used as this 
enzyme cut in the K5 promoter. Instead, an Xho I  site located in the polylinker at the 3' 
end of the K5 promoter and cloned into the plrv-Neo vector along with the K5
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Figure 12. Generation of the plrv-Neo-K5 expression vector.
(a) Diagram of the cloning strategy, (b) Restriction enzyme digestion of plasmids. 1) 1 kb 
ladder. 2) pIC-K5 construct linearised by digestion with Bam HI. 3) 1.4 K5 promoter 
excised by digestion with Bam HI/Bgl II enzymes. 4) plrv-Neo-Act linearised with Not I. 
5) 400 bp actin promoter removed from plrv-Neo-Act by digestion with Bgl 77/ Bam HI. 6) 
pIrv-Neo-K5 linearised by Not I. 7) 1.4 kb K5 promoter removed from pIrv-Neo-K5 by 
digestion with Bgl II.
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Figure 13. Cloning of lac Z fusion genes into plrv-Neo-K5.
Outline of the cloning strategy used to clone the fusion genes.
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promoter was used instead. Xho I  and Sal I  have compatible restriction overhang 
sequences which allowed the lac Z  fusion genes removed from the pBRLacZ vector by 
restriction with Sal I to be cloned directly into the Xho I  site at the 3' end of the K5 
promoter.
The cloning of the marker genes D and E into the pIrv-Neo-K5 vector was performed 
according to the methods outlined in Section 2.7. The vector was restricted with Xho 
and phosphatased to prevent self-religation. The marker gene-oligonucleotides were 
removed from the pBRlacZ vector by restriction with Sal I  and the fragment separated 
on a low-melting point agarose gel. The pIrv-Neo-K5 vector was mixed marker gene 
inserts at various concentrations and ligated with T4 DNA ligase in appropriate 
conditions overnight at 14°C. All ligations were transformed into SURE™ competent 
bacteria in order to maintain the integrity of the oligonucleotide sequences. This cloning 
step proved to be slightly more efficient than the cloning of the lac Z  fusion genes into 
the plrv-Neo-Act vector. Approximately 5% of the minipreps prepared from colonies of 
transformed SURE™ E. coli. contained the appropriate insert.
Once the marker gene constructs were cloned into the pIrv-Neo-K5 vector the 
oligonucleotides were sequenced to check that their integrity had been maintained 
(Figure 11). Both the constructs contained oligonucleotides which were intact and 
maintained their sequence. The vectors were named after the lac Z  fusion gene they 
contained. The vectors were called K5-LacZD and K5-LacZE and contained the fusion 
genes LacZD and LacZE respectively (Figure 9 describes the names of the constructs 
generated).
3.2.8 Cloning of fragments of lac Z  gene into pBluescript for generation 
of and DNA and RNA probes.
Three fragments of the lac Z  gene were cloned into the pBluescript™ plasmid for use as 
RNA and DNA probes for the analysis of transgenic mouse tissues. The pBluescript™ 
vector was used because it contains sites for the T3 and T7 RNA polymerases. Figure 
14 outlines the fragments of the lac Z  gene cloned for use as probes.
All the lac Z  inserts prepared were excised from the lac Z  gene by restriction with Cla I  
and a restriction enzyme that cleaved the DNA such that it is blunt ended (either Hpa I  
or Eco RV). The inserts were subsequently cloned into a the pBluescript™ SK+ vector
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Figure 14. Cloning of lac Z fragments for DNA and RNA probes.
(a) Diagram of the lac Z  fragments selected for use as probes and the pBluescript™ vector.
(b) Restriction enzyme analysis of the resultant constructs. 1) 1 kb ladder. 2) 398 bp 
fragment excised from pBluescript by digestion with Bgl II. 3) 290 bp fragment. 4) 227 bp 
fragment.
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that had been restricted with Cla I  and the blunt-end cutter Eco RV. The cloning was 
performed according to the methods detailed in Section 2.7. This cloning step worked 
very efficiently and approximately 75% of the minipreps screened contained inserts. 
Three different sized inserts were prepared to allow different sizes of probes to be 
prepared.
3.3 Testing of marker system in vitro.
3.3.1 CaP04 transfection of Act-Lac Z fusion genes into a murine 
fibroblast cell line.
The plrv-Neo-Act-LacZ fusion gene constructs were transfected into cells in vitro to 
test that the constructs allowed the appropriate expression of the p-galactosidase 
protein. The initial transfections were performed on the murine embryonic fibroblast cell 
line NIH 3T3. The NIH 3T3 cells were cultured according to the methods detailed in 
Section 2.11.1 and the transfections of the fusion gene expression constructs were 
carried out according to the CaP04 method detailed in Section 2.12.1. After 
transfection the cells were cultured for a further three days in growth medium. The 
cells then fixed and stained for (3-galactosidase activity with a stain containing the 
chromogenic (3-galactosidase substrate 5-bromo-4-chloro-3-indolyl (3-D-galactoside (X- 
gal) as detailed in Section 2.15.
The results of these transfection experiments are detailed in Figure 15. Two negative 
control transfections were set up. The first of these transfections was with the plrv- 
Neo-Act vector alone which has no lac Z  gene sequence at all. None of the transfected 
cells with this vector stained with the X-gal stain. This demonstrates that the cells have 
no intrinsic background enzymatic activity to convert the X-gal from colourless to blue. 
For the other negative control NIH 3T3 cells were transfected with the vector Act- 
\j&cLPMC18?1 (described in section 3.2.4). This vector includes a lac Z  gene with no 
endogenous ATG initiation codon and no oligonucleotide inserted in front of it. There 
was no staining in thejcells transfected with this construct either. This indicates that |3- 
galactosidase enzyme is not translated from a lac Z  gene which has no ATG initiation 
codon.
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Figure 15. Transfection of Act-LacZ constructs into NIH3T3 cells.
(a) Transfected NIH3T3 cell populations stained with X-gal for |3-galactosidase activity, (i) 
A c t-L a c Z ^ '^ . (ii) Act-LacZ'4. (iii)Act-LacZ5. (iv) Act-LacZD. (b) Table of (3- 
galactosidase activity in transient and stable transfections of NIH3T3 cells with the Act- 
LacZ constructs. Cells were stained in 25cm2 flasks according to the method outlined in 
Section 2.15. Transiently transfected cells were stained two days after transfection. Pools 
of stably transfected cells were stained after four weeks selection in G418 when sufficient 
numbers of selected cells had been obtained. Flasks were screened under a light 
microscope. Positive indicates that a high proportion (>1%) of cells stained strongly with 
X-gal. Negative indicates no staining cells were seen.
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(b)
Construct transfected. Transient NIH3T3 transfection. Stable NIH3T3 transfection.
plrv-Neo-Act Negative Negative
plrv-Neo-Act-LacZp/WC7877 Negative Negative
plrv-Neo- Act-LacZ lv//c/"fKpe Positive Positive
plrv-Neo-Act-LacZ7' Negative Negative
plrv-Neo- Act-LacZfi Positive Positive
plrv-Neo-Act-LacZc Positive Positive
plrv-Neo-Act-LacZD Positive Positive
plrv-Neo-Act-LacZE Positive Positive
A high level of p-galactosidase expression was observed in the cell transfected with the 
Act-LacZ*'1**'^ construct which contains the original intact lac Z  gene. This
demonstrates that the expression vector is functional and supports the expression of the 
p-galactosidase protein in fibroblast cells. These experiments also demonstrate that high 
levels of p-galactosidase expression can be achieved by transient transfection of the plrv- 
Neo-Act constructs into fibroblast cells and that this system would be useful for testing 
the lac Z  expression.
When the cells were transfected with the plrv-Neo-Act-LacZ'4 construct there was no 
staining observed in any of the cells. This indicates that the addition of the
oligonucleotide A sequences to the lac Z  gene did not initiate translation of the protein. 
This oligonucleotide consists of a sequence of GTG trinucleotides in-frame with the lac 
Z  coding region with no ATG initiation site. The possibility existed one of the GTG 
sequences in this oligo would act as an alternate start site in the absence of an ATG 
initiation codon and that translation would be started randomly within the sequence of 
this oligo. As there is no expression of the gene from the test oligo A sequences this 
suggests that it might be a useful marker gene.
Transfection of the Act-LacZ5 and Act-LacZc constructs into the fibroblast lines 
resulted in high expression of the p-galactosidase protein. These constructs contain the 
oligo//ac Z fusion genes constructed with the oligonucleotides B and C respectively. 
Oligonucleotides B and C are the two control oligonucleotides for the oligo to be 
activated by MNNG (detailed in Figure 2). Both these oligonucleotides contain a 
sequence of GTG trinucleotides but with one ATG trinucleotide in-frame with the 
sequence of the lac Z  gene. Both of these support the expression of the p-galactosidase 
protein in cell in vitro. This demonstrates that the principal of the marking system 
works. A mutation in the sequence of the GTG oligonucleotide to give an ATG 
sequence in-frame with the coding region of the lac Z  gene will cause translation of the 
mRNA and expression of the p-galactosidase protein. These results also indicate that 
the short amino acid sequences which to oligo adds to the coding sequence of the lac Z 
gene do not interfere significantly with the enzymatic activity of the p-galactosidase 
protein.
The oligonucleotide B has an ATG sequence at the 5' end of the GTG trinucleotide 
repeats and the oligonucleotide C has an ATG sequence at the 3' end of the GTG 
trinucleotide repeats. Both of these oligonucleotides support the expression of the p- 
galactosidase protein in transfected cells in vitro. Hence a start signal at either end of 
the inserted oligonucleotide is able to initiate translation of the protein. These results
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indicate that an ATG sequence anywhere along the sequence of the oligonucleotide 
would be able to initiate translation of the gene. Therefore a mutation which generates 
an ATG at any point along the sequence of the oligonucleotide should be able to initiate 
translation of the gene. There are a number of potential target sites in the sequence for 
activation of the marker gene by the chemical mutagen MNNG. Thus the first set of 
transfections demonstrated that the LacZA fusion marker gene would be useful as a 
marker gene for lineage analysis.
The results obtained by transfection of the constructs, Act-LacZD and Act-LacZ^, 
designed to be activated by the chemical mutagen AAF were not so encouraging. 
Transfections of the control construct Act-LacZ£ into the fibroblast cell line NIH 3T3 
resulted in the expression of the (3-galactosidase protein in these cells. This 
demonstrates that the expression of the gene can be supported by this oligonucleotide 
and that the short amino acid sequence added to the protein by the coding sequence of 
the oligonucleotide does not interfere with the activity of the (3-galactosidase protein. 
This also demonstrated that a mutation in the sequence of the test oligo D (described in 
Figure 3 and Section 3.1.3) which deleted a GC dinucleotide and brought the ATG 
sequence into frame with the coding region of the lac Z  gene would initiate translation 
of the gene.
Unfortunately transfection of the test construct Act-LacZ° also resulted in high 
expression of the (3-galactosidase in the transfected fibroblast cells. There were several 
possible explanations for the aberrant expression of the protein from this oligo. It is 
entirely possible that the oligonucleotide D did not prevent translation of the gene even 
though the ATG initiation codon is two bases out of frame with the rest of the lac Z  
gene. This would obviously make this oligo useless for the construction of a marker 
gene. Perhaps the oligonucleotide adopted a conformation in the cell that it allowed 
translation of the gene by missing out a few bases of the oligonucleotide bringing the 
ATG start codon into frame with the rest of the coding sequence of the lac Z  gene.
The observed anomalous expression in the fibroblasts could also have been due to 
mutation in a single construct. Transfecting cells by the CaP04 method may introduce a 
large number of copies of a transfected piece of DNA into each cell. If one of the copies 
of the Act-LacZ0 construct was rearranged or mutated during transfection then 
expression of the lac Z  gene may be detected in a number of transfected cells even 
though the majority of the constructs remain silent. Mutations often occur during 
transfection of constructs into cells. If for instance, the mutation rate was 5% and each 
transfected cell had on average 10 copies of the construct, the number of cells that
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would be expected to express the gene is 50% of the transfected cell population. This 
rearrangement could even occur in the bacteria when the constructs were grown up in 
order to make the DNA. When cloning in bacteria these oligonucleotides they proved to 
be very unstable (see Section 3.2.4). The integration site of the DNA constructs may 
also affect the expression of the transfected genes. In order to test these hypotheses it 
was decided to introduce low copy numbers of the gene into cells (detailed in Sections 
3.3.3 and 3.3.4). If the observed expression is due to a rearrangement in a small 
proportion of transfected pIrv-Neo-Act-LacZD vector then the majority of cells which 
contain a single copy of the gene should not express the (3-galactosidase protein.
3.3.2 CaP04 transfection of Act-Lac Z fusion genes into a murine 
keratinocyte cell line.
As the marker genes were designed for use principally in epidermal cells, CaP04 
transfections were carried out in murine keratinocyte cell lines in order to confirm that 
the conclusions reached from the results obtained from the transfections into fibroblast 
cells were also valid in epidermal cells. The murine epidermal cell line C5N was chosen 
as the recipient for the constructs as this cell line was not transformed and most closely 
resembled normal epidermal cells. These cells were cultured and maintained according 
to the methods detailed in Section 2.11.
The cells were transfected in duplicate both by CaP04 and lipofection for comparison 
(these techniques are described in Sections 2.12.1 and 2.12.2 respectively). 5 fig of 
DNA was transfected into cells in duplicate F75 flasks by each of these techniques in 
order to determine the efficiency of transfection in epidermal cells. Both techniques 
were almost equally effective for the transfection of epidermal cells, although the 
transfection efficiency obtained with the CaP04 techniques was probably slightly higher. 
The subsequent transfections described in this Section were performed by the CaP04 
technique.
The CaP04 transient transfections into the C5N cells largely confirmed the results 
obtained by transfection of the NIH 3T3 cells (detailed in Figure 16). Transfection of 
the negative control constructs plrv-Neo-Act and AcX-LsLc2fMCI871 produced no 
expression of the lac Z  gene in the transfected cells whereas transfection of the positive 
control construct Act-LacZ*^ ^  again resulted in a high level of (3-galactosidase
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Figure 16. Transfection of Act-LacZ constructs into C5N cells.
(a) Transfected C5N cell populations stained with X-gal for p-galactosidase activity, (i) 
Act-LacZ"M-m, (ii) Act-LacZ4. (iii)Act-LacZc. (iv) Act-LacZ^. (b) Table of p- 
galactosidase activity in transient and stable transfections of C5N cells with the Act-LacZ 
constructs. Cells were stained in 25cm2 flasks according to the method outlined in Section 
2.15. Transiently transfected cells were stained two days after transfection. Pools of stably 
transfected cells were stained after four weeks selection in G418 when sufficient number of 
selected cells had been obtained. Flasks were screened under a light microscope. Positive 
indicates that a high proportion (>1%) of cells stained strongly with X-gal. Negative 
indicates no staining cells were seen.
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Act-LacZ wild'type Positive Positive
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Act-LacZ B Positive Positive
Act-LacZ c Positive Positive
Act-LacZ 0 Positive Positive
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activity in the epidermal cells. The level of (3-galactosidase activity was rarely as high in 
epidermal cells as it was in the fibroblasts.
When the marker construct Act-LacZ'4 was transfected into epidermal cell lines no 
expression of the lac Z  gene was observed, confirming the result obtained in the 
fibroblasts. Transfection of the control constructs Act-LacZ5 and Act-LacZc generated 
high levels of expression in the epidermal cells. In accordance with the transfection of 
the positive control Act-LacZw / w construct the expression observed in the epidermal 
cells was markedly lower than the expression observed in the fibroblast cell 
transfectants.
This confirmed the conclusions drawn from the transfections into NIH 3T3 cells. The 
test construct did not express while the control construct produced (3-galactosidase 
expression. The next step is to test this hypothesis and determine whether the mutagen 
MNNG is able to activate the test construct Act-LacZ'4 in epidermal cells in vitro. In 
order to achieve this a population of stable transfectants is required.
Selection of clones of stable transfectants should ensure that a high proportion of the 
cells express the RNA for the lac Z  gene and would be available as a target population 
for the activation of the marker gene by MNNG. The levels of lac Z  RNA expression in 
the stable transfectants could be determined and clones with high expression of lac Z 
RNA could be used as a target for reactivation by chemical mutagens. It would be 
helpful if the stably transfected cell population contained only one construct, this would 
allow a reasonable estimate of the mutation frequency to be calculated. If the cells 
contained more than one construct it would be impossible to tell how many of the 
transfected vectors were expressed and therefore acting as a target for reactivation by 
the mutagen.
The results of the transfections with the Act-LacZD and Act-LacZ5 constructs were also 
in accordance with the results obtained by transfection of these constructs into fibroblast 
cells. High levels of expression were obtained with both the test and control constructs. 
The expression from the oligonucleotide in the test Act-LacZ° construct which does not 
have a in-frame initiation codon was unexpected. In order to test if the observed 
expression of the (3-galactosidase protein is due to mutation or rearrangement in a small 
proportion of constructs it was decided to use a transfection technique which is known 
to introduce only one or a few constructs into each cell. If each cell contains only one 
construct and then only a small number of cell should express the protein.
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The transfected C5N cell populations were cultured in G418 to select cells which are 
stably transfected. This was done to confirm that the expression patterns observed in the 
transient transfections were maintained, and not artefacts caused by the transfection 
efficiency of the various constructs. After the culture period of three weeks a control 
population of cells transfected with carrier DNA alone had been completely killed by the 
G418. Approximately the same number of cell colonies were obtained in the flasks from 
each of the transfected cell population. This suggested that the transfection efficiencies 
had been similar in all of the transfections. This also demonstrated that the product of 
the neo gene was expressed in the transfected cells and could be utilised for selecting 
transfected cell populations.
After three weeks of selection the resultant transfected cell clones were pooled. The 
cells were trypsinised and replated at high density into F75 flasks. After two days the 
cells were fixed and stained with X-gal to look at the activity of the (3-galactosidase 
protein. The expression observed in the stably transfected epidermal cell populations 
mirrored that observed in the transient transfections of both the fibroblast and epidermal 
cell lines. No expression was detected in the C5N epidermal cells stably transfected with 
the negative control constructs plrv-Neo-Act and A ct-LacZ^'7577, as well as the 
MNNG-test oligo fusion construct Act-LacZ'4. High levels of expression were observed 
in the cells transfected with the positive control construct Act-LacZ/^7777577 and the 
MNNG-strategy control constructs Act-LacZfi and Act-LacZc. In addition both the test 
and control constructs of the AAF-strategy fusion genes Act-LacZ75 and Act-LacZE 
were also observed to express (3-galactosidase protein at high levels in these cells. This 
confirmed the results obtained from the transient transfections of both the fibroblast and 
keratinocyte cell lines.
3.3.3 Production of retroviruses by CaP04 transfection of W2 cells with 
Act-LacZ fusion genes.
Retroviruses were produced from all of the Act-LacZ fusion genes by transfection of the 
murine embryonic fibroblast viral producer cell line, ^2 . This was done principally to 
test the AAF-test oligonucleotide construct Act-LacZ75. Expression of (3-galactosidase 
protein is obtained unexpectedly in cells transfected with this construct. The 
oligonucleotide in this gene codes for an ATG initiation codon which is 2 bp out of 
frame with the coding sequence of the lac Z  gene and should therefore not initiate 
translation of the protein.
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The lac Z  marker gene in the Act-LacZD construct was generated from an 
oligonucleotide sequence which proved to be highly unstable when cloned in bacteria 
(see Section 3.2.4). A mutation or rearrangement in the sequence of this oligonucleotide 
in a small proportion of the constructs transfected into cells by the CaP04 technique may 
cause expression in a significantly higher number of transfected cells. If the erroneous 
expression is caused by rearrangement or mutation in a small proportion of the 
constructs then, if each cell only contains one or a few transfected constructs, only a 
small proportion of the cells should express the (3-galactosidase protein.
The W2 cell line is a murine embryonic fibroblast line which contains a retrovirus with a 
DNA packaging deficiency. It contains all the elements necessary for the viral life cycle 
except that it lacks the correct sequences necessary for the packaging of the viral RNA 
genome into the viral particles. When a DNA construct is introduced into the T*2 cells 
which includes the appropriate packaging sequences, the introduced construct is 
packaged into the viral particles in place of the endogenous viral genome. The Act- 
LacZ fusion genes are based on a retroviral vector which has the appropriate packaging 
sequences and when introduced into W2 cell the constructs will be incorporated into 
infectious viral particles.
Retroviruses were produced from each of the Act-LacZ fusion genes by transfection of 
the W2 cells by the CaP04 techniques (described in Section 2.12.2). The T2 cells are 
cultured in under the same conditions and using the same medium as the NIH 3T3 cells 
(described in section 2.11). A proportion of the transfected cells were examined for (3- 
galactosidase activity by staining with X-gal (Figure 17). After G418 selection the 
surviving cells in the flasks transfected with the Act-LacZ fusion gene constructs were 
growing in discrete colonies. The transfected colonies were pooled and used as a source 
of retroviruses to infect murine epidermal cells as described below.
3.3.4 Infection of a murine keratinocyte cell line with retroviruses.
Retroviruses containing the Act-LacZ fusion genes were used to infect the murine 
epidermal cell line C50. The retroviruses were produced from pools of CaP04 
transfected W2 cells (described above in Section 3.3.3 and Figure 17) and used to infect 
the keratinocyte cell line as described in Sections 2.13 and 2.14. Pool of W2 
transfectants were used to generate retroviruses for each of the Act-LacZ fusion genes.
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Figure 17. Transfection of Act-LacZ constructs into W2 cells.
(a) Transfected W2 cell populations stained with X-gal for (3-galactosidase activity, (i) Act- 
'L?icZmld'type. (ii) Act-LacZ'1. (iii)Act-LacZc. (iv) Act-LacZ^. (b) Table of (3-galactosidase 
activity in transient and stable transfections of ^ 2  cells with the Act-LacZ constructs. Cells 
were stained in 25cm2 flasks according to the method outlined in Section 2.15. Transiently 
transfected cells were stained two days after transfection. Pools of stably transfected cells 
were stained after four weeks selection in G418 when sufficient number of selected cells 
had been obtained. Flasks were screened under a light microscope. Positive indicates that a 
high proportion (>1%) of cells stained strongly with X-gal. Negative indicates no staining 
cells were seen.
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Two days after infection the cells were fixed and stained for p-galactosidase activity with 
X-gal. The results from these infection experiments are shown in Figure 18.
Again the negative control construct Act-LacZ^MCw; showed no expression of P- 
galactosidase expression, while in the positive control cell population infected with the 
plrv-Neo-Act-LacZ*^'^ construct a high level of p-galactosidase expression was 
observed. Again the expression of the p-galactosidase protein produced from the 
MNNG-strategy test and control constructs was as expected. Cells infected with the 
test oligo construct Act-LacZ'4 showed no sign of expression of the lac Z  gene whereas 
cells infected with MNNG oligo control constructs Act-LacZ5 and Act-LacZc 
demonstrated consistently high levels of expression comparable to that observed in the 
positive control infections performed with the retrovirus containing the wild-type lac Z 
gene.
Disappointingly the expression of the AAF-strategy constructs in cells infected with 
retroviruses containing the LacZD and LacZE fusion genes also mirrored the results seen 
in previous transfection experiments. High levels of expression were seen in cell infected 
with retroviruses derived from both the Act-LacZD and the Act-LacZE constructs. The 
expression levels of the p-galactosidase protein observed in the cells infected with the 
construct was very similar when compared to each other and comparable to the positive 
control. More than 50% of the cells express the gene. These cells have not been 
selected and the remaining 50% of the cells which do not express the gene may not be 
infected. As the cells contain relatively few copies of the construct and a high number of 
the cells express p-galactosidase protein most of the Act-LacZD constructs must be 
expressing a functional enzyme. As the majority of the Act-LacZD constructs express 
the p-galactosidase protein the explanation of the aberrant expression of p-galactosidase 
from the oligo D/lac Z  fusion gene is very unlikely to be mutation or rearrangement of 
the oligonucleotide.
After this result the oligonucleotide in the Act-LacZD construct was sequenced again to 
check its integrity and ensure that it had not suffered a mutation resulting in the 
observed aberrant p-galactosidase expression. The sequencing revealed that the 
oligonucleotide D sequence is still intact but revealed that an ATG sequence is located in 
the 3' end of the p-actin promoter about 61 base pairs upstream of the oligonucleotide. 
This ATG sequence is in frame with the coding sequence of the lac Z  gene and there is 
an open reading frame stretching from this ATG sequence through the oligonucleotide 
to the coding region of the lac Z  gene. This ATG can probably initiate translation and 
adds about 27 amino acid residues onto the amino terminus of the p-galactosidase. This
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Figure 18. Infection of C50 with Act-LacZ retroviruses.
(a) Infected C50 cell populations stained with X-gal for p-galactosidase activity, (i) Act- 
LacZ'4. (ii) Act-LacZfi. (iii)Act-LacZZ). (iv) Act-LacZ£. (b) Table of p-galactosidase 
activity in virally infected C50 cells with the Act-LacZ constructs. After infection cells 
were selected in G418. Pools of stably transfected cells were stained after four weeks 
selection in G418 when sufficient number of selected cells had been obtained. Cells were 
stained in 25cm2 flasks according to the method outlined in Section 2.15. Flasks were 
screened under a light microscope. Positive indicates that a high proportion (>1%) of cells 
stained strongly with X-gal. Negative indicates no staining cells were seen.
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Act-LacZ8 Positive
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probably explains the aberrant expression of the (3-galactosidase protein from the Act- 
LacZ0 construct.
This upstream ATG only interfered with the expression of the Act-LacZ° construct 
because it is only in-frame with the lac Z  coding region if a 26 bp oligonucleotide is 
inserted in front of the lac Z  gene. The oligonucleotides for the MNNG-test and control 
construct are 30 base pairs long and the AAF-control oligonucleotide in the LacZ° 
fusion gene is 24 base pairs long and hence the upstream ATG sequence is not in-frame 
with the lac Z  gene in these cases.
This problem was circumvented simply by recloning the LacZ° gene in front of another 
promoter. Both the test and control fusion genes LacZ° and the LacZ° were recloned 
into the pIrv-Neo-K5 expression vector (described in Sections 3.2.6 and 3.2.7). The 
new constructs were then transiently transfected into the murine epidermal cell line C50 
by the CaP04 technique. Cells transfected with the K5-LacZ£ construct demonstrated a 
high level of expression of the (3-galactosidase protein. This construct contains the 
AAF-strategy control oligo/lac Z  fusion gene. This demonstrated that the 1.4 kb 
fragment of the BK III promoter was able to support expression of the lac Z  gene in the 
murine epidermal cell at a high levels. Transfections with the negative control construct 
A ct-LacZ^77577 and the AAF-strategy test fusion gene construct K5-LacZ° both 
resulted in no observed expression of the lac Z  gene when the cells were stained for (3- 
galactosidase activity.
The transfections with the K5-LacZ fusion gene constructs indicated that the AAF- 
strategy test fusion gene may in fact be useful for cell marking as it does not itself initiate 
the translation of the (3-galactosidase protein. This result also suggests that the 
expression of the lac Z gene observed in the cells transfected with the Act-LacZD 
construct was probably caused by the upstream in-frame ATG sequence which was 
discovered in the (3-actin promoter sequences. The next step in the in testing the AAF- 
fusion strategy constructs is to generate stably transfected cell lines which can be shown 
to express the mRNA from the lac Z  gene but not the (3-galactosidase protein. Such cell 
lines should allow reactivation of the fusion genes to be tested in vitro.
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Figure 19. Expression of (3-galactosidase protein in Act-LacZ*
electroporation ringclones.
(a) Electroporated C50 cell ringclones stained with X-gal for (3-galactosidase activity, (i) 
Act-LacZ'4 clone 5. (ii) Act-LacZ'4 clone 6. (b) Table of (3-galactosidase activity in the 
Act-LacZ'4 C50 electroporation ringclones. Transfected cells were selected in G418 for 
three weeks until discrete colonies were obtained. The colonies were then ringcloned and 
grown for a further week until sufficient numbers had been obtained to use in experimental 
proceedures. Cells were stained in 25cm2 flasks according to the method outlined in 
Section 2.15. The percentage figure given above represents an estimate of the proportion of 
staining cells based on screening 5 x 105 cells in a 25cm2 flask under an inverted light 
microscope.
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3.3.5 Electroporation of Act-LacZ and K5-LacZ fusion genes into a 
murine keratinocyte cell line.
Electroporation of constructs into epidermal cell lines was performed in order to 
generate stably transfected cell lines for testing the reactivation of the marker genes. 
Electroporation was chosen as the transfection method to introduce constructs into the 
murine epidermal cell line C50 as it is known to introduce a small number of constructs 
into each transfected cell. This method was chosen in preference to the generation of 
retroviruses as it eliminates the need for the intermediate transfection of W2 cells.
C50 is a murine epidermal cell line very similar to the C5N cell line used for the 
transient transfections described above in section 3.3.2. It is an untransformed cell line 
which is not tumorigenic when injected into nude mice in vivo. As such it represents a 
good model for the normal epidermal cell in vitro, the lineage of which the marker genes 
were designed to analyse. The C50 cell line was chosen in preference to the C5N cell 
line as previous work performed in the laboratory had shown that these cells were easily 
transferable by the electroporation technique.
The constructs Act-LacZ4, K5-LacZD and K5-LacZE were all electroporated into C50 
cells and used to generate stably-transfected cell lines. This was done according to the 
methods described in Section 2.12.3. The electroporated cells containing the positive 
and negative control constructs Act-LacZ*'*7'7' ^  and Act-LacZ^767577 were fixed and 
stained after two days. The cells electroporated with the positive control constructs 
contained cell expressing the (3-galactosidase protein at high levels but those which 
expressed the negative control construct Act-LacZ^7*77577 did not show (3-galactosidase 
expression in the transfected cells.
After growth for 3 weeks in the selective medium the transfected cell were growing is 
discrete visible colonies on the bottom of the tissue culture flask. Individual colonies 
were separated by ringcloning. The cell lines were maintained in selective medium 
containing G418 throughout this process. A number of the separate cell lines which 
contained the constructs Act-LacZ4, K5-LacZD and K5-LacZE were selected for analysis 
of marker gene expression.
All of the ringcloned cell lines were grown up and analysed for the expression of the (3- 
galactosidase protein by staining with X-gal. The cell lines ringcloned from the 
population transfected with the Act-LacZ4 construct showed very little expression of the
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Figure 20. Expression of (3-galactosidase protein in K5-LacZD
electroporation ringclones.
(a) Electroporated C50 cell ringclones stained with X-gal for p-galactosidase activity, (i) 
K5-LacZD clone 2. (ii) KS-LacZ75 clone 11. (b) Table of p-galactosidase activity in the 
Act-LacZ4 C50 electroporation ringclones. Transfected cells were selected in G418 for 
three weeks until discrete colonies were obtained. The colonies were then ringcloned and 
grown for a further week until sufficient numbers had been obtained to use in experimental 
proceedures. Cells were stained in 25cm2 flasks according to the method outlined in 
Section 2.15. The percentage figure given above represents an estimate of the proportion of 
staining cells based on screening 5 x 105 cells in a 25cm2 flask under an inverted light 
microscope.
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Figure 21. Expression of p-galactosidase protein in K5-LacZE
electroporation ringclones.
(a) Electroporated C50 cell ringclones stained with X-gal for p-galactosidase activity, (i) 
K5-LacZE clone 1. (ii) K5-LacZE clone 2. (iii) K5-LacZE clone 4. (iv) K5-LacZE clone 6.
(b) Table of p-galactosidase activity in the Act-LacZ4 C50 electroporation ringclones. 
Transfected cells were selected in G418 for three weeks until discrete colonies were 
obtained. The colonies were then ringcloned and grown for a further week until sufficient 
numbers had been obtained to use in experimental proceedures. Cells were stained in 
25cm2 flasks according to the method outlined in Section 2.15. The percentage figure given 
above represents an estimate of the proportion of staining cells based on screening 5 x 105 
cells in a 25cm2 flask under an inverted light microscope.
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lac Z  gene (Figure 19). Only one clone of the transfected cells (clone 5) showed any 
expression of the lac Z  gene at all. This expression was attributed to mutation arising 
during the transfection of the construct into the C50 cells. A similar pattern of 
expression was observed in the cells transfected with the KS-LacZ^ construct. Only 2 of 
18 transfected cell ringclones showed expression of the (3-galactosidase protein in a 
proportion of the cells greater than 1% of the total (Figure 20). In contrast most of the 
K5-LacZ£ expressed the |3-galactosidase protein at high levels (Figure 21).
3.3.6 Southern blot analysis of the Act-LacZ A electroporation 
ringclones.
Twelve ringcloned cell lines containing the Act-LacZ'4 introduced by electroporation (as 
described in Section 3.3.5) were selected and grown up for analysis. Cells from each of 
the ringcloned cell lines were grown to confluence in duplicate FI 75 tissue culture 
flasks. One of the flasks was used for the isolation of DNA from the individual 
ringclones, the other was used for the isolation of RNA from the ringclones. DNA was 
prepared from the cell lines by the method detailed in Section 2.17. After isolation the 
DNA from the different Act-LacZ'4 cell lines was analysed by Southern blot. The results 
of the Southern blot analysis are shown in Figure 22 (described in Section 2.19). The 
blots were probed with a 1 kb fragment of the lac Z  gene.
Twelve separate ringcloned cell lines, transfected with the Act-LacZ'4 construct, were 
analysed and bands were detected which corresponded to the sequences from the lac Z 
gene. This demonstrated that the transfection had worked and that copies of the 
construct had integrated into the genome of the electroporated cells. Of the 12 clones 
analysed only 9 had detectable fragments of the lac Z  gene and only 6 of these gave 
strong signals. Only four of the six electroporation cell clones with strong bands gave 
the correct size of fragment expected for the entire lac Z  gene. Two of these clones (A4 
and A5 in Figure 22b) contained a 9.6 kb band equivalent to the size of the whole 
plasmid when digested with Hind III. This enzyme cuts only once within the plasmid 
sequence and it is likely therefore that these clones contain more than one copy of the 
plasmid integrated in a tandem array. When this blot was repeated with the same DNA 
samples and probed with a fragment of the neo gene all the clones hybridised strongly to 
the probe (Figure 23). This demonstrates that both the transfection and the selection 
steps of the protocol had worked.
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Figure 22. Southern blot analysis of Act-LacZ4 electroporation ringclones.
(a) Southern blot of Bam HI digests of DNA samples from the Act-LacZ'4 electroporation 
ringclones, probed with a 1 kb fragment of the lac Z  gene. Only 4 of the twelve ringclones 
contain the expected 3.1 kb band, (b) Southern blot of Act-LacZ'4 plasmid (P) and Act- 
LacZ'4 cell line DNA (A3-6) probed with a 1 kb fragment of the lac Z  gene. The DNA 
samples have been digested with both Bam HI and Hind III. Clones A4 and A5 contain a
9.6 kb band upon digestion with Hind III which suggests that more than one copy of the 
gene is integrated.
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Figure 23. Presence of the neo  gene in the Act-LacZ4 electroporation
ringclones.
(a) Southern blot of Act-LacZA cell line DNA samples digested with Bam HI and probed 
with a 1 kb fragment of the neo gene. All the cell lines contain the neo gene, some which did 
not have strong bands when probed with lac Z  have strong bands when probed with neo 
suggesting that they have lost the lac Z  gene, (b) Diagram of construct used for 
electroporation. Plasmid was linearised by digestion at the Not I site and electroporated 
into C50 cells. The same strategy was used for both the Act and K5 vectors.
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It seems surprising that although that all the transfected cell lines contained the neo 
resistance gene that more of them do not hybridise strongly to the lac Z  sequences, 
especially as the two gene are located on the same DNA construct. It is obvious that 
some clones {e.g. A7, A8 and All)  hybridise very strongly with the neo probe but not 
with the lac Z  probe. This suggests that there is rearrangement of the lac Z  gene going 
on after electroporation into the cells.
These results were confirmed by PCR (polymerase chain reaction) analysis of the Act- 
LacZ'4 electroporation ringclone DNA samples with the LacZA and LacZB amplimers 
(described in Sections 2.23.1 and 2.23.3). Bands corresponding to the presence of lac Z  
DNA were identified in only six of the twelve clones. These clones were the same six 
which hybridised most strongly with the lac Z  probe when the DNA samples were 
analysed by Southern blot. The reason for this rearrangement of the lac Z  gene remains 
unknown.
3.3.7 Measurement of expression of lac Z  fusion gene levels in Act-Lac Z 
and K5-LacZ electroporation ringclones.
It was important to analyse the RNA and protein levels of the (3-galactosidase enzyme in 
order to identify cell populations in which the activation of the oligo/lac Z  fusion genes 
by chemical mutagens could be tested. The levels of RNA in these cell lines were 
analysed by three different methods: northern blots: the polymerase chain reaction and 
ribonuclease protection. The levels of protein were analysed by simply staining the cells 
with the chromogenic (3-galactosidase substrate, X-gal. Cell lines transfected by 
electroporation with the Act-LacZ'4, K5-LacZD and K5-LacZE were all analysed for 
expression of lac Z  RNA and protein.
The Act-LacZ'4, KS-LacZ^ and K5-LacZE cell lines which had already been analysed for 
the presence of the (3-galactosidase protein were subsequently analysed for expression of 
the lac Z  RNA. The levels of RNA were initially measured by northern blot analysis. 
Figure 24a shows a northern blot of RNA from 9 of the K5-LacZD cell lines. Although 
expression is detectable the levels of expression from the lac Z  under the control of the 
K5 promoter were low. The expression of the lac Z  gene from the (3-actin promoter was 
even lower. The blot was reprobed with a probe for the ubiquitous housekeeping 
enzyme probe, gapdh as a loading control (Figure 24b).
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Figure 24. Northern blot analysis of C50 electroporation ringclones.
(a) Northern blot of RNA derived from Act-LacZ'4 and K5-LacZD electroporation ringclone 
cell lines. Bands corresponding to approximately 7.9 and 4.0 kb are visible in the cell lines 
D2, D3, D5 and D6. The 7.9 kb band corresponds to a transcript of the entire viral genome 
while the 4.0 kb band corresponds to expression of the lac Z  gene from the internal K5 
promoter. Exposed for 3 days at -70°C. (b) Reprobe of the above blot with the gapdh as a 
loading control. Exposed for 5 hours at - 70°C.
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Only five of the nine K5-LacZD clones showed any sign of activity on the northern blot. 
An 8.0 kb band which probably corresponds to the whole virus is visible in lanes D2, 
D3, D5 and D6. In these lanes there is also a 3.9 kb band which probably correspond to 
expression of the lac Z  gene from the internal K5 promoter. When this blot was 
reprobed with the a fragment of the neo gene the 8.0 kb band was visible but not the 3.9 
kb band. This supports the hypothesis that the 8.0 kb band corresponds to a transcript 
of the whole virus.
As the northern analysis was not conclusive, as the levels of expression were extremely 
low it was decided to use PCR analysis of the RNA. This technique was performed 
according to the method detailed in Section 2.23.2. Basically this method involved 
initially generating single-stranded cDNA from RNA by reverse transcription. The 
downstream PCR oligonucleotide was used as a specific primer for this reaction. This 
cDNA was then amplified by PCR and produced a band if the sequence of interest was 
present in the cell RNA. A control to measure any DNA present in the RNA present in 
the sample was run at the same time. The LacZA/LacZB oligonucleotide primer pair 
were used to amplify the cDNA produced by reverse transcription of the RNA in the 
Act-LacZA C50 electroporation ringclones.
The results from this technique (shown in Figure 25) were largely in agreement with the 
northern blot analysis. Three clones which were shown to express the lac Z  RNA by 
northern blot also were shown to express the RNA by PCR analysis as well. Two clones 
showed low level expression of the lac Z mRNA when analysed by PCR. Although 
expression of the lac Z RNA was detectable by PCR, the results from the PCR technique 
proved to be highly variable.
In order to confirm the PCR results the RNA levels were further analysed by another 
technique, the ribonuclease protection assay (Figure 26). This technique was carried out 
according to the method described in Section 2.24. The results of the ribonuclease 
protection assays agreed largely with both the northern blot analysis and the PCR 
reaction (Figure 25). High levels of expression were detected in 3 Act-LacZ'4 clones 1,5 
and 6. Lower levels of expression were seen in clones Act-LacZ'4 3 and 4.
The only major difference was Act-LacZ'4 clone 12 which had been shown to express 
relatively high levels of RNA by PCR but showed no expression by both the northern 
blot and ribonuclease protection. This clone also showed rearranged bands on the 
Southern blot. As the techniques analyse different parts of the lac Z  gene it is possible 
that this clone only expresses part of the lac Z  RNA. The PCR analysis covers a 217 bp
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Figure 25. PCR analysis of lac Z  RNA expression in C50 electroporation
ringclones.
cDNA was generated from the RNA samples derived from the Act-LacZ'4 electroporated 
cell lines. 50 pg of plasmid was used as a positive control for the PCR reaction. The 
reaction were performed with reverse transcriptase (RT) and without (C) as a control for 
DNA contamination, (i) Cell lines A 1, A3 and A4. (ii) Cell lines A5, A6 and A7. (iii) Cell 
lines A8, A ll and A12. (iv)Cell lines A21, A22 and A24.
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Figure 26. Expression levels of lac Z  RNA in Act-LacZ4 electroporation
ringclones.
(a) RNAse protection assay performed with a 227 bp fragment of the lac Z  gene. 
Radiolabelled <|)X174 markers were used to size the bands on the gel. The probe is 
approximately 300 bp in size. tRNA was used as a negative control. The 227 bp protected 
fragment is visible in lanes A l, A3, A4, A5 and A6. (b) A graph of the relative expression 
levels of the lac Z  gene in the Act-LacZ'4 electroporated cell lines.
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Figure 26. Expression levels of lac Z  RNA in Act-LacZ4 electroporation
ringclones.
(a) RNAse protection assay performed with a 227 bp fragment of the lac Z  gene. 
Radiolabelled <j)X174 markers were used to size the bands on the gel. The probe is 
approximately 300 bp in size. tRNA was used as a negative control. The 227 bp protected 
fragment is visible in lanes A l, A3, A4, A5 and A6. (b) A graph of the relative expression 
levels of the lac Z  gene in the Act-LacZA electroporated cell lines.
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fragment of the gene from base 72 to base 289 in the gene, the ribonuclease protection 
assay probe covered the section of the gene from base 836 to base 1063 while the probe 
for the northern analysis covered the bases 1063 to base 1952. Therefore it is possible 
that Act-LacZA clone 12 may only express the first part of the lac Z gene up to base 863.
Eighteen K5-LacZD clones were analysed for the presence of lac Z  RNA and (3- 
galactosidase protein. This construct contains the AAF-strategy test oligo/lac Z  fusion 
gene. As the Act-LacZA cell lines had shown that the most reliable method of detecting 
RNA expression was the ribonuclease protection assay, this was the principal method 
used to determine the RNA expression levels in these cell lines. The level of protein 
expression in the cell lines had already been determined by staining cell with X-gal 
(Figure 20). The results of these analysis are shown in the graphs in Figure 27.
Six C50 electroporation ringclones containing the K5-LacZ£ construct were chosen for 
analysis. The results of these analyses are shown in Figure 28. Two of the six K5- 
LacZ^ clones (E3 and E5) analysed showed no expression of either the RNA (Figure 28) 
or the protein (Figure 22). All the cell lines which do express detectable levels of RNA 
also express the protein in a significant proportion of the cell population. However only 
in one of the four cell lines does the expression level approach 100% of the population. 
One of the four clones contains as little as 5% of cells which express the [3-galactosidase 
enzyme. These results perhaps again suggest that rearrangement of the lac Z gene is 
occurring after transfection of the marker gene constructs.
Comparison of the results of the K5-LacZD and K5-LacZE construct electroporation 
demonstrate that although the levels of protein expression in the Act-LacZD clones are 
detectable they are significantly less than the levels obtained in the pIrv-Neo-Act-LacZ£ 
cell ringclones.
3.3.8 Activation of |3-galactosidase expression in cells containing Act- 
Lac Z A by treatment with MNNG.
The final step in testing the marker genes in vitro is to demonstrate that the marker 
genes can be activated by treatment with a chemical mutagen. This has been attempted 
for the MNNG-test oligo construct Act-LacZ'4 . The activation experiment requires a 
stably transfected cell population which is known to be capable of expressing the (3- 
galactosidase protein. The Act-LacZ'4 clone 5 was selected for use in the MNNG
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Figure 27. Expression levels of lac Z  RNA in K5-LacZD electroporation
ringclones.
(a) RNAse protection assay performed with a 227 bp fragment of the lac Z  gene. 
Radiolabelled <j)X174 markers were used to size the bands on the gel. The probe is 
approximately 300 bp in size. tRNA was used as a negative control. The 227 bp lac Z  
fragment corresponding to expression of the lac Z  gene is visible in all lanes except D12.
(b) A graph of the relative expression levels of the lac Z  gene in the K5-LacZD 
electroporated cell lines.
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Figure 28. Expression levels of lac Z  RNA in K5-LacZ£ electroporation
ringclones.
(a) RNAse protection assay performed with a 227 bp fragment of the lac Z  gene. 
Radiolabelled <|)X174 markers were used to size the bands on the gel. The probe is 
approximately 300 bp in size. tRNA was used as a negative control. The 227 bp protected 
lac Z  fragment is visible in cell lines A6, E l, E2, E4 and E6. (b) A graph of the relative 
expression levels of the lac Z  gene in the K5-LacZ£ electroporated cell lines.
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treatment experiments. This cell line is a C50 murine epidermal ringclone transfected 
with the Act-LacZ4 construct by electroporation and selected on G418.
Analysis of the DNA of this cell line has shown that it contains the lac Z  gene and that 
the lac Z  gene is intact and not rearranged in any way (Figure 22). Furthermore the RNA 
from this cell line has been analysed by a three different techniques and shown to express 
a relatively high level of lac Z  RNA (Figures 25 and 26). The staining of the cells with 
X-gal revealed that a very small number (<0.01%) of the cells express the protein from 
the lac Z  gene. This very low expression of the (3-galactosidase protein indicates that 
when a mutation occurs in the lac Z  gene in this cell population it is capable of being 
expressed. The Act-LacZ4 clone 5 is therefore suitable for use in the MNNG-reactivation 
experiment.
The results of the reactivation experiment are detailed in Figure 29. After treatment with 
MNNG at a concentration of lpgm l'1, the cells were replated and were fixed and stained 
with X-gal three days later. At this concentration the MNNG kills 87.5% of the 
clonogenic cells in the culture. The number of lac Z  expressing cells detected in cell 
populations which were treated with MNNG was considerably greater than the number of 
lac Z  positive cells in the control mock-treated population. No blue cells were ever 
observed in untransfected cells treated with MNNG.
The frequency of activation was calculated in two separate ways. The total numbers of 
blue cells on each plate and the mutation frequency was calculated as the number of 
activated cells per 5 x 105 cells added to each plate. The average number of blue cells on 
each plate is 32 and hence the mutation frequency is determined to be 1.5 x 10*4. The 
other method depends on the calculation of the number of clonogenic cells cell in the 
population of 5 x 105. This was determined by plating out cells in small numbers into 
F25 flasks and looking at colony formation after 2 weeks. The number of clonogenic 
cells in the untreated population was 20% and therefore the surviving clonogenic cells in 
5 x 105 treated cells was determined to be 1.25 x 104. The number of blue cell colonies 
(groups of two or more adjacent expressing cells) on each plate was determined by 
examining the plates under an inverted microscope. The average number of blue colonies 
on each plate was 5.3 and hence the mutation frequency was determined to be 4.32 x 103 
per clonogenic cell.
The accuracy of both figures is debatable. The number of constructs present in Act- 
LacZ4 clone 5 was never accurately determined. Even if it had been determined the
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Figure 29. Activation of p-galactosidase expression in Act-LacZ4 clone 5 
cells by treatment with MNNG.
(a) Graph showing the numbers of lac Z  expressing single cells and clones (groups of two 
or more cells) expressing the lac Z  gene in plates containing 5 x 105 MNNG-treated or 
control Act-LacZA clone 5 cells. (b) Control (i) and MNNG-treated (ii) cells stained with 
X-gal. A single p-galactosidase expressing cell is visible in the treated cell population.
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number of cells in the population which could express the gene would then have to be 
determined. In some of the K5-LacZ£ ringclone cell lines as little as 5% of the total 
population actually expressed the gene when stained with the X-gal stain. Of the two 
figures obtained the second figure is possibly more accurate. The first figure may count 
a lot of dead and dying cells which are incapable of expressing the gene.
These reservations do not detract from the main conclusions of the experiment which 
shows that the LacZ4 marker gene is activated in cells by exposure of the cell to the 
chemical mutagen MNNG in vitro. The establishment of an exact frequency is not all 
that important for the aims of this project. Any mutation frequency determined would 
not be relevant to the conditions in vivo when the cell environment is totally different to 
the environment of the cells in tissue culture. Work with the AAF marking strategy 
(LacZD) was discontinued at this time due to time constraints on the project and the 
positive results with the MNNG strategy (LacZ4)marker gene.
3.4 Testing of the cell marking system in vivo.
3.4.1 Generation of transgenic mice.
Having demonstrated that the marker genes worked in vitro the next step was to test the 
marker genes in vivo, by introducing the constructs into the germline of mice. All 
transgenic mice generated in the course of this project were generated by pronuclear 
microinjection of fertilised embryos (this method is discussed in detail in Section 2.26).
The first marker gene construct used to generate transgenic mice was the Act-LacZ'4 
MNNG-marker gene construct. The first step in generating transgenic mice is the 
purification of the marker gene construct. As vector sequences are known to inhibit the 
expression of transgenes the majority of the vector sequences were removed by 
restriction enzyme digestion. The /^Act-LacZ4 insert used for the production of 
transgenic mice are shown in Figure 30.
The Act-LacZ4 vector was digested simultaneously with the restriction endonucleases 
Bgl II and Sea /. This removes a 4.3 kb fragment from the plasmid containing the (3- 
actin promoter, the LacZ'4 marker gene and the poly A sequence located in the 3' viral 
LTR sequences. This DNA fragment will subsequently be referred to as /£ Act-LacZ4.
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Figure 30. Structure of fgAct-LacZ4 construct used to generate transgenic 
mice.
(a) Diagram of the structure of the rgAct-LacZ4 construct used for microinjection, (b) 
Restriction enzyme analysis of the construct. 1) 1 kb ladder 2) Act-LacZA plasmid 
linearised by digestion with Not I. 3) 3.1 kb lac Z band excised from Act-LacZA plasmid by 
digestion with Sal I. 4) 4.3 kb rgAct-LacZA insert excised by digestion with Bgl II/Sca /.
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4.3kb insert purified and used 
for pronuclear microinjection
The prospective transgene sequences were the separated on an agarose gel and purified 
as described in Section 2.25.
The DNA samples were then introduced into mouse embryos by injection of the 
pronucleus of fertilised eggs. The fertilised mouse embryos were harvested from 
superovulated three week old (C57BL/6J x CBA/J) FI female mice. The superovulation 
protocol is described in section 2.26.2. After injection of the embryos, they were 
cultured overnight and transferred into pseudopregnant recipients the following day. 
Following the transfer the recipient mice were left alone in cages for a period of three 
weeks. If the mice became pregnant and produced offspring the offspring were analysed 
for the presence of transgenes (Figure 31 shows a table detailing the results of the 
microinjection experiments).
The Act-LacZ'4 transgene was injected into embryos at a range of concentrations. The 
concentrations used were 1, 2 and 5 ^gml'1. A total of 22 offspring were obtained from 
injection of tgAct-LacZ'4 DNA at a concentration of 1 //gml'1. Genomic DNA was 
isolated from the mice derived from injected embryos by tail tip biopsies according to the 
method outlined in Section 2.27. The DNA from the offspring were then analysed for 
the presence of Act-LacZ'4 DNA by Southern blot.
One of these 22 mice analysed contained a Act-LacZ'4 transgene. These results were 
confirmed by analysis of the genomic DNA by PCR. The low rate of incorporation of 
the transgene may be due to the slightly low DNA concentration. Figure 32a shows a 
Southern blot of DNA isolated from tail tip biopsies of offspring from embryos injected 
with 1 yMgml*1. Only one mouse (number 1591) contained a transgene band. The DNA 
on the blot is digested by the enzyme Kpn I  which cuts only once within the sequence of 
the transgene. This should help determine the organisation of the transgene insertions. 
Mouse 1591 seems to have a single copy of the gene inserted into the genome as 
digestion with Kpn I  results in the production of only 1 transgene band. Although it is 
possible that the integration site may contain a couple of constructs arranged in a head 
to head sequence, although this is an unusual arrangement of transgenes. Transgenes 
present in multiple copies are usually arranged in head to tail concatamers. If this was 
the case the extra copies of the transgene would be present as a 4.3 kb band equivalent 
to the size of the transgene.
The concentration of Act-LacZ'4 DNA injected was then raised Xo2pgm l1. A total of 
47 offspring were derived from embryos injected with the Act-LacZ'4 DNA injected at 
this concentration. Southern blot analysis determined that thirteen of these 47 offspring
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Figure 31. Table of results from injection of lac Z  fusion gene constructs 
into m ouse embryos.
In total 22 transgenic founder animals containing three separate constructs were generated 
from 147 offspring derived from embryos microinjected with DNA. Injected offspring 
represents the total number of live newborn mice derived from embryos which had been 
microinjected with DNA before transfer into pseudopregnant female mice. The transgenic 
offspring represent the total number of live newborn mice which were transgene positive 
when screened by Southern blot.
o
CD
*cnI
1“
CDO
N
m
0
01
cniI-
CDO
N
D
o
cn cn ro
>o
CDO
N
CD
3C/>
CD
CD
3
CD
o
o
3O
CD
3
Q>
o '
3
3
S'
CD
M M n  ^  id Q.
ro  °  nj po o
3: cn ■o 
2 , 
5 ’
CD
Figure 32. Southern blot analysis of founder mice containing the fgAct- 
LacZ4 transgene.
Southern blots of DNA derived from tail tip biopsies of mice injected with rg Act-LacZ4 
DNA. The DNA samples are digested with Kpn I  which cuts once in the 3' end of the DNA 
construct, (a) One mouse (1591) is transgene positive, (b) Blot of Act-LacZ'4 cell line and 
fgAct-LacZ4 injected mouse DNA. Untransfected C50 cell line DNA is used as a negative 
control. The Act-LacZ4 cell line show a 6.4 kb band corresponding to the size
of the Kpn I  fragment of the construct. Two positive mice contain a 4.3 kb band suggesting 
that the construct is integrated in a head to tail array.
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produced contained Act-LacZ4 transgenes. The organisation of the transgene bands in 
these mice demonstrated that most of the mice have a number of copies of the 
transgenes. Figure 32b shows a Southern blot of DNA samples derived from tail tip 
biopsies of offspring from embryos injected with Act-LacZ4 DNA at 2 //gm l1. The 
blot is probed for the presence of the lac Z  gene.
Two positive mice are detected on this blot of genomic DNA digested with the Kpn I  
restriction enzyme. Both the positive DNA samples exhibit bands at 4.3 kb which 
indicates a number of copies of the transgene inserted in a head to tail concatamer. The 
positive control lane shows cell line Act-LacZ4 DNA which contains the entire DNA 
construct. The Kpn I  enzyme cuts twice in the Act-LacZ4 construct to produce a 6.4 kb 
band containing the lac Z  gene sequence. The presence of a 4.3 kb band in the positive 
samples rules out the possibility of plasmid contamination, which would result in the 
presence of a 6.4 kb band instead of the 4.3 kb band.
In addition to the 4.3 kb band there are another two bands present in each of the positive 
DNA samples on the blot. One of these probably represents the integration site of the 
construct. The other band corresponds to a size roughly equivalent to two constructs. 
This could be produced by head to head concatamers of the construct, instead of head to 
tail. The Kpn I  enzyme site is located near one end of the construct. If the end of the 
construct including the Kpn I  site was deleted upon integration of the gene this might 
result in the two adjacent constructs becoming fused together. When the DNA is 
digested by Kpn I  the two constructs would not be separated as the site is lost and this 
would result in the production of an approximately 8.0 kb band. The other alternative 
explanation of this band is incomplete digestion of the DNA, although this pattern is 
maintained in DNA samples from offspring generated from these mice.
While the mice from the previous injections were being analysed the Act-LacZ4 DNA 
injection concentration was then increased again to 5 f igml"1. No positive offspring were 
obtained from injection of the Act-LacZ4 construct at this concentration. Although 
the injected embryos continued to progress to the two-cell stage the resultant litter sizes 
obtained from the transfer of embryos into pseudopregnant recipient females was very 
low. A few offspring were bom but these were in very small litters which were 
subsequently killed or abandoned by their mother. Presumably this reduction in litter 
size was due to a harmful effect of either the increased DNA concentration or the 
increased concentration of contaminants in the DNA sample.
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Injection of the Act-LacZ'4 construct was discontinued when 14 transgenic founders 
had been produced by injection of this construct at various concentrations. The next set 
of injections were performed with the /£K5-LacZD construct which contained the AAF- 
strategy control oligo//<2c Z fusion gene. The prospective transgene was removed from 
the K5-LacZD construct by digestion with the restriction enzymes Hind III and Sea I  
(this is shown in Figure 33). The /£K5-LacZD insert was injected at a concentration 
similar to that of the Act-LacZ'4 2 ^gm l1 sample which according to the optical 
density measurement on the spectrophotometer was 0.5 ^wgml1. The concentrations of 
the two DNA samples were compared by running them side by side on an agarose gel 
and judging the intensity of the bands b dsual inspection. The tg¥3-LacZD prospective
t
transgene DNA was purified by the sa/ method as described above for the purification 
of the Act-LacZ'4 DNA (this method is also outlined in Section 2.25).
DNA isolated from tail tip biopsies of mice derived from embryos injected with the 
tgK5-LacZD construct was analysed by Southern blot. DNA samples from four of the 
twenty-two offspring were positive for the tgK5-LacZD transgene. Figure 34a shows a 
Southern blot with two control and eight /£K5-LacZD-inj ected mouse
DNA samples digested with the restriction enzyme Kpn /. This blot was hybridised to a 
probe specific for the lac Z  gene sequences. The negative control lane shows no 
hybridisation to the lac Z  probe. The positive control is DNA from mouse number 1298 
previously shown to contain the Act-LacZ'4 transgene. The lac Z  probe hybridises to the 
characteristic 4.3 kb band produced by this transgene. There is one positive /£K5-LacZD 
sample on the blot in mouse number 2178. The BK III promoter in the /£K5-LacZD 
construct is 1 kb larger than the p-actin promoter in the tgAct-LacZ4 transgene. The 
size of this transgene is therefore 5.3 kb. This 5.3 kb band is observed in the DNA 
sample isolated from the tail tip biopsy of mouse number 2178.
The final construct which was injected into mouse embryos in order to generate 
transgenic mice was the (gK5-LacZE construct, which contains the AAF-strategy control 
oligo//<2C Z fusion gene. The prospective transgene sequences were isolated in the same 
fashion as the ^K5-LacZD transgene by digestion of the K5-LacZ£ plasmid with the 
restriction enzymes (Figure 33). The tgK5-LacZE DNA was purified (as described in 
Section 2.25) and also injected at a concentration of 0.5 p  gm l1.
Figure 34b shows a Southern blot of one positive control and five tg¥3-hacZE DNA 
samples digested with the restriction enzyme Kpn /. This Southern blot has been 
hybridised to a probe for the lac Z  gene sequence. The overall structure of the tgK5- 
LacZE transgene is the same as that of the tgK5-LacZD and it is therefore the same size
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Figure 33. Structure of fgK5-LacZ° and fgK5-LacZE constructs used to 
generate transgenic mice.
(a) Diagram of the structure of the rgK5-LacZD/£ construct used for microinjection, (b) 
Restriction enzyme digestion of the K5-LacZD plasmid. 1) 1 kb ladder. 2) K5-LacZD 
plasmid linearised by digestion with Not /. 3) 3.1 kb lac Z  gene excised from the K5-LacZD 
plasmid by digestion with Sal /. 4) 5.3 kb fgK5-LacZD insert excised from plasmid by 
digestion with Hind IH/Sca I.
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Figure 34. Southern blot analysis of founder mice containing the fgK5- 
LacZDand fgK5-LacZE transgenes.
Southern blots of DNA derived from tail tip biopsies of mice injected with f#Act-LacZD and 
r#Act-LacZ£ DNA. The DNA samples are digested with Kpn I which cuts once in the 3' 
end of the DNA construct, (a) Southern blot of DNA samples derived from mice injected 
with the /gAct-LacZD insert. DNA from mouse 1298 which contains the rgAct-LacZ4 
transgene was used as a positive control. One mouse contains the rgAct-LacZ0 transgene 
and contains a 5.3 kb band suggesting the transgene is integrated in a head to tail array, (b) 
Blot of fgAct-LacZ£ injected mouse DNA. Two positive mice contain a transgene band.
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at 5.3 kb (Figure 33). Two of the eleven K5-LacZE samples were positive and one 
(2193) contained the 5.3 kb /£K5-LacZ£ transgene band suggesting tandem array of the 
transgenes. The other mouse (2185) contained a single integration site band at 14.3 kb. 
Twenty-two mice were derived from embryos injected with the K5-LacZE transgene 
construct at 0.5 p  gml'1 and four of these proved to be transgenic.
In total 22 founder mice were generated with three different oligonucleotide/lac Z  fusion 
constructs. These 22 founder mice were produced from a total of 112 mice derived 
from injected embryos and hence the average frequency of transgenic mouse generation 
was very nearly 1 transgenic mouse in every five offspring obtained from injected 
embryos. The construct which had the highest frequency of transgene positive animals 
obtained from injected embryos was the Act-LacZ'1 construct. Of 47 animals bom from 
Act-LacZ'1 injected embryos 13 were transgene positive which represent a frequency of 
almost 30%.
3.4.2 Breeding mice and establishing transgenic lines.
After a number of transgenic founder animals had been produced they were bred with 
non-transgenic animals in order to establish permanent transgenic lines. All the 
transgenic animals (male or female) were initially bred with NIH mice. NIH mice were 
selected to breed with the transgenic mice as they were commonly used in the laboratory 
and breeding the transgenic mice with this strain would help to make this project 
compatible with the others in the laboratory at areas of overlap.
Ten of the fourteen tgAct-LacZ'1 founder mice were selected for breeding with the NIH 
founder mice. Five male founders were bred with NIH female mice and five female 
founder mice were bred with five NIH male mice. DNA isolated from tail tip biopsies of 
offspring from the breeding were screened by Southern blot analysis, slot blot analysis 
and the polymerase chain reaction (PCR).
All five of the male mice bred with the NIH female mice gave rise to transgene-positive 
offspring. Only three of the female mice bred with NIH mice gave rise to positive 
offspring. One of these female mice did not breed with the NIH male and produced no 
offspring. One of the female Act-LacZ"4 founder mice bred with the NIH male mouse 
and produced offspring but did not pass on the gene to its offspring. Figure 35 shows a 
Southern blot of DNA samples digested with the Kpn I  restriction enzyme and
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Figure 35. Analysis of the offspring of transgenic founder animals by 
Southern blot.
Southern blots of genomic DNA samples prepared from mouse tail tip biopsies and digested 
with Kpn I. (a) Blot of DNA from founder mouse 1591 and 9 offspring derived from 
breeding the founder mouse with an NIH male. Six of the nine mice are positive, (b) Small 
southern blot used to screen offspring. C50 cell line DNA is used as a negative control. 
Founder mice 1301 and 1313 and their offspring are screened. 5 of the 11 offspring derived 
from founder 1301 are positive. Mouse 1313 does not pass the transgene to any of its 
offspring.
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Figure 36. Table of transgenic lines generated from founder animals.
This table describes the breeding of eleven lines of transgenic mice containing three different 
DNA constructs from founder mice.
Construct Transgene Line Founder
p lrv -N eo-Act-LacZ tgA c t-LacZ "
p lrv-N eo-K5-LacZ^
p lrv-N eo-K5-LacZ£
tgK5-LacZ
tgK5-LacZ
£
A 1591
B 1296
C 1301
D 1303
E 1316
F 1320
G 1322
H 1323
1 2004
A 2 178
A 2193
hybridised to a radioactive probe. This was carried out according to the methods 
detailed in Sections 2.19, 2.21 and 2.22. The DNA samples included a negative 
control, a positive control which was the transgenic founder animal number 1591 DNA 
previously shown to contain the /£Act-LacZ'4 transgene. The other DNA samples were 
isolated from tail tip biopsies of offspring generated by breeding the transgenic founder 
mouse 1591 with a male NIH mouse. A positive transgene band is seen in the DNA 
sample from the parent founder mouse 1591. The same band can be observed in six of 
the nine offspring DNA samples indicating that mouse 1591 passed on the gene to its 
offspring. Mouse 1313 another /gAct-LacZ4 founder mouse does not pass the 
integrated transgene on to any of its offspring.
The founder mice for the four igK5-LacZD and /gK5-LacZ£ transgenic mice were also 
bred (Figure 36 shows a table of the transgenic lines bred). Only 1 out of 4 /£K5-LacZD 
founder mice passed the gene on to its offspring. One female founder did not breed and 
two produced offspring negative for the presence of the transgene. Three of the four 
/£K5-LacZE founder mice passed the genes onto their offspring but strangely only one of 
the lines showed expression in the mice bred from the founder although all the founder 
mice expressed the gene. PCR has now been developed to routinely analyse the 
offspring of transgenic animals for the presence of the lac Z  transgene sequences (Figure 
37).
3.4.3 Measurement of transgene expression in mice.
Before the activation of the marker genes could be attempted in vivo it is essential to 
check the expression levels of the transgenes introduced into the mice. The expression 
levels of two of the transgene constructs have been checked. The /£K5-LacZE construct 
contains the AAF-strategy control gene as has been shown in tissue culture to express 
high levels of (3-galactosidase protein in epidermal cell lines maintained in tissue culture. 
The tgAct-LacZA transgene construct on the other hand contains the MNNG-strategy 
test oligo and therefore expresses no (3-galactosidase protein. The expression levels of 
this construct had to be checked by measuring the lac Z  RNA levels.
The RNA levels produced by the *£Act-LacZ'4 transgene in eight lines produced by 
different founder animals were checked by ribonuclease protection. Figure 38 shows the 
results of this technique. The first analysis performed was to screen different tissues of 
an adult mouse of (gAct-LacZ'4 line D. RNA samples were prepared from a variety of
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Figure 37. Analysis of the offspring of transgenic founder animals by PCR.
PCR of genomic DNA samples obtained from tail tip biopsies of mice. PCR was performed 
with LacZ U2/LacZ L2 amplimers. The positive and negative controls are genomic DNA 
samples (a) Analysis of mouse samples 2490-2500 and 1001-1011. (b) Analysis of mouse 
samples 1026-1049.
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Figure 38. Expression of the fgAct-LacZ4 transgene in transgenic m ouse 
lines.
RNAse protection assay performed with a 227 bp fragment of the lac Z  gene. Radiolabelled 
(|)X174 markers were used to size the bands on the gel. The probe is approximately 300 bp 
in size. tRNA was used as a negative control. E6 cell line RNA, previously shown to 
express the lac Z RNA at high levels was used as a positive control, (a) RNA samples 
prepared from an adult mouse of fgAct-LacZ4 line D. No expression is detected in any of 
the tissues. (b) RNA samples from new-born mice from eight separate fgAct-LacZ4 
transgenic mouse lines (A-H). Expression is detected in lines A, C, E, G and H.
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the mouse tissues and analysed for lac Z  expression by ribonuclease protection. No 
expression was observed in any of the tissues of this mouse which were analysed. RNA 
samples were then prepared from newborn mouse tissue from each of eight separate 
/£Act-LacZ'4 transgenic mouse lines and analysed for RNA expression by ribonuclease 
protection with the 227 bp probe covering nucleotides 837 to 1063 of the lac Z  gene. 
Three of the tested lines (B, D and F) show no expression of the lac Z  RNA. Another 
two of the lines (A and C) show very little expression of the lac Z  RNA. Three lines (E, 
G and H) show relatively high expression but this is still significantly lower than the 
expression of the control construct in the cell lines.
The levels of expression of the control construct /gK5-LacZ£ were measured by staining 
the skins of transgenic animals with the chromogenic (3-galactosidase substrate, X-gal. 
The expression of this gene was confined mainly to the hair follicles in the transgenic 
animals. Figure 39 shows a picture showing the typical expression pattern of the gene in 
the epidermis of the mouse. Mice were routinely analysed for expression of the gene by 
analysis of ear punch biopsies stained with X-gal. Of the four founders generated with 
the /gK5-LacZE construct only three of them passed the gene onto the their offspring. 
Only one of these three passed on the expression of the gene to its offspring. The 
expression pattern of the gene in all four founder mice was restricted to the hair follicle. 
Treatment of TP A upregulated the expression level of the gene but did not widen the 
population of cells expressing the gene the gene expression was still confined to the hair 
follicle.
3.4.4 Activation of (3-galactosidase expression in skin and brain tissue  
of Act-LacZ A transgenic mouse line by treatment with MNNG.
The activation of the ^Act-LacZ4 fusion gene construct by MNNG has already been 
demonstrated in a stably transfected epidermal cell line in vitro. The Act-LacZ'4 
transgene construct contains an oligonucleotide/lac Z  fusion gene which is specifically 
designed to be activated by a mutation in the sequence of the oligonucleotide induced by 
the chemical mutagen N-nitro-N'-methyl-N-nitrosoguanidine (MNNG). The design and 
specificity of this reaction are discussed above in Sections 1.16 and 3.1.
Transgenic mice have been generated with the tgAct-LacZ'4 gene in the hope it can be 
used as a marker to analyse the lineage of cell populations in the tissues of mice in vivo. 
The mice have been shown to express RNA from the gene construct. The mice should
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Figure 39. Expression of the fgK5-LacZE transgene in the skin of 
transgenic animals.
Skin from tgK5-LacZ£ transgenic mice. Stained with X-gal and counterstained with eosin. 
(a) The animal is six weeks old and activity is restricted to the hair follicles. Magnification 
200x. (3-galactosidase (blue-staining cells) clearly visible in the hair follicle of the transgenic 
mouse. (b) Skin from a newborn mice stained with X-gal, haemotoxylin and eosin. 
Magnification 200x. (c) Newborn mice stained with X-gal and eosin only. Magnification 
lOOx. (d) Newborn mouse skin stained with X-gal and eosin only. (3-galactosidase activity 
is clearly visible in the basal layer of the epidermis and the follicle. Magnification 200x. (e) 
Separate newborn mouse skin again displaying high activity. Magnification 200x. (f) High 
magnification of newborn mouse skin.. Magnification 400x.
(a)
(c) (d)
(e) (f)
not produce any protein from this gene as it contains no ATG initiation sequence. In 
vitro the /^Act-LacZ'4 gene produces RNA for the lac Z  gene but no p-galactosidase 
protein. Exposing the mouse tissues to the chemical mutagen MNNG should produce 
mutations in the target sequences in the oligonucleotide. The specific mutations caused 
by MNNG should result in the production of an in-frame ATG sequence which will 
initiate translation of the mRNA and the production of the p-galactosidase protein.
Initial attempts to look for the activation of the marker gene in mouse embryos proved 
unsuccessful. Heterozygote female mice from the /gAct-LacZ'4 were mated to 
heterozygote male mice from the same transgenic mouse line. Each female mouse was 
inspected twice each day for signs of a coital plug. When the female mice were plugged 
this was taken to be day 0 of pregnancy. On day 8 of pregnancy the female mice were 
weighed and injected with MNNG solution such that they received a dose equivalent to 
25 m gkg1. Four days later the pregnant mice were sacrificed. The embryos were 
removed and stained for p-galactosidase activity with X-gal. Since the mouse litter was 
produced by mating two heterozygote mice the litter will be composed of homozygote, 
heterozygote and non-transgenic mice. The non-transgenic mice act as controls for the 
staining experiment as they should demonstrate no p-galactosidase activity. However no 
significant staining was observed in the tissues of the mouse embryos stained when 
inspected under a stereomicroscope. In addition 50 newborn mice treated by MNNG in 
the same way have been examined for activation of the marker gene in epidermis and 
intestine and no evidence of p-galactosidase expression has been discovered.
Subsequent experiments provided some good evidence to suggest that the marker gene 
system was working. Newborn mice from the (gAct-LacZ'4 line H were inspected for 
spontaneous mutational activation of the marker gene by staining a range of tissues with 
the chromogenic p-galactosidase substrate X-gal. Brain tissue was stained from both 
control non-transgenic mice and transgenic mice was stained and compared. No staining 
was observed in the brain tissue of the non-transgenic control mice. Small patches of 
staining tissue were observed in the brains of the /£Act-LacZA transgenic mice. The 
staining cells could not be identified by inspection of the tissue under a 
stereomicroscope.
These results were confirmed by staining frozen sections of brain tissue from six week 
old mice from the transgenic mouse strain /^Act-LacZ'4 line H. Newborn transgenic 
mice and control non-transgenic mice were treated by topical application of MNNG 
twice weekly for four weeks starting at three days of age (described in Section 2.30). 
After the MNNG treatment was stopped the mice were then left for two weeks in cages.
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When six weeks old the mice were sacrificed. Frozen sections of brain tissue were cut 
and stained according to the methods described in Section 2.29. Although five 
transgeic and three control mice had been treated, resources were only available to get 
frozen sections cut from one transgenic and one control mouse brain.
A total of 624 frozen serial sections were cut from the brain of one transgenic mouse 
which had been treated with MNNG. These frozen sections were all stained with X-gal 
for p-galactosidase activity before counterstaining with eosin and mounting. Upon 
inspection of the frozen sections under a light microscope a total of three potential 
colonies of cells were identified each containing a number of blue staining cells. Each 
of these colonies covered a number of frozen sections (22,12 and 14 respectively) and 
the colonies were separated by a number of serial sections in which no X-gal staining 
cells could be seen. Figure 40 shows the largest colony of p-galactosidase expressing 
cells located in the forebrain of a transgenic mouse, in a region of the brain overlying 
the olfactory bulb. This colony is visible in 22 consecutive serial sections.
No such colonies are visible in the brain of the non-transgenic control mouse. A total 
of 168 frozen serial sections of control mouse brain were checked and no sign of p- 
galactosidase activity was discovered. These sections were stained for p-galactosidase 
activity under exactly the same conditions as the control mouse.
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Figure 40. Activation of p-galactosidase activity in fgAct-LacZ4 transgenic 
animals following treatment with MNNG.
Photographs of mouse brain tissue sections stained with X-gal and counterstained with 
eosin. Magnification 400x. (i) Section of control mouse brain tissue, (ii) P-galactosidase 
positive cells in the brain of a six week-old fgAct-LacZ'4 line H transgenic mouse. 
Magnification 200x. (iii) View of same colony in subsequent serial section. Magnification 
200x. (iv) High magnification of lac Z positive cells in the brain. Magnification 400x.
(i) control mouse (ii) MNNG-treated mouse 1
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CHAPTER 4. 
Discussion.
4. Discussion
4.1 Design of a transgenic marker system.
The requirements of a good cell marking system have already been discussed in Sections 
1.12 and 3.1. The basis for the design of the system has been discussed in these sections 
so the discussion here is confined to a few highly speculative considerations the influence 
of which could not be predicted. The design of this project was extremely important for 
a number of reasons. The time taken to develop, clone and test the system in vitro and 
in vivo was likely to quite considerable. In order to ensure that the chances of a 
successful outcome great care was taken in the design of the project to maximise the 
chances of success.
The oligonucleotide system was conceived in order to attempt to maximise the chances 
of gene activation. There could be some degree of debate about how much of an 
increase in the rate of mutation the oligonucleotide would produce. Although there are 
eight potential target sites in the MNNG-strategy test oligo and nine target sites in the 
AAF-strategy oligonucleotide the frequency of mutation may not increase 
proportionately to the number of mutagen target sites. After all the target sites are all 
grouped in a very small part of the gene. Of course the opposite argument can also be 
made. That is that the grouping of a large number of mutagen target sites may act 
synergistically and attract the chemical mutagen more strongly increasing the mutagenic 
frequency by more than the number of target sites.
Although the mutagens that were used in the course of this project were chosen because 
they acted on defined target sequences very little is known about the effect of 
surrounding sequences on mutagens binding to DNA. As the oligonucleotide designs 
used in the course of this project were based on highly repetitive sequences it is highly 
likely that the oligonucleotides may take up unusual conformations in vivo. Indeed, it is 
known that stretches of purine pyrimidine repeats, which form the basis of the AAF- 
strategy oligonucleotide, are known to from Z-DNA. The influence of these potentially 
unusual DNA structures on the binding of chemical mutagens was largely unpredictable 
but is worth considering when interpreting the results of the activation experiments. It 
would be possible to test these ideas but it is not really worthwhile for the purposes of 
this project.
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One other advantage of the design of this marking system is the flexibility. Care was 
taken to ensure that the marking system developed would be a general system which 
would be applicable to tissues other than the epidermis which is the main focus of the 
project. The use of a transgene as a cell marker instead of selecting a tissue specific 
gene already in place ensures that a multitude of tissues are able to be analysed by this 
marker gene approach.
Another aspect of the flexibility of the system is the use of the oligonucleotide as a target 
for gene activation. The oligonucleotide strategy has already been used to generate lac 
Z  marker genes which can be activated by two separate types of chemical mutagen; 
MNNG is a point mutagen whereas AAF is a frameshift mutagen. If these chemicals had 
not worked to produce a functional marker gene the oligonucleotide could have been 
redesigned to take account of the mutational specificity of another chemical mutagen. 
This mutagen may have worked more effectively to activate the gene.
4.2 Construction of the lac Z fusion gene vectors.
The first step in this project was to clone a set of oligonucleotides in front of a lac Z  
gene in the vector pMC1871. During the cloning steps the oligonucleotides proved to 
be very unstable. The initial attempts to clone the oligonucleotides in front of the lac Z 
gene in the pMC1871 vector were unsuccessful because mutations in the sequence of the 
oligonucleotides. If the oligonucleotides were extremely mutable when they were 
cloned then they may be extremely mutable in the tissues of transgenic mice. This may 
result in the activation rate of the oligonucleotide by chemical mutagens being quite 
high.
This problem was eventually circumvented by cloning the oligonucleotides into a strain 
of bacteria which lacked recombination enzymes. This implied that the recombination 
enzymes must have been responsible for mutations occurring in the sequence of the 
oligonucleotides. The problem was not completely solved. There was still a high rate of 
deletions within the construct. The reason for these deletions remains to be adequately 
explained. Perhaps the most likely explanation is that recombination was taking place 
between some bacterial sequences and the initial part of the lac Z  gene. Recombination 
taking place between endogenous bacterial sequences and the plasmid may have resulted 
in the 200 base pair deletion. It is possible that the cloning site around the beginning of 
the lac Z  gene may be a frequently used sequence in cloning and may have caused the
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recombination. If this is this case then is a tremendous coincidence that the deletions 
occur in the area surrounding the oligonucleotide elsewhere.
Perhaps the most likely explanation for the instability of the oligonucleotide is that the 
oligonucleotide sequences mismatch when annealed. When they are subsequently 
transformed into bacteria a rearrangement occurs which results in mutations in the 
sequence of the oligonucleotide or perhaps the short deletions in the plasmid. All the 
oligonucleotides are composed of highly repetitive sequences. It is possible that when 
annealed that when the oligonucleotides anneal they are slightly offset. The mismatch 
annealing of the oligonucleotides may result in short deletions produced in the 
oligonucleotide sequences when transformed into bacteria. This explanation does not 
account for the apparently specific 200 bp deletions which resulted when the 
oligonucleotides were cloned into pBRLacZ in the SURE™ bacteria. It would explain 
the deletions observed in the oligonucleotide sequences when they are ligated into the 
pMC1871 plasmid. It also accounts for the fact that, when the oligonucleotides already 
forming the fusion genes were cloned from the pBRLacZ vector into the plrv-Neo-Act 
plasmid, the oligonucleotide sequences remained intact and no further mutations were 
observed in the sequence of the oligonucleotide.
Apart from those cloning steps which involved cloning the oligonucleotides or the lac Z 
fusion genes containing the oligonucleotides all the cloning reactions performed in the 
course of the project were achieved easily with high efficiency.
4.3 Transfection of the fusion genes into cell lines.
4.3.1 Expression of (3-galactosidase from the LacZD fusion gene.
The transfection of the various oligonucleotide lac Z  fusion genes also produced a few 
unexpected results. The first of these was the expression obtained from the transfection 
of the Act-LacZD vector. This vector contains the Act-LacZD oligonucleotide fusion 
gene under the control of the (3-actin promoter. This fusion gene contains 
oligonucleotide D, the AAF-strategy test oligo, which contains an ATG sequence which 
is two base pairs out of frame with the coding sequence of the lac Z  gene.
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When this construct is transfected into fibroblast or epidermal cells the level of 
expression is very similar to that of the positive control constructs A ct-L acZ *^ '^  and 
Act-LacZ^. Both the positive control constructs contain functional lac Z  genes and 
produce (3-galactosidase protein at high levels in transfected cells. It seems likely that 
the Act-LacZD vector expresses (3-galactosidase protein aberrantly from an ATG 
sequence subsequently located in the promoter sequence which is eighty base pairs 
upstream of the lac Z  gene and which is in-frame with the coding sequence of the gene.
When the Act-LacZD construct was transiently or stably transfected into epidermal cells 
in vitro the (3-galactosidase protein was expressed at the same levels and in the same 
proportion of the cell population. When the K5-LacZD construct was stably transfected 
into the epidermal cells the levels of expression was considerably lower than the control. 
This supports the hypothesis that the upstream ATG is supporting the expression of the 
(3-galactosidase protein from the Act-LacZD construct.
The K5-LacZ£ construct which contains the LacZE fusion gene with the AAF-strategy 
control oligonucleotide E was stably transfected in C50 cells and the expression of the 
protein was analysed in ringclones of selected cell colonies. Four out of six selected cell 
clones expressed the (3-galactosidase protein at reasonably high levels. Of these four 
expressing cell lines all contained detectable levels of mRNA from the lac Z  gene. No 
RNA was detectable in the two clones which showed no detectable expression of the (3- 
galactosidase protein.
Approximately two thirds of the K5-LacZD C50 epidermal cell ringclones which 
expressed the RNA in the did not express the protein. Of the remaining one-third which 
showed a degree of expression most of the clones (3 of 5) showed extremely low level. 
Only 2 of the fourteen clones which expressed the lac Z  mRNA showed a significant 
expression of the protein (> 1% of the total cell population express the (3-galactosidase 
gene). This means that of the K5-LacZD transfected cell ringlones, which express the 
lac Z  RNA, approximately 14% expressed a significant level of (3-galactosidase activity. 
In contrast, 100% of the K5-LacZF transfected ringclones which express the lac Z  RNA 
also express significant levels of the (3-galactosidase protein.
This level of expression obtained from the K5-LacZD transfected construct is still quite 
high but in contrast to the transfections with the Act-LacZD construct is considerably 
lower than the control. It is possible that the lower level of expression obtained during 
transfection of the K5-LacZD construct is caused by mutation or rearrangement of the 
gene or by an effect of the integration site. One other aspect of the expression of the (3-
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galactosidase expression that supports this conclusion is the level of expression in 
individual cells.
When (3-galactosidase protein is expressed from the K5-LacZD it is expressed at the 
same level as the protein in the control constructs i.e. each individual cell which 
expresses the protein stains with similar intensity to the cells in the control population. 
If the oligonucleotide in the LacZD fusion gene supported inefficient translation of the 
gene then the expected expression pattern would be a low level of expression in most of 
the transfected cells. Most of the transfected cells would therefore be expected to stain 
more faintly with X-gal than the control construct transfected cells. This is not the 
observed pattern. The pattern in K5-LacZD transfected cells is that a lower number of 
cells express the gene than in control transfections but that the cells which do express 
the protein express a similar amount of protein to the control construct transfected cells.
As the expression of the (3-galactosidase in the K5-LacZD in individual transfected cells 
is similar to that obtained in individual control transfected cells there is an implication 
that the expression in both cell populations is sustained by the same method. This 
common method could be that both cell contain a lac Z  construct with an in-frame ATG 
codon. If this is the case there may have been a mutation in the K5-LacZD construct in 
the cell which brings the ATG in the oligonucleotide D into frame with the coding 
sequence of the lac Z  gene.
If mutation within oligonucleotide D explains the reasonably high level of (3- 
galactosidase expression from the K5-LacZD construct the construct may prove to be 
very useful. It suggests that the mutation rate of this construct is quite high. The levels 
of expression obtained from this construct are considerably higher than the expression 
levels detected with the transfection of the Act-LacZ'4 construct. It is quite possible 
therefore that spontaneous mutations may occur in vivo in transgenic mice at a high 
frequency. If cells can be spontaneously marked then the relationships of cells in a tissue 
can be examined. For instance, this mouse could be used to determine whether cells in 
the hair follicle can divide to produce cells in the interfollicular epidermis.
A high spontaneous mutation frequency which activates a marker gene would have some 
potential advantage over a marker gene which is induced. To induce a marker gene by 
the system described in this thesis it would be necessary to treat the tissue of interest 
with a chemical mutagen. Other marker systems are even more disruptive. In order to 
mark epidermal cell effectively with retroviruses it would be necessary to scarify the 
tissue. Scarification of the tissue is extremely damaging to the tissue and the picture of
lineage relationships built up by cell marking in the damaged tissue by this technique 
could differ markedly from the normal relationships formed in untreated tissue. There is 
a possibility that this may disturb the behaviour of cell in the tissue and the picture of cell 
lineage obtained may be slightly distorted, although the chances of this being a 
significant problem are probably remote.
The one drawback of using spontaneous mutation is that it is impossible to determine 
when the cells became marked. It would therefore be impossible to do any work on the 
progressive restriction of lineages that occurs throughout development. If a treatment is 
used to induce cell marking the time of gene activation can be more or less assumed to 
be at the time of treatment. The half life of the chemical mutagen MNNG is only 30 
minutes and therefore the time at which mutation occurs is likely to be very shortly after 
application of the mutagenfBartsch et al., 1982).
A high spontaneous mutation rate also implies that the activation frequency induced by 
mutation may also be quite high. If the explanation of the high expression observed 
from the K5-LacZD construct is spontaneous mutation then the rate of mutation induced 
by treatment with the chemical mutagen N-acetoxy-AAF in vivo in the skins of 
transgenic mice may also be extremely high.
One way of attempting to determine if mutation is the cause of the expression of p- 
galactosidase in some cells in the ringclones electroporated with the K5-LacZD construct 
would be to isolate and sequence the gene from the expressing cells to look for 
mutations. This problem could have been approached by isolating cell transfected with 
the K5-LacZD construct. In one of the K5-LacZD electroporated ringclones 
approximately 30% of cells express the p-galactosidase protein. If these cell were plated 
out at low density so the cell grew as individual colonies it may be possible to isolate a 
pure clone of cells in which 100% of the cell population expresses the protein. The 
transfected construct, which would presumably be identical in these cells, could then be 
retrieved from these cells, cloned and sequenced or even sequenced directly.
This has not been done because any conclusions reached from such an experiment would 
not really generate any information useful to the progress of the project. One potential 
problem is that the cells may contain several constructs only one of which is expressing 
the p-galactosidase protein. This would confuse the analysis of the sequence. Even if 
the cells only contained the one copy of the gene and a mutation was identified in the 
sequence of the oligonucleotide the results would still be open to question. There is a
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possibility that the mutation in the sequence may have occurred when the construct was 
grown in bacteria, during transfection or due to contamination with control sequences.
The mutation frequency of the AAF-strategy test oligonucleotide fusion gene LacZD 
remains to be determined. This work with this construct was halted as there was not 
time to pursue both strategies during the course of the project and successful results had 
already been acheived with the MNNG-strategy marker gene.
4.3.2 Determination of the MNNG-activation frequency of the LacZ* gene.
No unexpected results were obtained during the transfection of the construct Act-LacZ4 
into cells in vitro. No significant levels of expression of the (3-galactosidase protein 
were observed in any of the cells which had been stably or transiently transfected with 
the Act-LacZ'4 construct. This construct contains the MNNG-test strategy 
oligonucleotide A which consist of a run of -^GTG7, trinucleotides with no ATG 
initiation codon. It was designed as a silent marker gene construct to be activated by the 
chemical mutagen MNNG and it was hoped that this construct would not produce any 
expression of the lac Z  gene when transfected into cells. The control constructs Act- 
LacZ5 and Act-LacZc which contained marker genes, in which one of the run of 5 GTG7 
had been replaced by an 5 ATG7 in order to initiate translation of the RNA, both 
produced high levels of (3-galactosidase activity. This indicated that if the specific 
mutation in the oligonucleotide, designed to be caused by MNNG, was induced then the 
silent marker gene would become activated and mark the cell.
This hypothesis was tested in ringclones of cells which had been electroporated with the 
Act-LacZ'4 construct and selected on G418. These cells were treated with MNNG 
(described in Sections 2.16 and 3.3.8). MNNG was shown to activate the marker gene in 
these cells at a frequency of ~ 4 x 10'3. The accuracy of this figure is open to dispute 
although it is probably approximately correct. Even if the figure was accurately 
determined it would probably have very little relevance to the treatment of mice in vivo. 
The concentration of MNNG used to treat cells in vitro is usually in the region of 1 
^gml"1 whereas the concentration used for the topical treatment of mice in vivo is 
approximately 3 mgml'1. This is a difference somewhere in the region of 3000 times and 
this fact alone is sufficient to indicate how the surrounding environment of cell 
influences their reaction to MNNG.
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The mutation frequency that was established for this construct is open to question is 
mainly due to the difficulty of determining the proportion of the transfected cell 
population which express the lac Z  RNA and are available to act as a targets for the 
gene reactivation. This is further complicated by the possibility that the cells may 
contain more than one construct. The calculation of an exact mutation frequency was 
not thought necessary. The figure obtained was likely to be approximately correct and 
the work that would have been required to calculate a more exact figure was impossible 
to do in the time scale of this project. Any mutation rate obtained in vitro may not be of 
much relevance to the situation in vivo where the environment of the cells is significantly 
different. The calculation of an exact figure for the activation rate in vitro was not 
critical for the progress of the project and would probably have had little bearing on the 
eventual aim of the project which is to apply the technology to the analysis of cell 
lineage on transgenic mice.
Since this project was started two studies have shown that genes can be activated by 
reverse mutation in mouse and human cells (Eccles et al., 1989; Schaff et al., 1990). 
One of these studies demonstrated the reversion of an amber mutation in the mouse H- 
2Kb gene in response to ultraviolet irradiation. In this system revertant were induced at 
a frequency of 3 x 10'6. The revertant clones were sorted by FACS analysis and 
sequence to show that the reactivating mutation was the expected mutation.
The other study was more comparable to the this project. The human cell line HT 1080 
A P R T  was transfected with the mouse APRT gene inactivated by an A to G transition. 
This was shown to be reverted by exposure to the chemical mutagen ethyl 
methanesulphonate (EMS) which had previously been shown to cause G to A transitions 
in both bacteria (Coulondre and Miller, 1977) and mammalian cells (Ashman and 
Davidson, 1987; Greenspan et a l,  1988; Lebkowski et a l ,  1986). This reversion was 
induced at a frequency of 4 - 7.5 x 1 O'4 in the cell lines transfected with the mutant 
construct. The construct was not reverted by treatment by 2-aminopurine (2AP) which 
has been shown to cause primarily A to G transition mutations (Caras et a l , 1982).
Both the previous study and this project have used chemical mutagens to specifically 
revert a mutation in a gene. The reactivation frequency obtained in this study (4 x 10'3) 
is slightly higher than the mutation frequency obtained in the APRT  gene in response to 
EMS (7.5 x 10-4). The APRT gene only contained one target site for the chemical 
mutation whereas the lac Z  gene used in this study contained nine potential target sites. 
Eight of the sites had been engineered to take account of the mutagenic sequence 
specificity of MNNG and had a guanine residue situated immediately 5' to the target
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guanine residue (Bums et a l,  1987). The mutation induced in the APRT gene took no 
account of any sequence specificity of EMS-induced mutation. It is therefore not 
surprising that the mutation rate obtained in this study is slightly higher than that 
obtained in the APRT gene.
Both these studies (Eccles et al., 1989; Schaffer a l,  1990) were performed in such a way 
that the reverted cells could be selected either by FACS analysis or by drug selection and 
the gene sequences retrieved and sequenced. An ideal method of testing gene 
reactivation with the oligonucleotide in this system would have been to use the oligo to 
activate a silent drug resistance gene, such as APRT, in the same fashion as it has been 
used to activate lac Z. This would have allowed large numbers of cells to be treated with 
MNNG and screened for reversion. It would also enabled the recovery of the selected 
genes and these could then be analysed for sequence specific changes. This though 
would have required the construction of another series of constructs which would not 
have been possible in the time frame of this project. The gene used in this study lac Z  
does not easily allow selection or FACS analysis, although there is a fluorescent p- 
galactosidase substrate available (Nolan et a l, 1988; Karttunen and Shastri, 1991). The 
usual assay for the p-galactosidase protein is a histochemical stain which first involves 
fixing the cells before they can be stained.
4.3.3 Instability of the transfected lac Z  sequences.
The analysis of the Act-LacZ4 constructs also produced another interesting result. Again 
the lac Z  fusion genes seemed to be unstable. Southern blot analysis of the Act-LacZ'4 
electroporated ringclone cells suggested that the construct may be unstable. Of the 12 
electroporation ringclones analysed only four of these gave the appropriate lac Z  bands 
when DNA samples were analysed by Southern blot. Three of the clones had no 
detectable lac Z  bands at all and a further five of the clones contained bands which were 
of an inappropriate size. All these clones contained the neo resistance gene which 
confers resistance to G418 when essentially the same blot was probed with a fragment of 
the neo gene.
Most of the transfected constructs were expected to remain intact and it was surprising 
that only four out of twelve did. The other ringclones exhibited rearranged lac Z  bands 
or no bands at all. There are a number of possible explanations for the apparent 
rearrangement of the lac Z  genes in these ringclones. The deletions of the lac Z  gene
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from the constructs could have occurred upon integration of the constructs into the 
cellular genome. The selection is based solely on the resistance of the cells to the 
antibiotic G418 and hence on the expression of the neo gene. The loss of the lac Z  gene 
upon integration would confer no selective disadvantage on the cells and there is no 
necessity to keep the lac Z  sequences. It is also possible that the oligonucleotides were 
responsible for the construct instability.
Another potential explanation of the deletions could be that the selection in G418 placed 
too strong a pressure on the cells. Although the concentration of G418 (200 //gml'1) 
had been used previously to select C50 cell populations in vitro it is possible that the 
selection was too strong. This may have resulted in the deletion of the lac Z  sequences 
in an attempt to maximise the expression of the neo gene. A much higher selection level 
was placed upon the transfected fibroblasts which survived in concentrations of up to 
800 jugm l1 to 1 mgml1 of G418. The fibroblasts seemed to cope perfectly well in the 
higher antibiotic concentrations although the level of expression of the construct as 
evidenced by staining for (3-galactosidase activity in these cells was higher than the 
expression levels obtained in the C50 epidermal cell line. This suggests that the 
construct is quite capable of generating resistance in cells to higher levels of G418 than 
used to select. This hypothesis could be tested by lowering the concentration of G418 
used to select the C50 electroporation ringclones. One of the cell lines was useful for 
testing the activation of the fusion gene with MNNG and hence this experiment would 
have been of little more than purely technical interest. Any subsequent transfections 
performed with these cells may benefit from a titration of the G418 concentration.
Despite these problems a Act-LacZ^ electroporation cell line has been used to 
demonstrate that the oligonucleotide/foc Z fusion gene cell marking strategy does work 
in vitro. This is certainly true with the MNNG-strategy construct and is also likely to be 
true with the AAF-strategy construct. Even if the AAF construct was no successful the 
system designed is sufficiently flexible to allow new oligonucleotides to be designed and 
used instead of the AAF construct. The general system has been demonstrated to work 
with MNNG and there is no reason why new oligonucleotides could not be engineered 
to take account of the specificity of other chemical mutagens and so be used to generate 
novel marker fusion genes.
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4.4 Transgenic mice.
4.4.1 Demonstration of activation of marker genes in vivo.
The results obtained with the transgenic mouse lines are very encouraging although the 
project has not progressed far enough for the lineage analysis on mouse skin to begin. 
The most important result so far achieved in the course of this project is the 
demonstration of colonies of lac Z  positive cells in the brain of MNNG-treated 
transgenic animals. This demonstrates that the marker genes can be activated in vivo as 
well as in vitro. Whether these colonies were induced by the exposure to MNNG is 
admittedly open to question. Even so this result still indicates that the basic design of 
the marker gene system is sound and should be useful in cell lineage analysis in 
transgenic mouse tissues.
Figure 40 shows a colony of p-galactosidase staining cells visible in the forebrain of a six 
week old Act-LacZ'4 transgenic mouse which had been treated with MNNG. The 
transgenic mouse line used in this experiment, /gAct-LacZ'4 line H, had previously been 
shown to express RNA for the lac Z  gene by ribonuclease protection.
The P-galactosidase positive cells in Figure 40 have been proposed to be a colony of 
neurons in the white matter tract above the olfactory bulb in the mouse forebrain (J. 
Price, personal communication). No such colonies were visible in the brains of non- 
transgenic animals which had been treated with MNNG. A total of 168 frozen sections 
from a control mouse brain were examined for lac Z  activity. Neuronal cells have a very 
low intrinsic activity towards the chromogenic p-galactosidase substrate, X-gal and 
therefore show very little background staining. The colony is also visible in the same 
spot fourteen consecutive serial sections. These three pieces of evidence suggest that 
the colony could not be a random effect of background staining. This suggests that the 
P-galactosidase staining colony is likely to have been caused by a mutation which has 
arisen in the progenitor cell of the cells in this colony.
The division of neuronal cell in the brain is largely completed by the birth of the animal 
and it may be unlikely that a large colony of neuronal cells could have been marked by a 
mutation after birth. This suggests that the MNNG treatment may not have been 
responsible for the activating mutation which switched on the transgene. The mutation 
may have arisen spontaneously during the development of the mouse. This is not
entirely unexpected as the treatment of MNNG was applied topically and the amount of 
MNNG which reached the brain having first to pass through the skin may have been 
minimal. Furthermore only three such colonies were seen in the brain of the with the 
one pictured being by far the largest. This alone suggests that the mutation rate must 
have been very low. Intraperitoneal injection of MNNG may be a more effective route 
to expose the brain cells to higher concentrations of the chemical mutagen.
Disappointingly no p-galactosidase positive cells were observed in the skin of the same 
transgenic animals which had been treated with MNNG. The likely reason for this is 
expression levels of the transgene may be very low in the skin. The expression of the 
Act-LacZ4 construct is quite low in vitro and this may also be the case for the tgkci- 
LacZ4 mice in vivo. It is quite possible therefore that the transgene underwent the 
appropriate mutation but went undetected because the promoter did not support 
expression of the RNA for the gene.
This p-actin promoter has already been uSed to make transgenic mice and is capable of 
giving widespread expression of a lac Z  reporter gene during embryogenesis 
(Beddington et al., 1990). This expression quickly declines after birth and is very patchy 
and often totally switched off in adult mice (R. Beddington, personal communication). It 
is therefore possible that the mice express sufficiently highly during embryogenesis for 
the cell marking to work. The one experiment carried out on embryonic mice did not, 
however, produce any marked cells. This experiment was not repeated as it was more 
important to acheive cell marking in adult mice for lineage analysis and because there 
was no suitable control available.
There is still good evidence from the generation of colonies in mouse brain that marker 
gene system works in vivo and should be useful for the analysis of cell lineages in the 
tissues of transgenic mice, in vivo.
4.4.2 RNA expression levels from the p-actin and K5 promoters.
Although the constructs generated so far may prove useful both sets of constructs (the 
/gAct-LacZ'4 and the /£K5-LacZD) demonstrate the same potential problem - the level of 
expression from the promoter is not very high. When the level of expression from these 
promoters was analysed in tissue culture, the levels of expression were barely detectable 
by northern blot analysis. The expression level from the BK III (K5) promoter was
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slightly higher in the epidermal cells than the expression from the (3-actin promoter in 
the same cells.
The low expression of the silent marker genes may have been predictable because 
evidence exists to suggest that RNA molecules which are not translated, are quickly 
degraded (Atwater et al., 1990; Peltz and Jacobson, 1992). As the marker gene 
constructs have no ATG sequences they may be unlikely to bind to ribosome and 
certainly should not be translated.
There was very little evidence for this occurring in cells in transfected cells in tissue 
culture. The control and test construct mRNA levels appear to be reasonably similar, 
although the control construct expression levels may be slightly higher. This suggests 
that the silent marker gene RNA is not subject to extremely fast turnover which reduces 
the apparent expression levels. The low level expression observed from the promoters is 
probably therefore intrinsically low. This correlates with the low levels of expression 
detected in the tissues of the /gAct-LacZ'4 transgenic mouse lines. No expression was 
detected in three of these lines with a further two expressing extremely low levels 
(Figure 38). Three of the lines assayed did express detectable amount but these did not 
appear to be very high in comparison to the levels expressed by the cell lines.
The p-actin and K5 promoters used for the generation of the first transgenes used in this 
project may not prove very useful in the long term, for lineage analysis in the mouse. 
The levels of expression obtained from these promoters seem extremely low in 
comparison to the endogenous gene expression levels in the cell lines transfected with 
the Act-LacZ and K5-LacZ constructs. The expression of the K5 constructs in mouse 
skin also seem more or less limited to the hair follicle with only the occasional 
interfollicular cell expressing the p-galactosidase protein. It may therefore be necessary 
to use alternate promoters to express the marker genes at high levels for cell marking in 
different tissues.
4.5 Stem cells and Carcinogenesis.
During the course of this project a number of advances have been made towards the 
understanding of the organisation of the proliferative hierarchy in the skin. These 
studies have concentrated mainly on the organisation of cell proliferation and 
proliferation in the hair follicles.
1 2 8
A study by Cotsarelis et al. (1990) demonstrated that there were label-retaining {i.e. 
slowly cycling) cells located in the bulge area of the murine hair follicle. These authors 
concluded that this area may be the location of the stem cells for the hair follicle. The 
conclusions of this study were reinforced by another recent report (Koyabashi et al., 
1993) in which the cells with the highest in vitro clonogenic potential in rat vibrissae 
were also localised to the bulge area, also a site of label retaining cells (Lavker et al., 
1991). Earlier work on the rat vibrissa had demonstrated that the lower part of the hair 
follicle (the matrix cells of the hair bulb) was not important for whisker growth in 
response to stimulus from the dermal papilla (Oliver, 1966; Oliver, 1967a, b).
More recently two conflicting reports have localised cells with a high proliferative 
potential to the outer root sheath of human hair follicles (Yang et a l ,  1993; Rochat et 
al., 1994). The first of these studies localised the highly clonogenic cells to the upper 
part of the follicle at or around the bulge area. Human hair follicles have a prominent 
bulge area during morphogenesis of the follicle (Holbrook, 1979; Holbrook et al., 1993) 
but this area diminishes soon after birth (Holecek and Ackerman, 1993). The latter of 
the studies localised the cells to an area of the outer root slightly lower than the bulge 
area at the insertion site of the arrector pilli muscle. Despite this conflict both results 
show that highly proliferative cells are located in the outer root sheath of the follicles 
and very few proliferative cells are located in the hair bulb.
The hair follicles have also been widely implicated as the origin of skin tumours in 
carcinogenesis studies. A series of grafting experiments performed by Billingham et al. 
(1951) suggested that only when carcinogen-treated skin grafts included the hair follicle 
would they give rise to tumours. This experiment was subsequently repeated using two 
strains of mice with different histocompatibility genes (Steinmuller, 1971). A thin skin 
graft from one strain was grafted onto carcinogen treated dermis of the other strain. 
Tissue typing of the resultant skin tumours demonstrated they had arisen from the 
recipient strain, implying that the tumours were derived from the follicles. When 
tumours are induced in mouse skin with ionizing radiation few tumours were induced 
when the radiation penetrated less than 0.3 mm, when the penetration of the radiation 
was deeper (0.4 - 1.4 mm in depth) numerous tumours were produced (Albert et al., 
1967a,b,1969). The number of tumours produced was directly proportional to the 
amount of damage inflicted upon the hair follicle.
One interesting anomaly in the hypothesis, that hair follicle cells are involved in the 
generation of a large proportion of skin tumours, has recently been challenged. It has 
previously been shown that dividing cells are most susceptible to tumour initiation
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(Bowden and Boutwell, 1974; Hennings et a l, 1978). However, it has been generally 
accepted that skin tumour initiation is best performed when the animals are in the 
telogen (resting) phase of the hair cycle to maximise the tumour yield (Stenbeck et al., 
1981). In the telogen phase the proposed stem cells in the bulge region are not dividing, 
these cells only come into cycle briefly during the anagen phase of the cell cycle (Lavker 
et al., 1993). However a recent report (Miller et al., 1993) contradicts the hypothesis 
that telogen initiation is more effective than anagen initiation. The authors showed that 
the highest yield of tumours was produced when animals were initiated in early anagen 
(growing) phase by either one or two-stage chemical carcinogenesis treatment protocols.
Also recent results obtained in this laboratory suggest a role for hair follicle cells in the 
generation of malignant skin tumours. The work performed with the K5-LacZ£ positive 
control mouse suggests that this 1.4 kb shortened version of the K5 promoter targets 
expression of the gene specifically to the outer root sheath of the hair follicles in adult 
mice(Figure 39). When the same promoter was used to drive expression of a mutant H- 
ras gene it was capable of producing spontaneous malignant tumours at a high rate 
(Brown et al., in preparation). This did not happen when the H-ras was expressed in the 
suprabasal layers of the interfollicular epidermis under the control of the K10 promoter 
(Ballieul et al., 1990). Although these animals developed papillomas at sites of 
wounding the tumours rarely progressed to malignancy. Taken together these results 
suggest that when the mutant W-ras is expressed in the stem cells, the resultant tumours 
are more likely to progress to malignancy.
The recent data described above demonstrate the importance of hair follicle cells in the 
maintenance of the follicle and as target cells for the generation of carcinogenesis. While 
this population of cells has been implicated in the maintenance of the follicle there is still 
relatively little information on the relationship between the stem cells of the follicle and 
other epidermal structures such as the interfollicular epidermis and the sebaceous gland. 
It is well known that after the destruction of the epidermis by abrasion (Argyris, 1976) 
or severe burning (Lavker et al., 1993) that replacement of the epidermal cells can occur 
from the hair follicles. No label retaining cells have ever been seen in the sebaceous 
glands suggesting that these structures do not contain a unique stem cell population. In 
addition there is evidence that glabrous cell can be recruited to form hair by the dermal 
papilla. This suggests that the differentiation state of the epidermis can be altered.
All these facts suggest the existence of a multipotential stem cell population in the 
epidermis. This is contrast to the usual proposed model of the epidermis which dictates 
that the epidermal stem cell is unipotential (e.g. Sell and Pierce, 1994). The lineage
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analysis system described in this thesis should be ideal for investigating the relationship 
between the different cell types in the epidermis. The extent to which the cells of the 
hair follicle can contribute to the interfollicular epidermis and the sebaceous gland could 
be determined. These structures may be descended from common stem cells or different 
sets of lineage restricted cells. The relationship between these different cell types is one 
of the most fundamental and important questions yet to be addressed in the study of the 
epidermal cell biology. The answers to these questions could have important 
implications both for the biology of the skin and in the development of disease states 
such as cancer.
4.6 The Way Forward.
4.6.1 The immediate prospects.
The p-actin promoter used in the Act-LacZ4 construct has previously been used to 
generate transgenic mice. The expression of the wild-type lac Z  transgene under the 
control of this promoter is widespread during mouse development but that expression 
falls off during post-natal growth. Mice carrying the Act-LacZ'4 transgene should be 
very useful for the study of lineage divergence during murine development.
The immediate priorities with the AAF-strategy oligonucleotide lac Z  fusion gene is to 
test the activation of the gene in the cell lines and in the transgenic mice. Expression of 
the gene in the epidermal cell lines could be tested by exposing these cell lines to the 
chemical N-acetoxy-AAF. Characterised cell lines are already available for this work.
Alternatively the construct K5-LacZD could be electroporated into liver cell lines. Oval 
cells, the proposed liver stem cells, can now be grown in culture and would represent an 
ideal system to test this construct (Brill et al., 1993). Unlike epidermal cells, liver cells 
are able to activate the AAF chemical and -AAF adducts will be produced on the DNA 
of these cells. These -AAF adducts have already been shown to cause a two base pair 
deletion in a series of GC base pairs, the sequence of the oligonucleotide in the K5- 
LacZD marker gene and should therefore activate translation of the p-galactosidase 
protein. Stably transfected cell lines could be used for testing of the AAF-strategy
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fusion gene in the same way that the C50 epidermal cell ringclones allowed the testing 
of the MNNG-strategy fusion marker gene.
There is considerable interest in the organisation and location of potential stem cells in 
the liver (discussed in Section 1.5). This construct would be extremely useful for lineage 
analysis in this tissue. This would require transgenic mice to be generated with the 
LacZD oligonucleotide//ac Z fusion gene under the control of a promoter which is highly 
expressed in liver cells. These mice could then be exposed to the AAF chemical in vivo 
both during development of the liver in embryos and maintenance of the liver in adult 
mice.
Transgenic mice at different ages and stages of development would be exposed to AAF 
at varying concentrations and left for times varying from a few days to a few months. 
Frozen sections of the liver could then be stained with the chromogenic p-galactosidase 
substrate X-gal. The clones of lac Z  cell could be identified and a picture of lineage of 
cells in the liver could be built up piece by piece through the analysis of clones from a 
large number of individuals. The response of liver stem cells to injury of the tissue could 
also be assessed.
It will be possible to assess the capacity of the developmental stem cells to contribute to 
the formation of different tissues and the of different cell types. The developmental stem 
cell may work in a different fashion to the stem cell in renewing tissues. In order to study 
the stem cells of renewing tissues it will be necessary to place the marker genes under 
the control of a promoter which can sustain high expression of a transgene in adult 
animals. It would be useful if such a promoter induced a high level of expression in the 
epidermis and other tissues of the mouse to enable the spectrum of lineage analyses to be 
broadened.
4.6.2 Cell lineage analysis and mutagenicity testing.
The control lac Z  fusion genes should be placed under the control of a wide variety of 
promoters which may induce widespread expression of the transgenes in the tissues of 
the transgenic mouse. A keratin fusion gene promoter which includes elements of both 
the K5 and K6 gene is available and could be used to increase the expression of the 
marker genes in the epidermis of transgenic mice. Other possible promoters would 
include the H-ras gene promoter which has already been characterised in the laboratory
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and shown to be widely expressed in a number of different tissues. Promoters of 
housekeeping enzymes such as 3-phosphoglycerate kinase (Pgk-1), may also be used to 
promote expression of the marker gene. Recently a promoter trapping experiment in 
embryonic stem (ES) cells (described in Section 1.2) has identified a gene which is 
widely expressed throughout adult mouse tissues. The promoter of this gene could be 
cloned in order to generate high expression of the marker genes in the tissues of 
transgenic mice.
Furthermore the mice generated in the course of this promoter trapping experiment may 
be used in a complementary approach to lineage analysis, along with the transgenic 
marker gene system developed in this laboratory. If the expression of the lac Z  gene is 
truly ubiquitous mutagenesis of the lac Z  gene would mark cells. A mutation occurring 
in the sequence of the gene would prevent expression in single cells and clones of cells 
derived from the original marked cells. These could be detected amongst the 
background of cell in the tissue should also express the gene (see Section 3.1). This 
does depend critically on expression of the gene being maintained at a constant level 
throughout the population. The promoter is maintained in its normal location, 
expression of the transgene may be maintained more efficiently than expression of a 
transgene under the control of a promoter located at a random position throughout the 
genome.
If the marker genes are expressed at high levels in the tissues of transgenic mouse the 
analysis of cell lineage both during development and the maintenance of tissues in adult 
mice will be able to progress. The mutation frequency of the transgene will be 
established. Obviously this will be restricted in a similar fashion to the work with the 
cell lines. Both the number of expressed marker gene constructs and the percentage of 
cell in the population that express the marker transgene will have to be determined to 
allow calculation of the mutation frequency. This work can be performed on mice 
containing the test oligos for both the MNNG and AAF oligo//<2c Z fusion gene 
strategies. The mice containing these fusion genes will be treated with different 
concentrations of the appropriate chemical mutagen and will then be left for times 
varying from a few days to months. The number of resultant clones can then be 
determined by staining the tissues with the lac Z  stain, X-gal. Approximate reactivation 
frequencies could be calculated by comparison of the clone numbers to the number of 
cells in a tissue which have be analysed for the presence of the stain.
It would be of interest to breed these marker gene mice with mice in which the p53  gene 
has been inactivated by homologous recombination. These mice have already been used
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in the laboratory in studies of tumour formation. These studies demonstrated that p53 
was involved in the benign to malignant conversion in chemically induced tumours of 
mouse skin (Kemp et a l,  1993). There is a possibility that thep53  gene influences the 
development of tumours by increasing the rate at which the cells which do not express 
this protein acquire novel mutations. Whether this phenomenon occurs by increasing the 
rate at which the cell will acquire point mutations or whether only the rate of gross gene 
rearrangements is open to question. As the marker gene constructs developed during 
the course of this project should allow the estimation of mutation frequencies, the 
breeding of the marker gene transgenic mice with the p53  knockout mice should allow 
the influence of the p53  gene of the rate of point mutation induced by chemical 
mutagens to be established. In fact breeding of the p53  knockout mice with the Act- 
LacZA transgenic mouse has already started.
The mutant gene constructs could also be used form the basis of a mutagenicity-testing 
system in vivo. As it requires a specific mutation to activate the gene, if activation of the 
gene is observed in the tissues of a mouse the predicted specific mutation must have 
occurred. Substances could therefore be tested to see if they are capable of inducing 
different types of mutation in the tissues of transgenic mice. A similar system already 
exists and utilises transgenic mice carrying the lac I  gene in phage X sequences (Provost 
et al., 1993; Shephard et al., 1993). After exposing the mice to the substance to be 
tested, the phage X sequences must then be extracted from the tissue of interest and 
transformed into E. coli. Any mutations in the lac I  gene resulting from this must then 
be sequenced.
There would be two significant advantages of using the oligonucleotide fusion gene 
constructs described in this thesis. Firstly as the marker genes are activated by a defined 
specific mutation, the mutation caused by the substance tested is determined without 
sequencing the gene. Secondly the pattern of mutations caused by the substance can be 
identified as the assay for mutant cells involves examining intact tissues for [3- 
galactosidase activity. The tissue can be sectioned and stained with X-gal or stained as a 
wholemount. The lac I  system requires the tissue to be disintegrated before analysis of 
the results and any significant pattern of mutagenesis is therefore lost. The creation of 
this system would require the design of a few new oligonucleotide/L#c Z fusion genes to 
cover the range of potential mutations which could occur.
There would be a couple of minor drawbacks of using this system. The system would 
require the expression of the gene in vivo. It would therefore require the use of reliable 
promoters in transgenic mice which allowed expression in the tissue of interest at a high
1 3 4
level. This may require the creation of several lines of transgenic mice with the marker 
genes under the control of different promoters. The lac I  gene in the system described 
above is silent and expression of the gene in transgenic mice is irrelevant. It is debatable 
whether or not the frequency of mutation would be easily calculable in the tissues of 
transgenic mice in vivo. This would require the estimation of the number of mutant cell 
arising within the population of cells tested. The estimation of mutation frequency in 
this way may be laborious and inaccurate. Despite these reservations the development 
of this system is probably still a worthwhile project as it reduces the work involved in 
isolating phage X constructs and sequencing large parts of the lac I  gene.
4.6.3 The overall goals of the project.
A number of other potential uses of these mice in the longer term exist. Once the 
normal patterns of cell renewal in the epidermis have been established it will be possible 
by the use of the techniques described above to look to see how these patterns are 
disturbed by the expression of an oncogene or growth factor in the same tissues. One 
possibility would be to breed these mice with mice expressing the H-ras oncogene under 
the control of the short 1.4 kb K5 promoter. These mice show an interesting pattern of 
abnormalities in the epidermis and hair follicles and develop epidermal tumours 
spontaneously as adults. The alteration of the pattern of stem cell division could be 
assessed in such doubly transgenic animals (containing a marker gene and H-ras 
oncogene). This could be done by treating the mice with chemical mutagens to activate 
the marker gene and look at the how the clones produced are altered when compared to 
animals containing the marker gene construct alone and which are essentially normal.
This type of analysis could performed not only with the H-ras oncogene but also with 
transgenic mice containing other oncogenes or growth factor. One of the most 
interesting aspects of this analysis would be that it allows the effect of oncogenes and 
growth factors on the behaviour of single cells as opposed to the gross effects on the 
whole tissue. These cells are obviously not excluded from the influence of the 
surrounding cells in the tissues but still the analysis of the behaviour of single cells may 
be expected to reveal some interesting aspects of the influence of an oncogene or 
growth factor on a particular tissue.
The construction of better transgenic models for oncogenesis could be another long­
term aim of this project. One of the drawbacks of all present' transgenic models of
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tumour development is that the mutant oncogene or growth factor is switched on in 
many or all cells of the tissue at the same time, even when under the control of a highly 
tissue-specific promoter. The system developed for the activation of marker genes could 
be used instead to activate an oncogene such as H-ras. This could be achieved by 
substituting an oligonucleotide in place of the first few amino acids of the oncogene 
protein. The oligonucleotide could then be used to activate translation of the gene in the 
same fashion as it has been used to activate the lac Z  marker gene for the purposes of 
this project (described in Section 3.1). The oncogene will not be expressed until a 
mutation in the sequence of the oligonucleotide occurs either spontaneously or by 
application of a chemical mutagen. The AAF-mutation strategy oligonucleotide could 
be used to specifically activate oncogene introduced into the skin. A mutant ras 
oncogene cloned behind the AAF-strategy oligonucleotide D would not be expressed as 
the ATG in the oligonucleotide would be out of frame with the coding sequence of the 
ras gene. It could then be specifically activated by treatment with AAF which will not 
activate the endogenous H-ras gene. This should activate the oncogene in individual 
cells which may help create a more accurate model of the true situation of oncogenesis 
in vivo where oncogenes are activated in discrete individual cells.
Another potentially intriguing use of this system would be to combine the cell marking 
aspect of the project with other genes which would influence the behaviour of the 
marked cells. This type of analysis has been used to great effect in Drosophila to 
establish some of the most fundamental rules about the development of this organism. 
Cell markers genes were combined with mutations at the Minute locus which influence 
the rate of growth of individual cells to establish the existence of developmental 
compartments cells in both the ectoderm and mesoderm of the fly. The combination of 
the marker gene approach with the activation of other genes which affect cell behaviour 
in the same single cell at the same time could be of enormous benefit to the study of 
developmental biology in the mouse.
The approaches which have been described in this thesis are mainly aimed towards the 
development of cell lineage analysis in the skin. Although this approach has been 
developed for use in the skin there are a wide variety of murine tissues which have been 
proposed to contain stem cells. The study and understanding of the function of stem 
cells in these tissues would benefit by the application of cell marking to these tissue. 
One of the most important aspects of the system developed for the purposes of this 
project is that it can be applied to any tissue in the mouse. This may require the use of a 
specific promoter to target expression of the genes to these tissues. The central nervous 
system and the liver are two tissues to which the application of this cell marking
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technique may be extremely effective. Brain cells express a low level of methyl 
transferase activity and may be extremely susceptible to mutagenesis with MNNG 
(Walter et al., 1993; Buecheler and Kleihues, 1977; Craddock and Henderson, 1984). 
The liver on the other hand is extremely susceptible to mutagenesis with AAF and this 
strategy may prove extremely effective for liver cell marking (Tiwawech et al., 1991; 
Poirier et al., 1991; Glauert et al., 1991). It will probably be necessary to collaborate 
with other labs with experience in working with other tissues to obtain the full benefit of 
the application of this technique to other tissues.
This thesis describes the design and development of a marker system for the analysis of 
cell lineage. The system has now been tested and shown to work in vitro in cell lines 
and in vivo in the tissues of transgenic mice. The marker system will now be applied to 
the analysis of skin cell lineage in the tissues of developing and adult transgenic mice 
which cany the marker genes described. In the future it is hoped to apply the same 
marker system to analysis of cell lineage in other tissues such as intestine, liver, and 
central nervous system. It is hoped that this system may also be applied to the activation 
of other genes leading to the creation of good transgenic models of oncogenesis and the 
study of the effect of the activation of genes in individual cells. The combination of 
these approaches may provide a good insight into the role of stem cells in the 
development and maintenance of tissues in the mouse.
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